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Abstract 
Nakadomarin A was first isolated from the sponge Amphimedon sp. by Kobayashi 
and co-workers in 1997. The structure showed a unique hexacyclic skeleton 
consisting of 5-, 6-, 8- and 13-membered rings. This natural 
product shows cytotoxicity, antimicrobial and inhibitory activities. 
The challenging structure, as well as the promising biological 
activity and limited availability make nakadomarin A an attractive 
target for total synthesis. The aim of the project was to design a 
synthesis of a common late-stage intermediate that could be used to prepare not 
only nakadomarin A, but also other members of the manzamine natural product 
family.  
 
The concise preparation of the common intermediate ABCD tetracyclic core was 
achieved in only 7 steps (longest linear sequence). The key features of the 
synthetic route are asymmetric construction of the AB ring using an asymmetric 
Pauson-Khand reaction; installation of the azocine D ring through metathesis 
reactions (CM, RCM) and Overman rearrangement; and introduction of the C ring 
by N-alkylation. Finally, several side chains were prepared and evaluated to find 
the optimum method for installation of the furan. This resulted in two advanced 
intermediates which could be malipulated to form nakadomarin A in only 3 steps. 
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1 Introduction  
 
1.1 The Manzamine Family of Natural Products 
 
Manzamine A (3) was first isolated in 1986 by Higa and co-workers from the 
marine sponge Haliclona sp.1 To date, more than 70 natural products which are 
structurally related to manzamine A (3) have been isolated from various marine 
organisms, 2 , 3  including  Pachypellina, Xestospongia, Ircinia and Amphimedon 
species, and their unprecedented molecular architectures have been elucidated 
by extensive spectroscopic studies.4 The manzamine family of alkaloids features 
a wide variety of structures, from simple macrocyclic 3-alkylpyridinium salts, 
such as cyclostellettamine A (5), to highly functionalised complex structures, 
such as manzamine A (3), which possesses a diazapentacyclic core containing an 
array of 5-, 6-, 8- and 13-membered rings and possessing 5 stereogenic centres 
(Figure 1).5 
  
 
Figure 1 Representative members of the manzamine family of alkaloids 
 
 
 
 
                                                                                                                         
1 Sakai, R.; Higa, T.; Jefford, C. W.; Bernardinelli, G. J. Am. Chem. Soc. 1986, 108, 6404−6405 
2 Tsuda, M.; Kobayashi, J. Heterocycles 1997, 46, 765−794 
3 Watanabe, D.; Tsuda, M.; Kobayashi, J. J. Nat. Prod. 1998, 61, 689−692 
4 Magnier, E.; Langlois, Y. Tetrahedron 1998, 54, 6201−6258 
5 Duval, R.; Poupon, E. Biomimetic Organic Synthesis Wiley-VCH, 2011 
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Members of the manzamine family of alkaloids possess a broad range of 
bioactivities, including cytotoxicity, antimicrobial activity,6 antibacterial activity 
7 and antimalarial activity.8 Manzamine A (3) was found to have in vitro activity 
against cancer cells, including P388 mouse leukaemia cells (IC50 = 0.07 µg/mL), 
human colon tumour cells, lung carcinoma cells and breast cancer cells (IC50 = 
0.5 µg/mL). Consequently, the manzamine alkaloids also represent important 
lead structures for the development of novel anti-infective drugs.9 
 
The unique molecular structures, including a complex array of rings, as well as 
their significant biological activities of manzamine A (3) and related alkaloids 
have held the attention of synthetic and medicinal chemists for the past three 
decades. 
 
 
1.2 Nakadomarin A 
 
1.2.1 Isolation and Biological Activity 
 
 
Figure 2 
 
Nakadomarin A (1) was first isolated from the sponge Amphimedon sp. by 
Kobayashi and co-workers in 1997 (Figure 2). 10  This natural product exhibits 
cytotoxicity against murine lymphoma L1210 cells (IC50 = 1.3 µg/mL), 
antimicrobial activity, and inhibitory activity against cyclin-dependent kinase 4. 
The structure of nakadomarin A was elucidated by exhaustive spectroscopic 
                                                                                                                         
6  Edrada, R. A.; Proksch, P.; Wray, V.; Witte, L.; Muller, W. E. G.; Soest, R. W. M. V. J. Nat. Prod. 
1996, 59,1056−1060 
7  Nakamura, H.; Deng, S.; Kobayashi, J.; Ohizumi, Y.; Tomotake, Y.; Matsuzaki, T.; Hirata, Y. 
Tetrahedron Lett.1987, 28, 621−624 
8  Ang, K. K. H.; Homnes, M. J.; Higa, T.; Hamann, M. T.; Kara, U. A. K. Antimicrob. Agents 
Chemother. 2000, 44, 1645−1649 
9  Winkler, J. D.; Londregan, A. T.; Hamann, M. T. Org. Lett. 2006, 8, 2591−2594 
10 Kobayashi, J.; Watanabe, D.; Kawasaki, N.; Tsuda, M.; J. Org. Chem. 1997, 62, 9236−9239 
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studies and was found to possess a unique hexacyclic skeleton consisting of fused 
5-, 6-, 8- and 13-membered rings. More specifically, nakadomarin A (1) is the 
only member of the mazamine family that includes a furan ring. It also contains 
four stereogenic centres, two Z-alkenes and two tertiary amines. The 
challenging structure, as well as the promising biological activity and limited 
availability make nakadomarin A (1) a highly attractive target for total synthesis, 
a fact that is reflected by the number of synthetic studies that have been 
devoted to its synthesis (see section 1.3). 
 
 
1.2.2 Biosynthesis 
 
The development of an understanding of biosynthetic pathways is of great 
importance for total synthesis and numerous synthetic strategies have been 
inspired by nature.11,12 Despite the fact that manzamine A (3) was isolated nearly 
30 years ago, the complete biosynthetic route for the creation of these 
molecules still remains unclear. However, synthetic chemists have presented 
several credible hypotheses for the potential biosynthetic pathway towards 
manzamine A (3).  
 
In 1992, Baldwin reported a biosynthetic proposal for manzamine alkaloid, which 
suggested manzamine A could be derived in vivo from four simple building blocks: 
2 units of ammonia, 2 units of the symmetrical dialdehyde 7, 2 units of acrolein 
and 1 unit of tryptophan (Scheme 1).13  
 
                                                                                                                         
11 Breslow, R.; Dong, S. D. Chem. Rev. 1998, 98, 1997−2011 
12 Yoder. Y. A.; Johnston, J. N. Chem. Rev. 2005, 105, 4730−4756 
13 Baldwin, J. E.; Whitehead, R. C. Tetrahedron Lett. 1992, 33, 2059−2062 
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Scheme 1 
 
As shown in Scheme 1, a reductive coupling reaction between ammonia, acrolein 
and dialdehyde 7 would lead to the formation of 3-alkylpyridinium intermediate 
8, which could undergo a transannular Diels-Alder reaction to afford polycyclic 
compound 9. The iminium 9 could be converted into iminium ion 10 either by a 
redox process or by reduction to form the pentacyclic alkaloid karamaphidin B 
(6), followed by an oxidation reaction. Hydrolysis of iminium ion 10 and further 
oxidation would provide pentacyclic natural product iricinal A (2). Finally, 
condensation between iricinal A (2) and tryptophan would generate manzamine 
A (3).  
 
The viability of this biogenetic pathway was confirmed by the biomimetic total 
synthesis of keramaphidin B (6) published by Baldwin and co-workers in 1999 
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(Scheme 2). 14  Keramaphidin B (6) is a pentacyclic alkaloid belonging to the 
manzamine family that was isolated by Kobayashi in 1994.15 The key macrocylic 
diamine 12 was prepared in 8 steps from 3-n-propylpyridine with an overall yield 
of 37%. Oxidation of diamine 12 with mCPBA and subsequent treatment with 
TFAA afforded bis-iminium dication 13 in high yield. Extensive work was then 
carried out for the key transannular Diels-Alder reaction. After screening various 
solvents, temperatures and reducing reagents, the total synthesis of 
keramaphidin B (6) was accomplished by treating the dication 13 with buffered 
methanol (pH = 7.3) to generate the pyridium intermediate 8 required for the 
Diels-Alder reaction and subsequent reduction of the resulting iminium 9 with 
NaBH4. 
 
 
Scheme 2 
 
Although this biomimetic synthesis verified Baldwin’s hypothesis, the Diels-Alder 
reaction and reduction sequence only produced a trace amount (0.2-0.3% yield) 
of the desired keramaphidin B (6) and the diamine 12 was recovered almost 
quantitatively. To account for this, Baldwin and co-workers proposed the 
existence of a “Diels-Alderase” directing enzyme capable of preorganising the 
substrate into a favourable conformation for the pericyclic reaction.  
 
                                                                                                                         
14  Baldwin, J. E.; Claridge, T. D. W.; Culshaw, A. J.; Heupel, F. A.; Lee, V.; Spring, D. R.; 
Whitehead, R. C. Chem. Eur. J. 1999, 5, 3154−3161 
15 Kondo, K.; Shigemori, H.; Kikuchi, Y.; Ishibashi, M.; Sasaki, T.; Kobayashi, J. J. Org. Chem. 
1992, 57, 2480−2483 
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Based on Baldwin’s hypothesis, Kobayashi proposed a biosynthetic pathway for 
(−)-nakadomarin A (1) from ircinal A (2, Scheme 3).16 Ircinal A (2) could undergo 
a retro-Mannich reaction to generate the iminium ion 14. σ-Bond rotation 
followed by a vinylogous Mannich reaction would afford the pentacyclic 
intermediate 16. Final dehydrative furan formation would then generate 
(−)-nakadomarin A (1). 
 
 
Scheme 3 
 
 
1.3 Total Syntheses of Nakadomarin A 
 
Due to its challenging molecular structure and promising biological activity, 
nakadomarin A has been a natural product target of great interest for the 
synthetic organic chemists over the past decade. The total syntheses of (−)-
nakadomarin A (1) and/or its enantiomer (+)-nakadomarin A (ent-1) have been 
published by seven groups: those of Nishida, 17 , 18  Kerr, 19  Dixon, 20 , 21 , 22  Mukai, 23 
Funk,24 Zhai25 and most recently Evans.26  
                                                                                                                         
16 Kobayashi, J.; Tsuda, M.; Ishibashi, M. Pure. Appl. Chem. 1999, 71, 1123−1126 
17 Nagata, T.; Nakagawa, M.; Nishida, A. J. Am. Chem. Soc. 2003, 125, 7484−7485 
18 Ono, K.; Nakagawa, M.; Nishida, A. Angew. Chem. Int. Ed. 2004, 43, 2020−2023 
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1.3.1 The Nishida’s Strategy 
 
1.3.1.1 The Total Synthesis of (+)-Nakadomarin A 
 
Nishida and co-workers published the first total synthesis of (+)-nakadomarin A 
(ent-1) in 2003 (Scheme 4).17 Their synthesis started with transformation of the 
relatively complex chiral acid 17 into the aldehyde 18 in three steps. Wittig 
olefination of aldehyde 18 and subsequent intramolecular Michael addition 
afforded the spirolactam 19 as an inseparable mixture of diastereoisomers (3.3:1) 
contaminated with triphenylphosphine oxide. Hydrolysis of ester 19 to its acid 
counterpart allowed the removal of non-polar impurities. Re-esterfication and 
reduction to the alcohol allowed the separation of diastereoisomers and 
delivered the enantiopure alcohol 20. Acetal group cleavage followed by 
protection of the alcohol and enol triflate formation furnished the lactam 21. 
Subsequently, the triflate 21 was coupled with furan-3-boronic ester 22 by 
Suzuki-Miyaura coupling, to deliver the tricyclic ester 23 in high yield. The 
subsequent 10-step synthetic sequence involving stereoselective hydrogenation 
and further functional group manipulation afforded hemiaminal 24. Treatment 
of 24 with pTsOH led to the generation of an iminium ion which then underwent 
a stereoselective Pictet-Spengler reaction. The removal of the tetrahydropyranyl 
(THP) group afforded tetracyclic alcohol 25 in 87% yield. 
                                                                                                                           
19 Young, I. S.; Kerr, M. A. J. Am. Chem. Soc. 2007, 129, 1465−1469 
20 Jakubec, P.; Cockfield, D. M.; Dixon, D. J. J. Am. Chem. Soc. 2009, 131, 16632−16633 
21 Kyle, A. F.; Jakubec, P.; Cockfield, D. M.; Cleator, E.; Skidmore, J.; Dixon, D. J. Chem. Commun. 
2011, 47, 10037−10039 
22 Jakubec, P.; Kyle, A. F.; Calleja, J.; Dixon, D. J. Tetrahedron Lett. 2011, 52, 6094−6097 
23 Inagaki, F.; Kinebuchi, M.; Miyakoshi, N.; Mukai, C. Org. Lett. 2010, 12, 1800−1803 
24 Nilson, M. G.; Funk, R. L. Org. Lett. 2010, 12, 4912−4915 
25 Cheng, B.; Wu, F. F.; Yang, X. B.; Zhou, Y. D.; Wan, X. L.; Zhai, H. B. Chem. Eur. J. 2011, 17, 
12569−12572 
26 Bonazzi, S.; Cheng, B.; Wzorek, J.; Evans, D. A. J. Am. Chem. Soc. 2013, 135, 9338−9341 
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Scheme 4 
 
Selenation of primary alcohol 25 followed by sequential oxidation, selenoxide 
elimination, Boc deprotection and N-alkylation formed diene 26 (Scheme 5). 
Treatment of this diene with the second-generation Grubbs catalyst to 
accomplish ring closing metathesis (RCM) followed by the hydrolysis of acetate 
gave the azocine 27 in good yield. The synthesis continued with conversion of 
the alcohol 27 into the bisamide 28 in 4 steps. The diene 28 then underwent 
another RCM reaction upon treatment with the first-generation Grubbs catalyst, 
to afford a separable mixture of E and Z isomers; the desired Z isomer 29 was 
the minor isomer and was isolated in 26% yield. Finally, reduction of the 
bislactam 29 with Red-Al, provided the target molecule in a total of 38 steps.  
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Scheme 5 
 
Although the 1H NMR data of the synthetic nakadomarin A matched with data 
reported by Kobayashi for the natural product, the opposite specific rotation 
suggested that (+)-nakadomarin A (ent-1) had been obtained. This result allowed 
assignment of the absolute configuration of natural (−)-nakadomarin A (1). 
 
 
1.3.1.2 The Total Synthesis of (−)-Nakadomarin A 
 
One year after the synthesis of (+)-nakadomarin A (ent-1), the Nishida group 
published the first total synthesis of (−)-nakadomarin A (1) in which a different 
route to the ABCD core was used (Scheme 6).18 
 
The synthesis started from chiral amide 31 which was prepared from L-serine in 
10 steps. Dienophile 31 underwent a Diels-Alder reaction with Danishefsky’s 
diene 3227 to give enone 33. Enone reduction under the Luche conditions28 
followed by actonide cleavage and SN’ cyclisation reaction afforded the fused 
tricyclic alcohol 34. Subsequent selective protecting group removal provided 
alkene 35. Double bond cleavage by ozonolysis and subsequent aldol 
                                                                                                                         
18 Ono, K.; Nakagawa, M.; Nishida, A. Angew. Chem. Int. Ed. 2004, 43, 2020−2023 
27 Danishefsky, S.; Kitahara, T. J. Am. Chem. Soc. 1974, 96, 7807−7808 
28 Gemal, A. L.; Luche, J. L. J. Am. Chem. Soc. 1981, 103, 5454–5459 
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condensation delivered the desired aldehyde 36, which then underwent a Wittig 
olefination to deliver the conjugated diene 37. Oxidation of the diene 37 with 
singlet oxygen generated the peroxide 38 and furan formation was accomplished 
by base catalysed rearrangement. Removal of the TBDPS protecting group on 
workup then gave the primary alcohol 39. 
 
 
Scheme 6 
 
Alcohol 39 was converted into the alkyne 40 in 7 steps and 48% yield. Reductive 
removal of the N-Bs group by treatment with sodium naphthalenide followed by 
acylation delivered diene 41. Protection of the terminal alkyne with dicobalt 
octacarbonyl and subsequent RCM provided the pentacyclic lactam 42. One-pot 
decomplexation and reduction afforded diene 43 and this was converted into 
(−)-nakadomarin A (1) in four steps using the strategy previously developed for 
the synthesis of (+)-nakadomarin A (ent-1). 
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Scheme 7 
 
 
1.3.2 Kerr’s Approach  
 
The second total synthesis of (+)-nakadomarin A (ent-1) was reported by Kerr in 
2007.19 The key feature of this synthesis was the use of a three-component 
coupling reaction developed by Kerr and co-workers in 2005.27   
 
The synthetic sequence commenced with the three-component reaction of 
aldehyde 44, cyclopropane 45 and hydroxylamine 46 to give a highly 
functionalised tetrahydro-1,2-oxazine 47 (Scheme 8). Selective diisobutyl-
aluminium hydride (DIBAL) reduction of the equatorial ester group in bicyclic 
intermediate 47, followed by Horner-Wadsworth-Emmons (HWE) olefination and 
intramolecular Heck coupling provided tricyclic intermediate 49. Removal of the 
PMB protecting group and N-acylation afforded the amide 50. Cleavage of the 
N—O bond with SmI2, followed by mesylate formation and subsequent SN2 
displacement with the amide delivered the desired pyrrolidine 51. 
Stereoselective conjugate reduction of the α,β-unsaturated ester with nickel 
                                                                                                                         
19 Young, I. S.; Kerr, M. A. J. Am. Chem. Soc. 2007, 129, 1465−1469 
27 Young, I. S.; Williams, J. L.; Kerr, M. A. Org. Lett. 2005, 7, 953−955. 
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boride was carried out to give diester 52. Thus, all the stereocentres required 
for (+)-nakadomarin A (ent-1) were installed correctly. Double ester reduction 
and mesylation generated a dimesylate that underwent a tandem SN2 
displacement with an amine to form a piperidine and deliver the tetracyclic 
amine 53.  
 
 
Scheme 8 
 
The tetracyclic system 53 was readily converted to azocine 55 by sequential 
benzyl protecting group removal, oxidation, Wittig olefination and RCM. An 
analogous 4-step sequence was used to convert the bis-TBDPS-ether 55 into 
macrocycle 57, the key RCM reaction delivering the macrocycle in moderate 
yield and as an inseparable mixture of E and Z isomers (E:Z = 5:3). The last step 
was the reduction of bis-lactam to afford (+)-nakadomarin A (ent-1).  
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Scheme 9 
 
In conclusion, the Kerr group completed the total synthesis of (+)-nakadomarin A 
(ent-1) in 28 linear steps. Unfortunately, the E and Z isomers could not be 
separated at any stage and the final natural product was contaminated by its E 
isomer. 
 
 
1.3.3 Dixon’s Syntheses 
 
In 2009, Dixon and co-workers published a convergent total synthesis of 
(−)-nakadomarin A (1).20 The key features of this strategy were a 
diastereoselective Michael addition reaction and a three-component nitro-
Mannich/lactamisation cascade developed within the group.  
 
Dixon’s sequence commenced with the synthesis of the CD ring fragment of (−)-
nakadomarin A (1, Scheme 10). Nucleophilic substitution of the tosylate of 
pyroglutamol 58 by sodium thiolate 59 gave sulfide 60, which underwent 
                                                                                                                         
20 Jakubec, P.; Cockfield, D. M.; Dixon, D. J. J. Am. Chem. Soc. 2009, 131, 16632−16633 
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sequential N-alkylation, deprotection and oxidation to provide aldehyde 62. 
Intramolecular Julia-Kocienski olefination28,29 then took place to generate azocine 
63. Claisen condensation of amide 63 with dimethylcarbonate finished the 
synthesis of the CD fragment 64. 
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Scheme 10 
 
The synthesis of the furan fragment started with allylation of ketophosphonate 
65 followed by a Horner-Wadsworth-Emmons olefination reaction using diacetyl 
dihydroxyacetone to give enone 66 (Scheme 11). Subsequent acid catalysed 
deprotection and dehydrative cyclisation provided furan 67.  Subsequent Swern 
oxidation followed by Henry condensation with nitromethane afforded the nitro 
olefin 69 in 4 steps and 21% overall yield.  
 
 
Scheme 11 
 
                                                                                                                         
28 Julia, M.; Paris, J. M. Tetrahedron Lett. 1973, 14, 4833−4836 
29 Kocienski, P. J.; Lythgoe, B.; Ruston, S. J. Chem. Soc., Perkin Trans. 1 1978, 829−834 
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Completion of both key fragments allowed the Michael addition reaction 
between CD ring system 64 and nitro olefin 69 to be investigated (Scheme 12). 
Unfortunately, an inseparable mixture of diastereoisomers (60:40, dr) was 
obtained. A chiral catalyst was then sought to increase the selectivity. By using 
the bifunctional cinchona catalyst 70, the diastereomeric ratio was increased to 
91:9 in favour of the desired isomer. Subjecting the resulting coupled product 71 
to a stereoselective nitro-Mannich/lactamisation cascade sequence provided 
lactam 72 in good yield. Reduction of the nitro group by a modified Ono 
procedure30 followed by selective reduction of the δ-lactam to the corresponding 
amine while the γ-lactam remained untouched, afforded amide 74. Subsequent 
partial reduction generated an aminol intermediate, which underwent acid 
catalysed iminium formation and cyclisation to provide pentacyclic diamine 75. 
A Z-selective olefin metathesis was achieved by using the first-generation 
Grubbs catalyst in the presence of an excess of camphor sulfonic acid (CSA) 
giving the final target (−)-nakadomarin A (1) in good yield (63:37 Z/E ratio; 
isomers were separable by semi-preparative HPLC).  
 
Scheme 12 
                                                                                                                         
30 Ono, N.; Miyake, H.; Tamura, R.; Kaji, A. Tetrahedron Lett. 1981, 22, 1705−1708 
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In conclusion, Dixon and co-workers synthesised (−)-nakadomarin A (1) in 12 
steps (longest linear sequence). Moderate Z selectivity in the final RCM reaction 
was achieved by using (+)-CSA as an additive.  
 
In 2011, the Dixon group reported a modified synthesis of (−)-nakadomarin A 
(1).22 In this paper, sequential alkyne ring closing metathesis and Lindlar 
reduction was employed to install the Z olefin moiety of the macrocycle in a 
highly stereoselective manner. The dialkyne 78 was prepared using a similar 
coupling strategy to that used originally (Scheme 13). Unfortunately, after 
extensive screening of various reaction conditions, it was found that the 
pentacyclic diyne 78 was unreactive towards alkyne RCM.  
 
 
Scheme 13 
 
This problem was solved by performing the alkyne RCM at an earlier stage in the 
synthesis. Thus, the intermediate 80 was converted into the desired alkyne RCM 
product 81 in moderate yield (Scheme 14). Subsequent Lindlar hydrogenation 
afforded Z alkene 82. The synthesis was completed in a similar manner to their 
                                                                                                                         
22 Jakubec, P.; Kyle, A. F.; Calleja, J.; Dixon, D. J. Tetrahedron Lett. 2011, 52, 6094−6097 
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first strategy led to the total synthesis of (−)-nakadomarin A (1) in 13 steps 
(longest linear sequence).        
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Scheme 14 
 
 
1.3.4 Funk’s Total Synthesis  
 
Funk and co-workers published their total synthesis of (−)-nakadomarin A (1) in 
2010.24 Their strategy was based on a retrosynthetic analysis that led to the 
furan 90 and the pyrrole 95 as early-stage intermediates. The key reaction in 
this route was a stereoselective Lewis acid catalysed iminium 
formation/conjugate addition cascade reaction previously developed within the 
group.31  
 
The furan fragment was prepared following Maldonado’s procedure (Scheme 
15).32 Condensation of ester 85 and dimethyl methylphosphonate 86 provided 
ketone 87, which underwent Horner-Wadsworth-Emmons olefination with 
diacetoxyacetone to afford the enone 88. Acid-catalysed deprotection and 
                                                                                                                         
24 Nilson, M. G.; Funk, R. L. Org. Lett. 2010, 12, 4912−4915 
31 Nilson, M. G.; Funk, R. L. Org Lett. 2006, 8, 3833−3836 
32 DiazCortes, R.; Silva, A. L.; Maldonado, L. A. Tetrahedron Lett. 1997, 38, 2207−2210 
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cyclisation of 88 gave furan 89, which was then converted into the aldehyde 90 
under standard Swern oxidation conditions. 
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The synthesis of the dihydropyrrole fragment 95 started from the pyrrolidinone 
91 (Scheme 16). Pyrrolidinone 91 was first protected to give the amide 92 which 
was reduced to the corresponding hemiaminal and further dehydrated by 
trifluoroacetic anhydride (TFAA) to yield the dihydropyrrole 93. 33  Vilsmeier-
Haack formylation of the enamine provided the aldehyde 94. Subsequent 
reductive amination and N-acylation with methyl malonyl chloride afforded the 
desired pyrrole fragment 95 in 8 steps.  
 
 
Scheme 16 
 
                                                                                                                         
33 Yu, J. R.; Truc, V.; Riebel, P.; Hierl, E.; Mudryk, B. Tetrahedron Lett. 2005, 46, 4011−4013 
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Knoevenagel condensation of the aldehyde 90 with the 1,3-dicarbonyl compound 
95 provided cyclisation precursor 96 in good yield (Scheme 17). The next step in 
the synthesis was a one pot Lewis acid (InCl3) catalysed Michael addition/Pictet-
Spengler cyclisation cascade reaction. This key reaction delivered the tetracyclic 
framework 97 in a stereoselective manner. Removal of the ester group in a two-
step sequence provided the lactam 98 in good yield. Subsequent sequential 
alkyne metathesis using a molybdenum catalyst developed by Fürstner, 34  
hydrogenation with Lindlar’s catalyst and triisopropylsilyl (TIPS) deprotection 
provided the macrocyclic Z alkene 99. Further installation of a diene and then 
RCM afforded the azocine ring. Finally, reduction of the bis-lactam led to the 
completion of (−)-nakadomarin A (1). 
 
 
Scheme 17 
  
                                                                                                                         
34 Bindl, M.; Stade, R.; Heilmann, E. K.; Picot, A.; Goddard, R.; Furstner, A. J. Am. Chem. Soc. 
2009, 131, 9468−9470 
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1.3.5 Mukai’s Formal Synthesis  
 
In 2010, a formal synthesis of (+)-nakadomarin A (ent-1) was published by Mukai 
and co-workers.23 Their synthetic strategy was based on the use of a 
stereoselective Pauson-Khand reaction to construct the ABC core.  
 
The synthesis started from the simple iodide 102 which was prepared in 2 steps 
from 4-pentyn-1-ol (Scheme 18). The iodide 102 underwent Sonogashira coupling 
with 3-butyn-1-ol to give alcohol 103, which was further converted into primary 
amine 104  in high yield.30  
 
 
Scheme 18 
 
The coupling partner, aldehyde 107, was prepared from the L-glutamic acid 
derivative 105 in 3 steps and in good yield (Scheme 19). Subsequent reductive 
amination of 107 with amine fragment 104 and tosyl protection of the resulting 
secondary amine afforded enyne intermediate 108. Subjecting enyne 108 to the 
key intramolecular Pauson-Khand reaction generated enone 109 
stereoselectively. Replacing the p-methoxybenzyl (PMB) protecting group with a 
benzoyl group provided tricyclic intermediate 110. 
                                                                                                                         
23 Inagaki, F.; Kinebuchi, M.; Miyakoshi, N.; Mukai, C. Org. Lett. 2010, 12, 1800−1803 
Chapter 1: Introduction  21 
 
 
Scheme 19  
 
The dienone 110 was converted to the fused tetracyclic system 111 by 
dihydroxylation, acid-catalysed dehydrative furan formation and 
fluorenylmethyloxycarbonyl (Fmoc) protection of the secondary amine (Scheme 
20). Screening of conditions for the selective hydrogenation of the 
tetrahydropyridine showed the protecting group on the nitrogen had a crucial 
influence on the outcome of the reaction. Only a trace amount of the desired 
product was formed with free amine while its tert-butyloxycarbonyl (Boc) 
protected counterpart was hydrogenated in 32% yield. The Fmoc-protected 
intermediate 111 proved to give the highest conversion to piperidine 112 (51%). 
A similar strategy to that employed by Nishida was used to transform piperidine 
112 to Nishida’s intermediate 28.17 
 
                                                                                                                         
17 Nagata, T.; Nakagawa, M.; Nishida, A. J. Am. Chem. Soc. 2003, 125, 7484−7485 
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Scheme 20 
 
 
1.3.6 Zhai’s Total Synthesis  
 
In 2010, Zhai and co-workers accomplished the total synthesis of 
(−)-nakadomarin A (1) in 20 steps.25 The key feature of the strategy was the use 
of a stereoselective Pt(II)-mediated cyclisation reaction that had been 
developed in Zhai’s group to construct the ABCD core.35 
 
The preparation of the iodide 119 for the key Sonogashira coupling reaction 
from THP protected propargyl alcohol 117 was accomplished in four steps 
(Scheme 21). Deprotonation of propargyl alcohol 117 with n-BuLi followed by 
nucleophilic attack of the lithium acetylide on γ-butyrolactone afforded ynone 
118. Addition of HI to the ynone 118 gave a vinyl iodide intermediate, which 
                                                                                                                         
25 Cheng, B.; Wu, F. F.; Yang, X. B.; Zhou, Y. D.; Wan, X. L.; Zhai, H. B. Chem. Eur. J. 2011, 17, 
12569−12572 
35 Deng, H.; Yang, X.; Tong, Z.; Li, Z.; Zhai, H. Org. Lett. 2008, 10, 1791−1793 
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was subjected to THP deprotection, acid catalysed cyclisation and TBDPS 
protection to provide the desired furan 119 in good yield. 
 
 
Scheme 21 
 
The aldehyde 120 was prepared from D-pyroglutamic acid in four steps (Scheme 
22). Reductive amination and protection of the resulting secondary amine with a 
benzylsulfonyl group gave alkyne 121. 36 , 37  Sonogashira coupling between the 
alkyne 121 and the iodide 119 afforded the furan 122. Subsequently, the key 
Pt(II)-promoted stereoselective cascade cyclisation reaction converted alkyne 
122 into the tetracyclic core 123. The alkene moiety in compound 123 was inert 
to various hydrogenation conditions and so sequential hydroboration-oxidation 
and Barton-McCombie deoxygenation38 was employed instead, which led to the 
formation of piperidine 125.  
 
Scheme 22 
                                                                                                                         
36 Harrison, T. J.; Patrick, B. O.; Dake, G. R. Org. Lett. 2007, 9, 367−370 
37 Shono, T.; Matsumura, Y.; Inoue, K.; Ohmizu, H.; Kashimura, S. J. Am. Chem. Soc. 1982, 104, 
5753−5757 
38 Barton, D. H. R.; McCombie, S. W. J. Chem. Soc. Perk. Trans. 1 1975, 1574−1585 
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The ester 125 was transformed into the diene 126 by a 5-step sequence 
(Scheme 23). Assembly of the azocine ring by RCM reaction, followed by Swern 
oxidation and Wittig olefination afforded the pentacyclic compound 127. The 
alkene 127 was converted into (−)-nakadomarin (1) using a four-step sequence 
that is similar to that in previously established routes. 
 
Scheme 23 
 
 
1.3.6 Evans’ total synthesis 
 
The most recent total synthesis of (−)-nakadomarin (1) was reported by the 
Evans group in 2013.26 Retrosynthetic analysis (Scheme 24) revealed that 
(−)-nakadomarin (1) could be constructed from a lactam intermediate by 
reduction, iminium formation and Pictet-Spengler reaction. The requisite lactam 
would be made by preferential reduction of the δ-lactam over the γ-lactam in 
bis-lactam 131. A key stereoselective double Michael addition reaction 
developed in the Evans group would deliver the pentacyclic intermediate 131 
from the pyrrolidinone 132 and furan macrolactam 133.  
                                                                                                                         
26 Bonazzi, S.; Cheng, B.; Wzorek, J.; Evans, D. A. J. Am. Chem. Soc. 2013, 135, 9338−9341 
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Scheme 24 
 
The synthesis of the furan fragment started with regioselective iodination of 3-
furancarboxaldehyde (136) (Scheme 25). Acetal protection of the aldehyde in 
iodide 137 followed by Heck coupling with allyl alcohol under Jeffrey’s 
conditions 39  delivered aldehyde 138. Wittig olefination and removal of the 
dimethylacetal protecting group by acidic workup generated aldehyde 139, 
which was converted into the furan fragment 133 by a sequence of Z-selective 
HWE reaction, saponification and macrolactam formation. 
 
 
Scheme 25 
 
The synthesis of bicyclic lactam fragment 132 commenced with chiral imine 134 
which was derived from the condensation between (R)-tert-butyl sulfinamide 
and acrolein (Scheme 26). Allylation of 134 with ethyl 2-(bromomethyl) acrylate 
under Barbier conditions provided sulfonamide 141 in good yield and with 
excellent diastereoselectivity (dr > 95:5). Removal of the chiral auxiliary 
followed by lactamisation afforded pyrrolidinone 142. N-Alkylation and RCM 
medited by the first-generation Grubbs catalyst gave the desired bicyclic lactam 
132 in excellent yield. 
                                                                                                                         
39 Jeffrey, T. Tetrahedron Lett. 1991, 32, 2121−2124 
Chapter 1: Introduction  26 
 
 
tBu
S
N
O
H
+ EtO
O
Br
Zn, LiCl
82%, dr > 95:5
EtO
O
H
N
S
O
tBu
H
HCl, MeOH
then NaOH
N
O
H
86%
NaH,
1-iodo-5-hexene 85%
NH
O
H
Grubbs I
3 x 0.5 mol %
DCM
83%
132
134 135 141 142
143
N
O
H
 
Scheme 26 
 
With the furan fragment 133 and the azocine fragment 132 available, the key 
double Michael addition was then investigated (Scheme 27). After various 
screening and optimisation reactions, it was found that slow addition of lactam 
132 into a solution of Lewis acid pre-activated α,β-unsaturated amide 133 
afforded the desired coupling product 146 in good yield and  diastereoselectivity 
(dr >9:1). More interestingly, only two of the four possible diastereomers were 
obtained and these compounds were readily separable by simple flash column 
chromatography on silica gel. Single-crystal X-ray diffraction was used to 
establish that the major product was (10R)-146, the diastereomer required for 
synthesis of (−)-nakadomarin A (1). It was proposed that the pentacyclic 
intermediate 146 was formed by the addition of the achiral unsaturated 
macrolactam 133 to the less hindered convex face of the bicyclic 132. 
Subjecting the bis-lactam 146 to Meerwein’s salt led to the selective 
electrophilic attack at the less hindered δ-lactam. Subsequent reduction of the 
activated iminium intermediate 148 provided the lactam 149. The total 
synthesis of (−)-nakadomarin (1) was completed by sequential activation of the 
γ-lactam and cyclisation to afford the iminium intermediate 151 and reduction. 
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Scheme 27 
 
A more efficient procedure to convert the bis-lactam 146 directly to 
(−)-nakadomarin A (1) was also developed (Scheme 27). Activation of bis-lactam 
146 by triflic anhydride led to iminium formation and cyclisation, and one-pot 
reduction provided (−)-nakadomarin A (1). 
 
In contrast to the previous synthetic strategies, the Evans’ synthesis elegantly 
avoided the use of a late-stage RCM reaction. The synthesis of (−)-nakadomarin A 
(1) was completed in 9 steps (longest linear sequence) from 3-furaldehyde with 
10% overall yield.   
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1.4 Fragment Syntheses towards Nakadomarin A 
 
The potent biological activity of nakadomarin A combined with its alluring 
molecular architecture has made it an attractive target for total syntheses. 
Several other groups also worked on the total synthesis of this complex natural 
product and have reported the construction of various ring systems that are 
present in the target. The following section describes several representative 
elegant approaches.  
 
1.4.1 Fürstner strategies: RCAM and RCM 
 
The first effort towards the synthesis of (−)-nakadomarin A (1) was reported in 
1999 by Fürstner and co-workers.40 In their strategy, (−)-nakadomarin A (1) was 
disconnected into a 15-membered macrolactam EF ring fragment and a bicyclic 
azocine CD ring fragment. 
 
The synthesis of 15-membered unsaturated lactam 156 started from the readily 
available diyne intermediate 153 (Scheme 28). Oxidation of allylic alcohol 153 
followed by acid-catalysed dehydrative cyclisation gave furan 154. Treatment of 
the diyne 154 with catalytic amount of the Schrock tungsten alkylidyne complex 
157 41 led to rapid formation of the desired macroalkyne 155 in excellent yield. 
Lindlar reduction of the resulting alkyne provided the target lactam EF ring 
fragment 156. 
 
                                                                                                                         
40 Fürstner, A.; Guth, O.; Rumbo, A.; Seidel, G. J. Am. Chem. Soc. 1999, 121, 11108−11113 
41 Schrock, R. R.; Clark, D. N.; Sancho, J.; Wengrovius, J. H.; Rocklage, S. M.; Pedersen, S. F. 
Organometallics 1982, 1, 1645−1651 
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Scheme 28 
 
The Fürstner group created a functionalised macrocycle corresponding to the EF 
ring system of (−)-nakadomarin A (1) in 9 steps with high overall yield. A highly 
convergent disconnection strategy for the synthesis of (−)-nakadomarin A (1) was 
presented, as well as various examples of diyne RCM for the first time. This 
approach was an efficient way to construct macrocyclic Z-alkenes. 
 
In 2001, Fürstner and co-workers reported the synthesis of ACD ring fragment of 
(−)-nakadomarin A (1, Scheme 29). 42  Their synthesis commenced with the 
conversion of (R)-(+)-pyroglutaminic ester 158 into the thioester 159, which 
underwent sequential amide formation, intramolecular Michael addition and 
stereoselective hydrogenation to afford spirobislactam 162. The diene 163, 
obtained from diester 162 in 5 steps and in high yield, was subjected to RCM by 
the treatment with a catalytic amount of ruthenium phenylinenylidene complex 
164 to deliver the ACD fragment 165 in quantitative yield. 
 
                                                                                                                         
42 Fürstner, A.; Guth, O.; Duffels, A.; Seidel, G.; Liebl, M.; Mynott, R. Chem. Eur. J. 2001, 7, 
4811−4820 
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Scheme 29 
 
The ACD ring fragment 165 was completed in 10 steps and in high yield by 
Fürstner and co-workers. Three of the four stereogenic centres in (−)-
nakadomarin A (1) had been introduced correctly. The utility of ruthenium 
phenylinenylidene complex 164 as a catalyst for olefin metathesis was well-
demonstrated by applying to the highly functionalised substrate 163.  
 
 
1.4.2 Magnus Approach: Pauson-Khand Reaction 
 
In 2002, Magnus and co-workers published a synthesis of the ABC ring system of 
(−)-nakadomarin A (1) featuring an intramolecular Pauson–Khand reaction.43 The 
synthesis started from the Boc-protected 2-pyrrolidinone 166, which was 
converted into the aldehyde 167 in 3 steps and in good yield (Scheme 30). 
Reductive amination of the aldehyde 167 with 1-amino-3-butyne hydrochloride 
followed by tosyl protection of the free amine provided the cyclisation precursor. 
Alkyne 168 was then subjected to the key Pauson-Khand reaction with a 
stoichiometric amount of dicobalt octacarbonyl to afford the tricyclic compound 
                                                                                                                         
43 Magnus, P.; Fielding, M. R.; Wells, C.; Lynch, V. Tetrahedron Lett. 2002, 43, 947−950 
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169 in good yield. Finally, hydrogenation of the alkene delivered the desired 
ABC ring fragment 170 in 62% yield. 
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Scheme 30 
 
Magnus had shown that it is possible to construct the five-membered B ring by 
Pauson-Khand reaction, but poor selectivity was observed for hydrogenation of 
the enone after screening of various conditions (the best result was 2:1 
diastereomeric ratio in favour of the desired isomer 170). 
 
 
1.4.3 Williams’ Strategy: Azomethine Ylide Cycloaddition 
 
In 2004, an asymmetric synthesis of the ACD ring system of (−)-nakadomarin A (1) 
was reported by Williams and co-workers, employing an elegant azomethine 
ylide 1,3-dipolar cycloaddition reaction as the key step (Scheme 31). 44  The 
synthesis commenced with the key three-component condensation of enone 171, 
aldehyde 172 and morpholinone 173 in a stereoselective manner. This 
transformation proceeded through the sequence of azomethine ylide formation 
between aldehyde 172 and morpholinone 173 and subsequent 1,3-dipolar 
cyclisation to provide the spirolactam 175 as a single diastereoisomer in 35% 
yield. Cleavage of the chiral template in bis-lactam 175 to provide amino acid 
176 was accomplished by hydrogenolysis mediated by Pearlman’s catalyst. 
Further functionalisation of the spiroamide 176 by alkylation and RCM led to the 
completion of the ACD fragment 177.  
                                                                                                                         
44 Ahrendt, K. A.; Williams, R. M. Org. Lett. 2004, 6, 4539−4541 
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Scheme 31 
 
Williams completed the asymmetric synthesis of the ACD ring fragment of (−)-
nakadomarin A (1) in nine linear steps from commercially available materials 
using a stereoseletive three-component cyclisation reaction as the key 
transformation, although the yield was only modest. 
 
 
1.4.4 Stockman strategy: Synthesis of the CD Ring 
 
In 2012, Stockman published a synthesis of the CD ring fragment of (+)-
nakadomarin A (ent-1).45 The synthetic sequence started with esterification and 
Boc-protection of the L-pyroglutamic acid 178 to deliver the ester 179 in high 
yield (Scheme 32). Subsequent reduction of the lactam functionality led to an 
aminol which was protected to give the pyrrolidine 180. The ethyl protection 
proved to be necessary in order to achieve a high yield from the subsequent 
Wittig olefination reaction (98% in comparison with 8% for the free aminol and 21% 
for the methyl ether). The alkene 181 was further subjected to sequential 
oxidation, deprotection and tosylation to provide the lactam 182, which then 
underwent intramolecular nucleophilic substitution under basic conditions to 
produce the azocine ring.  
 
                                                                                                                         
45 Stockman, R. A.; McDermott, P. J.; Newton, A. F.; Magnus, P. Synlett  2010, 559−562 
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Scheme 32 
 
Stockman completed the synthesis of CD ring fragment ent-63 in 10 steps, which 
could be further converted (+)-nakadomarin A (ent-1) in 7 steps following 
Dixon’s strategy.20 This work demonstrated a simple and highly efficient 
methodology for the synthesis of chiral 5-substituted pyrrolidin-2-ones. 
 
 
1.4.5 Takemoto’s ABCDE Fragment Synthesis: Allylic Amination 
 
In 2012, Takemoto and co-workers reported an asymmetric synthesis of ABCDE 
pentacyclic core of (−)-nakadomarin A (1).46 The strategy featured a palladium 
catalysed allylic amination reaction and intramolecular Friedel-Crafts cyclisation 
via an oxazolidine intermediate.  
 
Takemoto’s synthesis commenced with α,β-unsaturated aldehyde 183, which 
underwent enantioselective Michael addition with dimethyl malonate (Scheme 
33). After a screen of various organocatalysts, it was found that the Hayashi-
Jørgensen catalyst 18947,48 showed the highest activity. Adduct 184 was formed 
in good yield (78%) and with high enantiomeric excess (97% ee) when a low 
loading (2 mol %) of the proline-derived catalyst 189 was employed. Reductive 
                                                                                                                         
20 Jakubec, P.; Cockfield, D. M.; Dixon, D. J. J. Am. Chem. Soc. 2009, 131, 16632−16633 
46 Tsuji, N.; Stadler, M.; Kazumi, N.; Inokuma, T.; Kobayashi, Y.; Takemoto, Y. Org. Biomol. Chem. 
2014, 12, 7919−7922 
47 Brandau, S.; Landa, A.; Franzøn, J.; Marigo, M.; Jørgensen, K. A. Angew. Chem. Int. Ed. 2006, 
45, 4305−4309 
48 Gotoh, H.; Ishikawa, H.; Hayashi, Y. Org. Lett. 2007, 9, 5307−5309 
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amination and amide formation afforded the lactam 185, which was subjected 
to standard Tsuji-Trost allylation 49 , 50  with the allylic acetate 186 to provide 
allylic TBS-ether 187 with correct configuration at the quaternary centre. 
Removal of the TBS protecting group, reduction of the ester to the aldehyde and 
reprotection of the primary alcohol as acetate gave key intermediate 188.  
 
 
Scheme 33 
 
The first attempt to construct the ABCE tetracyclic core 192 from the aldehyde 
188 started with imine formation, followed by the Pd-catalysed allylic amination 
to generate an iminium intermediate 190, which was expected to undergo a 
one-pot Pictet-Spengler type reaction with the furan moiety (Scheme 34). 
Unfortunately, all the attempts to perform this transformation failed due to the 
instability of the iminium intermediate 191 under the reaction conditions.  
 
 
Scheme 34 
 
                                                                                                                         
49 Tsuji, J.; Takahashi, H.; Morikawa, M. Tetrahedron Lett. 1965, 6, 4387−4388 
50 Trost, B. M.; Fullerton, T. J. J. Am. Chem. Soc. 1973, 95, 292−294 
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The strategy was then revised by the introduction of a removable nucleophilic 
moiety to trap the unstable iminium cation. The oxazolidine 193 was prepared 
from the aldehyde 188 in good yield by applying this method (Scheme 35) and 
this compound was used as an iminium equivalent under acidic conditions 
allowing installation of the cyclopentane unit in a stereoselective manner and in 
high yield. Attempts to perform direct functionalisation of the hydroxyethyl 
group in the tetracyclic compound 194 to give the desired side chain were first 
investigated without success. Removal of the hydroxyethyl group by sequential 
Swern oxidation, enamine formation and hydrolysis afforded free amine 196, 
which underwent N-acylation and RCM to provide the pentacyclic fragment 198. 
 
Scheme 35 
 
In conclusion, Takemoto and co-workers described a facile and efficient 
asymmetric synthesis of the pentacyclic core of (−)-nakadomarin A (1) in 14 
steps with the all four stereogenic centres installed with correct configurations. 
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Summary  
 
To date, eight total syntheses of (−)-nakadomarin A (1) and/or its enantiomer 
(+)-nakadomarin A (ent-1) have been published as well as several fragment 
syntheses. The viability of constructing the azocine E-ring and 15-membered 
F-ring by alkene or alkyne RCM have been well-illustrated using various 
substrates. Installation of the 5-membered B-ring was achieved in various ways 
including the use of the Pauson-Khand reaction, Pictet-Spengler reaction and 
metal-catalysed cyclisations. Rings A, C and D were introduced mostly using 
building blocks derived from natural sources. 
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1.5 Furan Formation 
 
1.5.1 Furan Moiety in Natural Products 
 
Substituted furans appear in a variety of natural products, such as polyketides, 
phenylpropanoids, alkaloids, and terpenes. 51  Natural compounds containing a 
furan and or derivatives have been found in many classes of terrestrial and 
marine organisms. The target molecule (−)-nakadomarin A (1) is among those 
bioactive natural products (Figure 3). Other examples include the neurologically 
toxic marine furanocembranes, providencin (199) and pukalide (200),52 ,53 the 
bacterial macrolide furanoephithilone B (201), 54  and furoscrobiculin B (202), 
which provide chemical defense against other organisms such as bacteria, fungi, 
animals and insects. 55 
 
Furan sub-units are also present in numerous biologically-active pharmaceuticals. 
Ranitidine (203, Zantac®, GSK) is an H2-receptor antagonist for the treatment 
of stomach ulcers and was one of the biggest-selling drugs in 1988 (Figure 3).56 
Vilazodone (204), consisting of an indole and a benzofuran, shows 
pharmacological activity against major depressive disorders and was approved by 
the FDA in 2011.57 
 
                                                                                                                         
51 Boto, A.; Alvarez, L. Heterocycles in Natural Product Synthesis, Wiley-VCH Verlag & Co. KGaA, 
2011 and references herein 
52 Donohoe, T. J.; Ironmonger, A.; Kershaw, N. M. Angew. Chem. Int. Ed. 2008, 47, 7314−7316 
53 Kobayashi, J.; Watanabe, D.; Kawasaki, N.; Tsuda, M. J. Org. Chem. 1997, 62, 9236−9329 
54 Groebe, D. R.; Abramson, S. N. J. Biol. Chem. 1995, 270, 281−286 
55 Maki, S.; Toshihiro, S.; Hiroshi, S.; Kanematsu, K. J. Chem. Soc., Perkin Trans. 1 1997, 11, 
1707−1714 
56 Wright, R. J. Health Care Mark. 1996, 16, 24−29 
57 Banerjee, R.; Banerjee, K. H. M. Int. J. Rev. Life Sci. 2012, 2, 7−16 
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Figure 3 Representative Furan Containing Natural Product 
 
 
1.5.2 Furan Synthesis 
 
Due to the importance of furan motif, strategies for the synthesis of substituted 
furans attract extensive interest from synthetic chemists. In addition to classic 
approaches, methodologies for the furan construction by transition metal 
catalysis and organocatalysts have given ecellent results.58 
 
1.5.2.1 Traditional Furan Synthesis 
 
In 1884, Carl Paal and Ludwig Knorr, reported independently a synthetically 
valuable method for the preparation of furans from 1,4-diketones (Scheme 
36). 59 , 60  In this most widely used approach, furans are formed by the acid 
catalysed dehydrative cyclisation of 1,4-diketones 205. The mechanism shows 
that the first step of the Paal-Knorr reaction is protonation of the oxygen in one 
                                                                                                                         
58 Newkome,  G. R.; Sauer, J. D.; Roper, J. M.; Hager, D. C. Chem. Rev. 1977, 77, 513−597 
59 Paal, C. Chem. Ber. 1884, 17, 2756−2767 
60 Knorr, L. Chem. Ber. 1884, 17, 2863−2870 
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of the carbonyl groups. This positively charged intermediate 206 can react 
through several pathways. In the generally accepted mechanism, protonation is 
followed by intramolecular nucleophilic attack of the protonated carbonyl group 
by the enol tautomer to deliver the dihydrofuran 207. Subsequent dehydration 
of intermediate 207 provides the furan product 208.61 
 
 
Scheme 36 
 
In 1902, Feist described methodology for the formation of highlysubstituted 
furans 215. 62,63 Condensation of 1,3-dicarbonyl 209 with an α-chloroketone 211 
takes place under basic condition to furnish the aldol adduct 212 (Scheme 37). 
Intramolecular nucleophilic substitution of chloride by the corresponding enolate 
213 occurs, giving dihydrofuran 214 which undergoes dehydration to afford 
furan 215.64 
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Scheme 37 
Studies towards the synthesis of substituted furans have been an important 
research area since the 1990s. Most recently, research has focused on the 
transition metal and organocatalyst mediated formation of highly functionalised 
furans.  
                                                                                                                         
61 Amarnath, V.; Amarnath, K. J. Org. Chem. 1995, 60, 301−307 
62 Feist, F. Chem. Ber. 1902, 35, 1537−1544 
63 Benary, E. Chem. Ber. 1911, 44, 489−493 
64 Calter, M. A.; Philips, R. M.; Flaschenriem, C. J. Am. Chem. Soc. 2005, 127, 14566−14567 
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1.5.2.2 Metal Catalysed Furan Formation 
 
Developments in the area of transition metal-catalysed processes continue to 
lead to highly efficient and selective synthetic procedures. 65  Thus, metal 
catalysis is an important approach to the synthesis of valuable organic 
compounds. In recent years, metal catalysis has been well-developed for the 
synthesis of substituted furans from simple precursors under mild conditions. 
The use of complexes of many metals (e.g. palladium, copper, gold, silver and 
zinc) has been reported and some representative examples are described 
below.66 
 
Palladium-Catalysed Synthesis of Furans 
 
In 1995, Trost and co-workers reported a protocol for the Pd-catalysed 
construction of furans.67 The synthesis commenced with conjugate addition of 
terminal alkynes 216 to γ-hydroxyalkynoates 217 to give enynols 218, which 
underwent complexation with palladium and subsequent intramolecular 
nucleophilic attack by the hydroxyl group to provide the hydroxyfuran 
intermediate 219. Decomplexation of palladium and isomerisation led to the 
desired furan product 220 (Scheme 38). 
 
 
Scheme 38 
 
 
                                                                                                                         
65 Moran, W. J.; Rodríguez, A. Org. Prep. Proced. Int. 2012, 42, 103−130 
66 Corma, A.; Leyva-Pérez, A.; Sabater, M.J. Chem. Rev. 2011, 111, 1657−1712 
67 Trost, B. M.; McIntosh, M. C. J. Am. Chem. Soc. 1995, 117, 7255−7256 
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Copper-Catalysed Synthesis of Furans 
 
In 2008, the López group developed a copper(I)-catalysed regioselective 
synthesis of tri- and tetrasubstituted furans (Scheme 39).68 The synthesis started 
from bispropargylic esters 221, which underwent copper-catalysed cyclisation to 
form the 2-furyl copper(I)-carbene intermediates 222. Further functionalisation 
of the copper carbenoids 222 led to formation of highly substituted furans. By 
investigating the scope of the reaction, it was found that the alkyne could be 
substituted with various groups (e.g. aryl, alkyl, trimethylsilyl and alkenyl) and 
that variation at R2 did not affect the cyclisation process.  
 
 
Scheme 39 
 
Gold-Catalysed Synthesis of Furans 
 
Among the transition metals that are commonly employed in the construction of 
furans (Cu, Ag, Pd and Au), gold has proven to be particularly suitable given the 
strong pi Lewis acidic property of cationic gold species and their ability to 
activate alkynes and allenes towards the addition of oxygen nucleophiles.69 Four 
examples of gold-catalysed furan formation represented in the work of Pale,70 
Arcadi,71 Hashmi72 and Liu73 are described in the following session. 
 
In 2009, the Pale group reported a gold-catalysed isomerisation of alkynyl 
oxiranes 224, using triphenylphosphine gold(I) triflate as catalyst (Scheme 40).70 
Trisubstituted furans 225 are generated in good yields and the presence of an 
alcohols as an external nucleophile is required for the reaction to proceed.  
 
                                                                                                                         
68 Barluenga, J.; Riesgo, L.; Vicente, R.; López, L. A.; Tomás, L. J. Am. Chem. Soc. 2008, 130, 
13528−13529. 
69 Hashmi, A. S. K. Chem. Rev. 2007, 107, 3180−3211 
70 Blanc, A.; Tenbrink, K.; Weibel, J. M.; Pale, P. J. Org. Chem. 2009, 74, 5342−5348 
71 Arcadi, A.; Alfonsi, M.; Chiarini, M.; Marinelli, F. J. Organomet. Chem. 2009, 694, 576−582 
72 Hashmi, A. S. K.; Haffner, T.; Rudolph, M.; Rominger, F. Eur. J. Org. Chem. 2011, 4, 667−671 
73 Du, X.; Song, F.; Lu, Y.; Chen, H.; Liu, Y. Tetrahedron 2009, 65, 1839−1845 
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Scheme 40 
 
In the same year, Arcadi illustrated another gold-catalysed reaction for furan 
formation (Scheme 41).71 It was found that coupling between a propargylic 
alcohol 226 and a 1,3-dicarbonyl compound 227 took place in a tandem process 
to deliver tetrasubstituted furan 228 in good yield. 
 
 
Scheme 41 
 
Hashmi and co-workers reported a new route for furan synthesis by gold-
catalysed cyclisation of 2-alkynylallyl alcohols 229 under mild conditions 
(Scheme 42).72 The cyclisation occurred at room temperature to form 
disubstituted furans 230 employing the gold-N-heterocyclic carbene (NHC) 
catalyst 231. 
 
 
Scheme 42 
 
An interesting study concerning the construction of furan rings was reported by 
Liu and co-workers in 2009.73 A wide range of substituted furans 233 were 
prepared by gold-catalysed cycloisomerisation of 2-en-4-yn-1-ols 232 (Scheme 
43). 
 
                                                                                                                         
72 Hashmi, A. S. K.; Haffner, T.; Rudolph, M.; Rominger, F. Eur. J. Org. Chem. 2011, 4, 667−671 
73 Du, X.; Song, F.; Lu, Y.; Chen, H.; Liu, Y. Tetrahedron 2009, 65, 1839−1845 
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Scheme 43 
 
Zinc-Catalysed Synthesis of Furans 
 
In 2012, the López group reported new methodology for the formation of 
cyclopropyl-substituted furans. 74  The reaction between enynones 234 and 
alkenes 235 in the presence of catalytic amount of zinc(II) chloride delivered 
the desired cyclopropyl furans 236 in good yield (Scheme 44). It was assumed 
the reaction proceeded through a Fischer-type 2-furyl zinc(II) carbene complex. 
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Scheme 44 
 
It was also found that the reaction could be applied to a wide variety of alkene 
partners 235, ranging from monosubstituted to disubstituted alkenes. 
Additionally, the R1, R2 and R3
 group in enynones 234 could bear aryl, alkyl and 
alkenyl groups.  
 
 
1.5.2.3 Organocatalytic Furan Synthesis 
 
The term “organocatalysis” which was first used by MacMillan in 2000, 75 
describes the acceleration of chemical reactions by employing a 
sub-stoichiometric amount of an organic compound. The interest in this field has 
increased enormously in the last decade as a result of its high efficiency and 
selectivity as well as the relatively low cost and toxicity of some catalysts. 
                                                                                                                         
74 Vicente, R.; González, J.; Riesgo, L.; González, J.; López, L. A. Angew. Chem. Int. Ed. 2012, 51, 
8063−8067. 
75 Ahrendt, K. A.; Borths, C. J.; MacMillan, D. W. C. J. Am. Chem. Soc. 2000, 122, 4243–4244 
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Organocatalytic reactions are becoming powerful tools for the construction of 
complex molecules.76  
 
Despite the fact that organocatalysis has become a thriving area and many of 
the reactions are widely applicable, it has rarely been used to construct furans 
in comparison to the metal-mediated methods. However, Jørgensen and co-
workers have reported an enantioselective synthesis of 2-hydroxyalkyl- and 2-
aminoalkyl furans based on a modified Feist-Benary synthesis.77  
 
The synthetic sequence started from the epoxidation of enal 237 in the presence 
of catalytic amount of the Jørgensen catalyst 23878 to deliver the 2,3-epoxy 
aldehyde 239, which underwent the Feist-Benary reaction with 1,3-dicarbonyl 
compounds 240 to provide dihydrofuran intermediate 241 (Scheme 45). Further 
dehydration by treating diol 241 with CSA led to the desired furan product 242 
in moderate to good yield. 
 
 
Scheme 45 
 
 
  
                                                                                                                         
76 Dalko, P. I.; Moisan, L. Angew. Chem. Int. Ed. 2001, 40, 3726–3748 
77 Albrecht, Ł.; Ransborg, L. K.; Gschwend, B.; Jørgensen, K. A. J. Am. Chem. Soc. 2010, 132, 
17886–17893 
78 Marigo, M.; Wabnitz, T. C.; Fielenbach, D.; Jørgensen, K. A. Angew. Chem. Int. Ed. 2005, 44, 
794–797 
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Phosphine-Mediated Furan Formation 
 
In 1991, Kuroda and co-workers reported a protocol for the preparation of 
substituted furans 244 by phosphine-initiated cyclisation reactions of enynes 
243 (Scheme 46).79 
 
 
Scheme 46 
 
It has been suggested that the mechanism proceeds through phosphine-initiated 
1,6-addition to the enynone 243 (Scheme 47), followed by the cyclisation of 
allene intermediate 245 to afford the phosphonium ylide 247. Subsequent Wittig 
reaction between the ylide 247 and an aldehyde delivers the furan 244.  
 
 
Scheme 47 
 
In 2004, Kuroda applied this method to the synthesis of highly substituted 
furans.80 In this paper, more details of the mechanism were given following a 
screen of reaction conditions and substrates.  
 
The initial experiments were performed in the presence of a stoichiometric 
amount of tributylphosphine, which led to the formation of the furans 244 in 
                                                                                                                         
79 Kuroda, H.; Hanaki, E.; Kawakami, M. Tetrahedron Lett. 1999, 40, 3753−3756 
80 Kuroda, H.; Hanaki, E.; Izawa, H.; Kano, M.; Itahashi, H. Tetrahedron 2004, 60, 1913−1920 
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good yield. Similar results were obtained with a slight drop in yield when 
triphenylphosphine was used (73% conversion of the desired furan product 
compared to 83% for tributylphosphine catalysed case). However, the use of 
triethylamine as a catalyst did not lead to formation of any furan product. It was 
suggested that the failure was possibly due to aza-ylide formation not taking 
place. Based on the proposed mechanism, it was noted that a stoichiometric 
amount of phosphine nucleophile is required. This was further confirmed when 
the amount of phosphine was reduced to half of the stoichiometric equivalent 
resulted in an approximate reduction in yield by half.  
 
The versatility of the reaction was investigated by changing different 
substituents on enynone 243 and aldehyde partner. It was found that the yields 
are remarkably dependent on the nature of the R1
 substituent on the alkyne. 
Low yields were obtained with precursors possessing an aromatic substituent at 
this position. Additionally, the desired furan product was not observed in the 
cases where R3 was an alkyl group.  
 
Organosulfur-Catalysed Furan Formation 
 
Inspired by Kuroda’s work, the Clark group reported an organosulfur catalysed 
synthesis of furfuryl alcohols and amines in 2012.81 It was proposed that the 
cyclisation could be carried out with a thioether catalyst, and the resulting 
sulfur ylide intermediate could be used to introduce new substituents to the α-
position of the furan, leading to the synthesis of highly substituted furans. 
 
In the work, a range of enynone substrates 248 was prepared with different R1 
and R2 substituents (Scheme 48). Treatment of enynone 248 with catalytic 
amount (10 mol %) of tetrahydrothiophene (THT) provided an intermediate in 
which a sulfonium ylide lies α to the furan. Further reaction with a nucleophile 
(X-H) affords the furan product 249. 
 
The suggested mechanism commences with the 1,6-addition of the 
tetrahydrothiophene onto the reactive enynone 248 in a process similar to the 
                                                                                                                         
81 Clark, J. S.; Boyer, A.; Aimon, A.; Garcia, P. E.; Lindsay, D. M.; Symington, A. D. F.; Danoy, Y. 
Angew. Chem. Int. Ed. 2012, 51, 12128−12131 
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phosphine-initiated reaction by Kuroda. The sulfur ylide 251 is formed by the 
intramolecular nucleophilic attack of the resulting enolate 250 onto the allene. 
The ylide 251 then undergoes protonation in the presence of an appropriate 
protonated nucleophile (X-H), giving a sulfonium salt 252. Elimination of 
tetrahydrothiophene affords the oxocarbenium ion 253 and nucleophilic attack 
of X- to 253 generates the desired furan product 249.  
 
X
252
H
S
R2R1
R1
O
O
253
251
250
X
H-X
R2R1
R1
O
O
S
R2R1
R1
O
O
R2
S
R1
R1
O
O
S
O
R2
X-H DCM, reflux
56-83%
248
249
O
R1 R1
+
S
(10 mol %)
O
O
R1
R1
R2
X
 
Scheme 48 
 
The initial experiment was carried out using tetrahydrothiophene as the catalyst 
and benzoic acid as the nucleophile, resulting in good yields while the use of 
other nitrogen (DMAP, DABCO) or phosphine (tributylphosphine) based catalysts 
only led to the decomposition of the starting enynones 248. After careful 
screening of the reaction conditions, the highest yields of desired furans 249 
were obtained using 10 mol % of THT in dichloromethane under reflux. The 
versatility of the reaction was explored by employing a diverse set of 
nucleophiles, including electron-rich and electron-poor aryl carboxylic acids, 
various alcohols and sulfonamides. Good to excellent yields were observed in 
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most case. This work demonstrated an elegant organocatalytic synthesis of 
highly functionalised furans under mild conditions in good yields.  
 
Brønsted Acid Catalysed Furan Formation 
 
Following the success of organosulfur-catalysed furan formation, it was of 
interest for Clark and co-workers to extend the methodology and investigate 
several aspects of the reaction. 
 
In 2015, the Clark group published new methodology involving the synthesis of 
cyclopropyl-substitued furans by a Brønsted acid promoted cascade reaction.82 A 
wide range of enynone susbtrates 254 with an alkene chain (3 or 4 carbons away 
from the alkyne moiety) were prepared with various R1 substituents (Scheme 49). 
Treatment of enynone 254 with stoichiometric amount of chloroacetic acid 
provided the product 255 featuring a 2,3,5-trisubstituted furan bearing a fused 
cyclopropyl group at 5-position in good yield.  
 
 
Scheme 49 
 
 
1.5.2.4 2-Acyl Furan Synthesis 
 
Although various methodologies have been developed for the synthesis of 
substituted furans, few examples of the formation of 2-acyl furans have been 
reported. 
 
In 2010, Zhang and co-workers reported an efficient approach to the 
construction of 2,4,5-trisubstituted 2-acyl furans (Scheme 50). 83  Treating 
                                                                                                                         
82 Clark, J. S.; Romiti, F.; Hogg, K. F.; Hamid, M. H. S. A.; Richter, S.; Boyer, A.; Redman, J.; 
Farrugia, L. J. Angew. Chem. Int. Ed. 2015, 54, 5744−5747 
83 Wang, T.; Zhang, J. Dalton Trans. 2010, 39, 4270−4273 
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enynones 256 with catalytic amount of gold catalyst in DCM at room 
temperature in the presence of hydrogen peroxide provided good yields of the 2-
acyl furans 257. Following Zhang’s work, Liu84 and Cui85 also described similar 
transformations mediated by silver and copper catalysts respectively. 
 
R1
O
R1
O
R2
O
R2
O
R1
R1
a. Ph3PAuCl/AgOTf, H2O2, DCM, 23-88% or
b. AgBF4, O2(1 atm), perfluorodecalin, 62-87% or
c. Cu2O@Fe3O4, L-proline, air, THF, RT, 79-87%
O
256 257
R1, R2 = alkyl or aryl
 
Scheme 50 
 
In the proposed mechanism, coordination of the metal catalyst to enynone 256 
enhances the electrophicility of the alkyne moiety (Scheme 51). Subsequent 
intramolecular nucleophilic attack of the carbonyl oxygen onto the Lewis acid-
activated alkyne provides the oxonium intermediate 259, which further 
rearranges to generate the metal-carbenoid 260. Subsequent oxidation with 
hydrogen peroxide affords the 2-acyl furan 257 and regenerates the catalyst 
ready for re-entry into the cycle. 
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Scheme 51 
                                                                                                                         
84 Chen, Z.; Luo, M.; Ye, D.; Zhou, Z.; Ye, M.; Liu, L. Synth. Commun. 2014, 44, 1825−1831 
85 Liu, Y.; Liu, Z.; Cui, Y. Chin. J. Chem. 2015, 33, 175−180 
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In 2011, the Jiang group described a one-pot transition-metal catalysed domino 
reaction to form highly functionalised furans (Scheme 52). 86  The reaction 
proceeded through base-catalysed conjugate addition of alkynols 262 to ynones 
261, followed by copper-catalysed cyclisation in the presence of oxygen to 
generate target 2-acyl furans 263 in good yield.  
 
 
Scheme 52 
 
 
1.5.2.5 Furan Synthesis in Nakadomarin A 
 
Nakadomarin A is a unique member of the manzamine alkaloid family because it 
possesses a furan motif.  In most of the syntheses of nakadomarin A and  
advanced intermediates, the furan has been introduced as a simple building 
block, but there are three examples in which a late-stage furan formation 
strategy has been employed on highly functionalised intermediates. 
 
The first example was reported by Fürstner and co-workers during the 
construction of the EF fragment of nakadomarin A.40 Alcohol 153 was oxidised to 
give the aldehyde 264 by manganese dioxide, which underwent acid-catalysed 
dehydrative cyclisation to deliver the furan product 154 in excellent yield 
(Scheme 53). 
 
 
Scheme 53 
                                                                                                                         
86 Cao, H.; Jiang, H.; Huang, H. Synthesis 2011, 7, 1019−1036 
40 Fürstner, A.; Guth, O.; Rumbo, A.; Seidel, G. J. Am. Chem. Soc. 1999, 121, 11108−11113 
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In Nishida’s total synthesis of nakadomarin A, the diene 37 was converted into 
the desired fused furan intermediate 39 in good yield through a two-step 
sequence of peroxide 38 formation and dehydrative rearrangement (Scheme 
54).18 
 
 
Scheme 54 
 
In 2010, Mukai and co-workers described a formal synthesis of nakadomarin A, in 
which a dihydroxylation reaction of the alkene 110 was employed to provide diol 
265 as a mixture of diastereoisomers. The crude diol was directly subjected to 
the dehydrative cyclisation to afford furan 266 upon the treatment with CSA 
(Scheme 55).23 
 
 
Scheme 55 
 
 
  
                                                                                                                         
18 Ono, K.; Nakagawa, M.; Nishida, A. Angew. Chem. Int. Ed. 2004, 43, 2020−2023 
23 Inagaki, F.; Kinebuchi, M.; Miyakoshi, N.; Mukai, C. Org. Lett. 2010, 12, 1800−1803 
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1.6 Metathesis  
 
1.6.1 Olefin Metathesis 
 
1.6.1.1 General Introduction 
 
Over the past two decades olefin metathesis has been of great interest to 
synthetic chemists engaged in natural product synthesis. Olefin metathesis was 
discovered in the mid-1950s by Karl Ziegler during the study of ethylene 
polymerisation catalysis, 87  which involves two alkenes undergo bond 
reorganisation in the presence of metal catalysts, resulting in the redistribution 
of the alkene motifs (Scheme 56).88  
 
 
Scheme 56 
 
The scope of metathesis reaction has been extended to different pi-systems:  
ring-opening metathesis polymerisation (ROMP), ring-closing metathesis (RCM), 
acyclic diene metathesis (ADMET), cross-metathesis (CM), ring-closing enyne 
metathesis (RCEYM) and ring-closing alkyne metathesis (RCAM, Scheme 57).  
 
 
Scheme 57 
                                                                                                                         
87 Fink, G.; Mülhaupt, R.; Brintzinger, H. H. Ziegler Catalysts 1995, Eds. Springer: Berlin 
88 Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413−4450 
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The design of metathesis catalysts has undergone a dramatic evolution since the 
early discovery of Ta-based metathesis catalysts.89 To date, there are two main 
types of catalysts that are utilised practically, which are the molybdenum 
catalyst 267, developed by Schrock and co-workers,90 along with the ruthenium 
complexes 268 and 269, developed within the Grubbs group (Scheme 58).91  
 
 
Scheme 58 
 
Molybdenum catalyst 267 is highly reactive towards a broad range of substrates 
and especially suitable for the sterically hindered cases.92 However, its utility is 
limited by the poor functional group tolerance, as well as the high instability 
towards air, moisture and any impurities present in the solvent.92  
 
In contrast, ruthenium catalysts 268 and 269 developed by Grubbs and co-
workers have received great attention because of their improved stability and 
functional group tolerance. More recently, Hoveyda and co-workers have 
synthesised a series of ruthenium complexes such as 270 based on the Grubbs 
catalysts. 93  These modified catalysts have shown enhanced lifetimes and 
turnover rates.94 
 
 
  
                                                                                                                         
89 Kotha, S.; Dipak, M. K. Tetrahedron 2012, 68, 397−421 
90 a) Schrock, R. R. Acc. Chem. Res. 1986, 19, 342−348; b) Feldman, J.; Murdzek, J. S.; Davis, W. 
M.; Schrock, R. R. Organometallics 1989, 8, 2260−2265 
91 a) Schwab, P.; France, M. B.; Ziller, J. W.; Grubbs, R. H. Angew. Chem. Int. Ed. 1995, 34, 
2039−2041; b) Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953−956 
92 Grubbs, R. H.; Chang, S. Tetrahedron 1998, 54, 4413−4450 
93 Kingsbury, J. S.; Harrity, J. P. A.; Bonitatebus, P. J.; Hoveyda, A. H. J. Am. Chem. Soc. 1999, 
121, 791−799 
94 Schrock, R. R.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2003, 42, 4592−4633 
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1.6.1.2 Macrolactam Formation Using RCM 
 
As a consequence of the promising bioactivities and alluring chemical structures 
of natural alkaloids, nitrogen-containing heterocycles have been popular targets 
for synthetic chemistry community for many decades. Several successful cases 
proved RCM could be an effective method for macrolactam formation, though 
the Lewis basicity of nitrogen could be problematic for the outcome of reactions 
and for the lifetime and reactivity of the catalysts.95,96 
 
In 2004, Fürstner and co-workers published an efficient total synthesis of 
(−)-isooncinotine (272), a spermidine alkaloid containing a 22-membered 
macrolactam motif (Scheme 59).97 The synthesis featured an efficient one-pot 
RCM-hydrogenation sequence to deliver the desired macrocycle. It was found 
that the RCM reaction had to be performed in the presence of the ruthenium 
indenylidene catalyst 164 under acidic conditions to avoid the poisoning of the 
catalyst by amine.  
 
 
Scheme 59 
 
 
  
                                                                                                                         
95 a) De Clercq, B.; Verpoort, F. Tetrahedron Lett. 2001, 42, 8959-8963; (b) Fürstner, A.; Thiel, O. 
R.; Ackermann, L.; Schanz, H. J.; Nolan, S. P. J. Org. Chem. 2000, 65, 2204−2207 
96 Martin, S. F. Chem. Rev. 2004, 104, 2199−2238 
97 Scheiper, B.; Glorius, F.; Leitner, A.; and Fürstner, A. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 
11960−11965 
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1.6.1.3 Z-Selective RCM 
 
The stereoselectivity of RCM reactions in terms of macrocycle synthesis has 
remained problematic for synthetic chemists over the past two decades. In 
general, the ring size tends to dictate the selectivity for Z or E. However, 
significant progress has been made recently towards the stereoselective 
synthesis of macrocycles, which could be divided into two different approaches: 
substrate-controlled and catalyst-controlled Z-selective RCM. 
 
Substrate-Controlled Z-Selective RCM 
 
In 2011, Schreiber and co-workers reported an elegant strategy for the synthesis 
of macrocycles with Z-configured double bonds (Scheme 60). 98  The synthesis 
commenced with silyl-substituted substrates 273, which underwent RCM 
reaction to provide the E-silylalkene intermediate 274. Subsequent removal of 
the silyl group afforded the desired Z-cycloalkene product 275. The scope of this 
methodology was demonstrated by the preparation of several Z-configured RCM 
products of various ring sizes (277-280) in moderate to good yield.  
 
 
Scheme 60 
 
 
                                                                                                                         
98 Wang, Y.; Jimenez, M.; Hansen, A. S.; Raiber, E. A.; Schreiber, S. L.; Young, D. W. J. Am. 
Chem. Soc. 2011, 133, 9196−9199 
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Catalyst-Controlled Z-Selective RCM 
 
In 2011, Hoveyda and co-workers described the first example of a 
catalyst-controlled Z-selective RCM reaction and its application to the synthesis 
of macrocyclic natural products.99,100 A series of tungsten or molybdenum based 
catalysts were synthesised and their reactivity and selectivity were explored 
with regard to various substrates. Acyclic compound 281 underwent RCM 
reaction in the presence of the Z-selective catalysts to provide the 
16-membered macrocyclic lactone 282 in moderate to good yield (Scheme 61). 
Pleasingly, high yields and stereoselectivities were observed when W-alkylidene 
286 was employed as the metathesis catalyst. This catalyst has the advantage 
that it can be manipulated in air unlike its molybdenum counterparts 284 and 
285.  
 
 
Scheme 61 
 
In 2013, the Grubbs group reported the first Z-selective RCM reaction using the 
ruthenium catalyst 290.101 The catalyst 290 was used to prepare 13- to 17-
membered macrocyclic compounds 289 from the dienes 288 in moderate to 
                                                                                                                         
99 Yu, M.; Wang, C.; Kyle, A. F.; Jakubec, P.; Dixon, D. J.; Schrock, R. R.; Hoveyda, A. H. Nature 
2011, 479, 88−93 
100 Wang, C.; Yu, M.; Kyle, A. F.; Jakubec, P.; Dixon, D. J.; Schrock, R. R.; Hoveyda, A. H. Chem. 
Eur. J. 2013, 19, 2276−2740 
101 Marx, V. M.; Herbert, M. B.; Keitz, B. K.; Grubbs, R. H. J. Am. Chem. Soc. 2013, 135, 94−97 
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good yield and with excellent selectivity (Scheme 62). It is worth noting that 
catalyst 290 also promotes Z-selective homocoupling, cross-metathesis and ring-
opening metathesis polymerisation. It was demonstrated that the adamantyl 
group is crucial for the high Z-selectivity, and the nitrato-type ligand 
significantly improves the reactivity of the catalyst. 
 
Scheme 62 
 
 
1.6.2 Alkyne Metathesis 
 
Alkyne metathesis has gained significant importance recently, because it allows 
access to both E- and Z-configured olefins through the sequence of RCAM and 
stereoselective reduction. In particular, the utility of RCAM has been extended 
by the wide application in natural products synthesis.  
 
The first example of an alkyne metathesis reaction was reported by Bailey and 
co-workers in 1968. In the study, WO3/silica (6.8% w/w) was used as a 
heterogeneous catalyst in a continuous-flow system to initiate the 
disproportionation reaction of 2-pentyne at high temperatures.102 Shortly after 
Bailey’s discovery, Mortreux and Blanchard 103  found that the same type of 
                                                                                                                         
102 Pennella, F.; Banks, R. L.; Bailey, G. C. Chem. Commun. 1968, 1548−1549 
103 Mortreux, A.; Blanchard, M. J. Chem. Soc., Chem. Commun. 1974, 786−787 
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transformation could also be promoted by the homogenous catalyst generated in 
situ from Mo(CO)6 and resorcinol in decalin at 160 °C(Scheme 63). 
 
 
Scheme 63 
 
In 2004, the Grela group published studies in which RCAM reaction conditions 
were optimized to improve the yield and the functional group tolerance.104 In 
this work, RCAM reactions of various substrates were performed in the presence 
of various substituted phenols along with Mo(CO)6. It was found that 
2-fluorophenol was the most effective additive and the desired ring-closure 
product 297 was obtained in excellent yield (Scheme 64).  
 
 
Scheme 64 
Alkyne metathesis has emerged as a powerful tool in synthesis and RCAM has 
been applied widely in natural products synthesis. There has been steadily 
increasing growth in this field in terms of catalyst development and substrate 
scope.105 
 
 
  
                                                                                                                         
104 Grela, K.; Ignatowska, J. Org. Lett. 2002, 4, 3747−3749 
105 Fürstner, A. Angew. Chem. Int. Ed. 2013, 52, 2794−2819 
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1.6.3 Ring Closing Metathesis Strategy towards the Synthesis of 
Nakadomarin A 
 
1.6.3.1 Olefin RCM 
 
Nakadomarin A bears two Z-olefins within medium to large rings, which makes it 
a natural target for metathesis. The construction of the 8-membered ring 
through ring closing metathesis has proved to be successful, furnishing the 
desired azocine motif in good yield in several cases.18,24 In contrast, the 
installation of the macrocycle by a late-stage alkene RCM was found to be 
problematic. The initial attempts by Nishida18 and Kerr19 only resulted in poor 
yield and low E/Z selectivity (Figure 4). Dixon20 later improved the selectivity by 
employing a sub-stoichiometric amount of CSA during the metathesis process, 
but the conversion remained low. A similar result was obtained by Zhai25 when 
applying Dixon’s conditions on a slightly different substrate. In 2011, Hoveyda 
reported a series of tungsten or molybdenum metathesis catalysts for Z-selective 
RCM.106 Good yields and excellent selectivities were obtained when Hoveyda’s 
catalysts were applied to Dixon’s intermediate. 
 
 
Figure 4 
 
  
                                                                                                                         
18 Ono, K.; Nakagawa, M.; Nishida, A. Angew. Chem. Int. Ed. 2004, 43, 2020−2023 
24 Nilson, M. G.; Funk, R. L. Org. Lett. 2010, 12, 4912−4915 
19 Young, I. S.; Kerr, M. A. J. Am. Chem. Soc. 2007, 129, 1465−1469 
20 Jakubec, P.; Cockfield, D. M.; Dixon, D. J. J. Am. Chem. Soc. 2009, 131, 16632−16633 
25 Cheng, B.; Wu, F. F.; Yang, X. B.; Zhou, Y. D.; Wan, X. L.; Zhai, H. B. Chem. Eur. J. 2011, 17, 
12569−12572 
106 Yu, M.; Wang, C.; Kyle, A. F.; Jakubec, P.; Dixon, D. J.; Schrock, R. R.; Hoveyda, A. H. Nature 
2011, 479, 88−93 
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1.6.3.2 Alkyne RCM 
 
As a result of the problems encountered during the macrolactam formation by 
olefin metathesis, an alternate strategy was used in which RCAM was employed 
to close the ring and thereafter selective reduction of alkyne to give the Z 
alkene was performed using Lindlar conditions.  
 
The first example of this approach was reported by Funk and co-workers,24 who 
treated the diyne 98 with molybdenum nitride complex to deliver the cyclised 
product 99 (Scheme 65). Subsequent Lindlar reduction and TIPS protecting group 
cleavage afforded the Z-macrocycle 100 in good yield. 
 
 
Scheme 65 
 
The Dixon group employed the tungsten catalyst for the alkyne RCM of bis-alkyne 
298, which led to the desired cyclised product 299 with similar efficiency 
(Scheme 66).107 Importantly, the catalyst proved to be highly compatible with the 
terminal alkene moieties.  
 
 
Scheme 66 
                                                                                                                         
24 Nilson, M. G.; Funk, R. L. Org. Lett. 2010, 12, 4912−4915 
107 Kyle, A. F.; Jakubec, P.; Cockfield, D. M.; Cleator, E.; Skidmore, J.; Dixon, D. J. Chem. 
Commun. 2011, 10037−10039 
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Later in the same year, Dixon further investigated the RCAM strategy on an 
earlier intermediate, diyne 80 (Scheme 67). A Mortreux-type108 mixture was 
chosen as the metathesis catalyst, which led to the construction of the 
macrocycle in only modest yield.22 Subsequent hydrogenation in the presence of 
Lindlar’s catalyst provided Z-lactam 82 in good yield. 
 
 
Scheme 67 
 
 
  
                                                                                                                         
108 Mortreux, A.; Blanchard, M. J. Chem. Soc., Chem. Commun. 1974, 786−787 
22 Jakubec, P.; Kyle, A. F.; Calleja, J.; Dixon, D. J. Tetrahedron Lett. 2011, 52, 6094−6097 
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1.7 Previous Work within the Clark Group 
 
1.7.1 Clark Syntheses of Fragments of Manzamine A 
 
Among the studies towards the total synthesis of manzamine A (3), the syntheses 
of CE ring fragment as well as the AB ring fragment of manzamine A (3) have 
been developed within the Clark group.109,110 
 
1.7.1.1 Synthesis of the CE Ring Fragment: [2,3]-Sigmatropic Rearrangement 
 
The first effort from the Clark group resulted in a very efficient enantioselective 
synthesis of the CE ring system of manzamine A (3). The azocine fragment 304 
was obtained from the key intermediate, the diazo ketone 302, prepared from 
(S)-prolinol (298) in 4 steps (Scheme 68).109  
 
 
Scheme 68 
 
The synthesis started from the protection of the secondary amine 298 as an 
ethyl carbamate to afford alcohol 299 in high yield. Oxidation of the alcohol 299 
to the aldehyde 300 and subsequent methylenation delivered the vinyl 
pyrrolidine 301. The carbamate was deprotected using hydrazine and the 
resulting amine was immediately alkylated with 4-bromo-1-diazobutan-2-one to 
give the key diazoketone 302 in good yield over two steps. Treatment of the 
                                                                                                                         
109 Clark, J. S.; Hodgson, P. B. Tetrahedron Lett. 1995, 36, 2519−2522 
110 Clark, J. S.; Townsend, R. J.; Blake, A. J.; Teat, S. J.; Johns, A. Tetrahedron Lett. 2001, 42, 
3235−3238 
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cyclisation precursor 302 with catalytic amount of Cu(acac)2 (2 mol %) afforded 
the fused bicyclic system 304. It was thought that the reaction proceeded 
through a [2,3]-sigmatropic rearrangement of the spiro-fused bicyclic ammonium 
ylide 303, resulting in the ring-expansion of the pyrrolidine.  
 
This synthesis of the CE ring fragment 304 was completed in 6 steps with 13% 
overall yield from (S)-prolinol (298). It provided an efficient and stereoselective 
method for accessing similarly fused bicycle system. 
 
 
1.7.1.2 Synthesis of the AB Ring Fragment: Enyne Metathesis and Sharpless 
Aminohydroxylation 
 
In addition to the stereoselective strategy for the synthesis of the CE ring system 
of manzamine A (3), the Clark group also developed a concise synthesis of the 
AB ring system in 2004.110  
 
The synthesis commenced with the conversion of (−)-quinine (305) into the 
meroquinene ester 306 in high yield by sequential oxidation, [2+2] cyclisation 
and ring opening reaction (Scheme 69). Protection of the amine as the t-butyl 
carbamate and further ester reduction afforded the alcohol 307 which 
underwent tosylation and SN2 substitution reaction with lithium acetylide to 
provide the alkyne 308. Treating 308 with a catalytic amount of the Grubbs 
first-generation catalyst resulted in an efficient enyne metathesis delivering the 
diene 309 in good yield. A regioselective hydroboration-oxidation of the 
terminal double bond gave the alcohol 310, which was further protected as 
benzyl ether 311. A highly diastereoselective and regioselective Sharpless 
aminohydroxylation reaction was then carried out to complete the AB ring 
system 312. 
 
                                                                                                                         
110 Clark, J. S.; Townsend, R. J.; Blake, A. J.; Teat, S. J.; Johns, A. Tetrahedron Lett. 2001, 42, 
3235−3238 
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Scheme 69 
 
The Clark group’s novel approach provided a new method for the synthesis of 
highly functionalised AB core using an enyne metathesis and Sharpless 
aminohydroxylation sequence. 
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1.7.2 Previous Work towards Total Syntheses of Manzamine A  
 
Following the successful syntheses of the AB and CE fragments of manzamine A 
(3), studies towards the total synthesis of manzamine A (3) were then carried 
out in the Clark group.111 
 
1.7.2.1 Retrosynthetic Analysis  
 
The strategy developed by the Clark group featured the Pauson-Khand and ring 
closing metathesis as key reactions. The retrosynthetic analysis of mazanamine A 
(3) is depicted in Scheme 70.  
 
 
 
Scheme 70 
 
                                                                                                                         
111 Hansen, A. M. PhD thesis, University of Glasgow, 2010 
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Ircinal A (2) could be converted into manzamine A (3) in a two-step process 
involving reductive amination and cyclisation following Kobayashi’s work.15 
Ircinal (2) could be prepared from the diyne 313 by alkyne metathesis and 
Lindlar reduction. The bis-alkyne 313 could be synthesised through alkylation of 
the tetracyclic intermediate 314, which could be obtained by sequential ring 
closing metathesis, allylic oxidation and substitutive cyclisation of the diene 315 
Cyclopropanation followed by ring expansion would convert the cyclopentanone  
316 into the cyclohexenone 315. The amide 316 could be prepared by 
conjugate addition and N-alkylation of the enone 320, which could be 
constructed by Pauson-Khand reaction of the alkyne 319. 
 
 
1.7.2.2 Synthesis of the AB Core: Pauson-Khand  
 
The proposed synthesis of manzamine A (3) commenced with Pauson-Khand 
reaction (Scheme 71). Commercially available propargylamine (317) was 
protected with tosyl chloride under basic conditions to afford a sulfonamide 
derivative which was subsequently alkylated with 4-bromo-1-butene to provide 
the enyne 319 in good yield.112 The racemic bicyclic enone 320 was then 
prepared by a catalytic intramolecular Pauson-Khand reaction in 71% yield.  
 
 
Scheme 71 
 
 
1.7.2.3 Efforts towards the Formation of the E Ring  
 
After an efficient synthesis of the AB core of manzamine A (3) in 4 steps, studies 
towards the formation of the E ring were then explored.  
 
Introduction of a functionalisable side chain by conjugate addition of a cuprate 
to the enone 320 was investigated first (Scheme 72). Treatment of the enone 
                                                                                                                         
15 Kobayashi, J.; Tsuda, M.; Ishibashi, M. Pure. Appl. Chem. 1999, 71, 1123−1126 
112 Patel, M. C.; Livinghouse, T.; Pagenkopf, B. L. Org. Synth. 2003, 80, 93−103 
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320 with allylmagnesium bromide and a sub-stochiometric of copper(I) iodide 
delivered the desired ketone 321 as well as the 1,2-addition by-product 321’. 
Intensive work was carried out on screening reaction conditions to increase both 
the yield and regioselectivity, but with only moderate success (40% yield, 321: 
321’, 5.8:1). It was found that the allylic side chain was added to the enone 320 
in a diastereoselective manner (cis to the bridge-head proton) which was 
confirmed by single crystal X-ray diffraction studies of ketone 321.  
 
 
Scheme 72 
 
Due to the poor yield of the allylation reaction, alkyne side chain 318 was then 
synthesised for the study of the conjugate addition (Scheme 73). Alkyl iodide 
318 was submitted to a lithium-halogen exchange with t-BuLi, followed by 
transmetalation with copper iodide to form the dialkyl cuprate. Subjecting the 
resulting cuprate to the mixture of the enone 320 and TMSCl led to the 
formation of the desired 1,4-adduct 322 in good yield and regioselectivity. TMS 
enol ether 322 then went on nucleophilic addition to functionalise the α-position 
of the carbonyl group. Due to the instability of the intermediate 322, it was 
used directly for the Mukaiyama aldol reaction without further purification. 
Unfortunately, ketone 323 was only isolated in low yield (15%).   
 
 
Scheme 73 
 
Electrophilic amination was then explored by the Clark group in attempt to 
directly install an amino moiety α to the carbonyl group (Scheme 74). 
Hydroxylamine-O-sulfonic acid was employed as the electrophile in reaction with 
enol ether 324. However, the desired amine 325 was never isolated.  
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Scheme 74 
 
In an alternative route, the Clark group also investigated Carreira’s methodology 
for the direct introduction of the N-trifluoroacetyl group to the α-position of the 
carbonyl group using manganese complexes, such as (salen)Mn(N) or 
(saltmen)Mn(N) (Scheme 75).113 Activation of the nitromanganese complexes by 
trifluoroacetic anhydride resulted in the nitrogen transfer reaction. In the Clark 
group, both (salen)Mn(N) and (saltmen)Mn(N) complex were prepared, following 
the literature precedent. Unfortunately, the Clark group failed to replicate the 
amination reaction and compound 327 could not be prepared in this way.  
 
 
Scheme 75 
 
 
  
                                                                                                                         
113 DuBois, J.; Hong, J.; Carreira, E. M.; Day, M. W. J. Am. Chem. Soc. 1996, 118, 915−916 
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1.7.3 Previous Work towards Total Syntheses of Nakadomarin A 
 
Due to the failure encountered during the study towards the synthesis of 
manzamine A (3), (−)-nakadomarin A (1) was chosen instead as a structurally less 
complicated target for developing a total synthesis strategy.114   
 
1.7.3.1 Retrosynthetic Analysis  
 
The retrosynthetic strategy started from allylic oxidation and cyclisation of 
amide 328, was proposed to deliver the desired natural product (1) (Scheme 76). 
Diene 328 would be obtained by double alkyne ring closing metathesis of the 
tetra-alkyne 329 and subsequent Lindlar reduction. N-Alkylation followed by 
aldol reaction and furan formation could convert the ketone 330 to the furan 
329. Finally, bisalkyne 330 could be derived from conjugate addition and 
N-alkylation of enone 320. 
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114 Poltronieri, E. M. PhD thesis, University of Glasgow, 2012 
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1.7.3.2 Radical Cyclisation 
 
Based on the previous work on delivering the E ring of manzamine A (3), a new 
strategy towards the synthesis of the tricyclic sulfide was investigated. It was 
believed that this could lead to the introduction of an α-amino carbonyl moiety 
through oxidative cleavage and Beckmann rearrangement. The initial strategy 
involved the cleavage of the TIPS protecting group to afford the terminal alkyne 
332 (Scheme 77). The intermediate 332 would undergo a radical cyclisation by 
treatment with thiophenol and AIBN to provide the tricyclic system 336 
employing the conditions reported by Roberston and co-workers.115 Unfortunately, 
no formation of the tricycle 336 occurred.  
 
 
Scheme 77 
 
The mechanism of the proposed cyclisation is shown in Scheme 77. It was hoped 
that the addition of the phenylsulfide radical to the alkyne 332, followed by a 
1,5-hydrogen shift would lead to the thioenol ether 334, which on undergoing a 
5-exo-trig radical cyclisation would generate tricyclic radical 335. Finally, 
quenching of the radical would deliver the desired sulfide 336.  
 
  
                                                                                                                         
115 Robertson, J.; Pillai, J.; Lush, R. K. Chem. Soc. Rev. 2001, 30, 94−103 
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1.7.3.3 Photochemistry 
 
Due to the difficulties encountered during the installation of the side chain on 
the B ring, attentions turned to the direct formation of the C ring by 
photocycloaddition. In 1964, Corey and co-workers described a [2+2] 
photochemical reaction between cyclohexenones and allenes to provide bicyclic 
compounds.116  
 
When applying this method to the reaction of the enone 320 with the allene 337, 
the desired tricyclic compound 338a was obtained along with regioisomers 338b 
and 338c (Scheme 78).114 Various conditions including solvent, concentration and 
reaction time were screened, but the best yield observed was only 63% 
(338a:338b:338c as 7:3:2).  
 
 
Scheme 78 
 
1.7.3.4 Nucleophilic Introduction of Nitrogen to the C3 Position 
 
Previous unsuccessful strategies of radical and photocyclisations led to a new 
investigation of nucleophilic introduction of a C3 amine.114 
 
 
Scheme 79 
                                                                                                                         
116 Corey, E. J.; Lemahieu, R.; Mitra, R. B.; Bass, J. D. J. Am. Chem. Soc. 1964, 86, 5570−5583 
114 Poltronieri, E. M. PhD thesis, University of Glasgow, 2012 
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Model system 339 was first synthesised for the study of α-carbonyl amination by 
conjugate addition of methyl cuprate to the enone 320 (Scheme 79). The TMS 
enol ether then underwent Rubottom oxidation with dimethyldioxirane, which 
was followed by acidic opening of the epoxide intermediate to afford the 
α-hydroxyketone 340. Oxidation of the alcohol 340 with Dess-Martin periodinane 
and subsequent TBS enol ether formation of C4 carbonyl group provided the 
ketone 341. Sequential oxime formation, hydrogenation and amide coupling 
were carried out to deliver the desired C3 α-amino ketone 342 in moderate yield. 
The configuration at C3 position was confirmed by single crystal X-ray diffraction 
of amide 307 to be trans respect to the C2 methyl group, which proved to 
unfortrunately be the undesired diastereoisomer. 
 
 
1.7.3.5 Studies towards the Furan Formation 
 
The installation of the furan E ring on the AB bicyclic core was also explored in 
the Clark group. According to the proposed synthetic strategy, the furan moiety 
could be installed via an aldol condensation between AB ring fragment 320 and 
α-hydroxypropionaldehyde derivative, followed by the acid catalysed 
deprotection and/or dehydrative cyclisation to afford the tricycle 344 (Scheme 
80).114 Model system hydroxylenone 343 and ketone 345 were prepared in low 
yield, but proved unstable for the acidic conditions employed pTSA or acetic 
acid. 
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114 Poltronieri, E. M. PhD thesis, University of Glasgow, 2012 
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2 Results and Discussion 
 
2.1 Evolution of the Strategy towards Nakadomarin A 
 
Due to the structural similarity between (−)-nakadomarin A (1), ircinal (2) and 
manzamine A (3), the project focused on developing syntheses of all three 
natural products from a common late-stage intermediate (Scheme 81).  
 
Scheme 81 
 
(−)-Nakadomarin A (1) could be prepared from the pentacyclic intermediate 346 
by macrolactam formation and amide reduction (Scheme 82). The furan 
intermediate 346 could be derived from the ynenone 347 by employing prior 
methodology developed within the Clark group. The ynenone 347 could be 
formed by aldol condensation between the ABCD tetracyclic ketone 348 and the 
propargylic aldehyde 349, which provides the first stop towards the synthesis of 
nakadomarin A.  
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2.2 Synthesis of the ABCD Core  
 
2.2.1 Asymmetric Synthesis of the AB Ring Fragment 
 
Initial investigations towards the new strategy focused on the stereoselective 
synthesis of the AB ring system. As described before (Section 1.7.2.2, Scheme 
71), the synthesis of (−)-nakadomarin A (1) started with Pauson-Khand reaction. 
Previous work had shown that the AB ring system 320 could be synthesised 
successfully as the racemate (Scheme 83) and so the initial goal was to access 
this product in an enantioselective manner. The Pauson–Khand reaction is well 
known for the preparation of 2-cyclopentenone derivatives.117 However, only 
limited examples of asymmetric Pauson–Khand reactions, using chiral 
auxiliaries118 and chiral ligands,119 have been reported.  
 
Scheme 83 
 
In 2000, Hiroi and co-workers reported an enantioselective Pauson-Khand 
reaction in which catalytic amounts of dicobalt octacarbonyl and chiral 
phosphine ligands were used (Scheme 84).120 Using this methodology, the fused 
bicyclic enone 351 had been formed in good yield and with an excellent 
enantiomeric ratio by treatment of the alkyne 350 with cobalt catalyst and 
(R)-BINAP in DME under a carbon monoxide atmosphere.  
 
 
Scheme 84 
                                                                                                                         
117 Pauson, P. L.; Khand, I. U. Ann. N.Y. Acad. Sci. 1977, 295, 2−14 
118 Castro, J.; Moyano, A.; Pericas, M. A.; Riera, A.; Greene, A. E. Tetrahedron: Asymmetry 1994, 
3, 307–310 
119 Bladon, P.; Pauson, P. L.; Brunner, H.; Eder, R. J. Organomet. Chem. 1988, 355, 449−454 
120 Hiroi, K.; Watanabe, K.; Kawagishi, R.; Abe, I. Tetrahedron: Asymmetry 2000, 11, 797−808 
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The application of this reaction was first evaluated with the sulfonamide 319. 
Moderate yield and enantioselectivity were observed when Hiroi’s conditions 
were employed to cyclisation of the enyne 319 (Table 1, entry 1). Further 
studies were performed in order to optimize the outcome of the reaction 
through screening of solvents and varying the catalyst loading. The optimal 
result was achieved when 0.3 equivalent of cobalt catalyst and (R)-BINAP in 
toluene was used. In this case, the bicyclic enone 320 was oibtained in 76% yield 
and 97% ee (Table 1, entry 3).121 
 
Table 1 
 
Entry 
Co2(CO)8 
(equiv.) 
(R)-BINAP 
(equiv.) Solvent Yield (%) 
ee 
(%)a 
1 0.2  0.2  DME 58 78 
2 0.2  0.2 toluene 65 85 
3 0.3 0.3  toluene 76 97 
4 0.4  0.4  toluene 77 94 
 
a The ee was determined by chiral HPLC. 
 
 
  
                                                                                                                         
121 Enantiomeric excess was determined by HPLC analysis of intermediate 320. Column Chiralpak 
OD-H, temperature 25 °C, hexane: propan-2-ol 67:33, flowrate 0.5 mL.min-1, retention time 17.2 
min. 
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2.2.2 Synthesis of the CD Ring Fragment 
 
2.2.2.1 First-Generation Retrosynthetic Analysis 
 
The successful enantioselective synthesis of the AB ring system provided a 
promising starting point for the total synthesis of nakadomarin A. Our attention 
now turned to the construction of rings C and D. 
 
In the initial retrosynthetic analysis of the ABCD ring system 352 it had been 
envisaged that formation of ring D would be accomplished by RCM of the diene 
353, which itself could be obtained from the lactam 354 by vinylation and 
amide coupling (Scheme 85). Oxime formation and Beckmann rearrangement122 
would convert the ketone 355 into the pyrrolidinone 354, and the ketone 355 
would be generated from a hydroboration-oxidation reaction of the alkene 356. 
Finally, the tricyclic ketone 356 could be formed by [2+2] photocycloaddition of 
the enone 320 and trimethylsilylacetylene. 
 
 
Scheme 85 
 
 
  
                                                                                                                         
122 Beckmann, E. O. Ber. Dtsch. Chem. Ges. 1886, 19, 988–993 
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2.2.2.2 Construction of the ABC Ring System: Photocycloaddition  
 
As illustrated previously (Scheme 78, section 1.7.3.2), attempts had been made 
to introduce the C ring to the bicyclic AB system by photocyclisation.114 However, 
low regio and stereoselectivity had been observed when using 1,1-
dimethylallene. In order to solve the regioselectivity problem, 
trimethylsilylacetylene was chosen as a sterically hindered addition partner. 
Pleasingly, excellent regioselectivity was obtained, but unfortunately the 
photoaddition reaction proceeded slowly; 1H NMR spectroscopic monitoring of 
the reaction mixture indicated only 10% conversion after 6 h under UV irritation. 
Prolonging reaction time resulted in an improvement in the level of conversion 
but without an increase in the isolated yield (18 h, 21% yield). Moreover, facial 
stereoselectivity proved to be problematic and an inseparable mixture of 
diastereoisomers 358 and epi-358 was obtained in a ratio of 4:3 (Scheme 86).  
 
 
Scheme 86 
 
The isolated mixture of cis- and trans-photoaddition products 358 and epi-358 
was used to explore subsequent steps (Scheme 87). Removal of the TMS group 
with TBAF afforded the tricyclic ketone 356 in quantitative yield and the ketone 
was protected as a ketal to give the compound 359. Hydroboration-oxidation of 
the alkene proved to be unsuccessful and resulted in decomposition of the 
starting material.   
 
                                                                                                                         
114 Laloy, E. M. PhD Thesis, University of Glasgow, 2012 
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Scheme 87 
  
Photoaddition reactions were also performed between the enone 320 and 
various alternative partners, but all attempts failed to provide the required 
cyclic system (Scheme 88). Cyclisation between the enone 320 and the vinyl 
silane 361 as well as ethynyltrimethylsilane 363 resulted in the recovery of the 
starting material without product formation, an outcome that was assumed to 
be a consequence of steric hindrance.  
 
 
Scheme 88 
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2.2.2.3 Second-Generation Retrosynthetic Analysis 
 
Due to the failure of C ring formation through [2+2] photoaddition, an 
alternative synthetic route for the construction of rings C and D was explored. 
The second-generation strategy relied on intramolecular N-alkylation of the 
amide 365 as the key strategy to access the desired ABCD core 352 (Scheme 89). 
The alkene 365 could be synthesised by RCM of the diene 366, which in turn 
could be obtained by deprotection and amide coupling of the alkene 367. The 
trichloroacetamide 367 would be prepared by Overman rearrangement of the 
alcohol 368. The allylic alcohol 368 could then be prepared by cross-metathesis 
of the chiral allylic alcohol 369 with the alkene 321. Finally, the ketone 321 
could be generated by conjugate addition of the core Pauson-Khand product 320. 
 
 
Scheme 89 
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2.2.2.4 Introduction of the Allyl Side Chain to C2 Position 
 
As demonstrated previously (Section 1.7.2.3, Scheme 72), the introduction of an 
allyl side chain to the enone 320 through conjugate addition had been explored 
during studies directed towards the synthesis of manzamine A (3),111 and 
problems of low yield and regioselectivity had been encountered. 
In order to solve the regioselectivity problem and improve the reaction yield, 
various conditions were investigated (Table 2). The enone 320 was treated with 
a premixed solusion of copper(I) iodide, lithium chloride and allyl magnesium 
chloride to give the 1,4-addition product 321. It was found that the quality of 
copper(I) iodide was critical to the success of this reaction and that it should be 
purified freshly before use (washed with water, ethanol and ether, then dried at 
65 °C under vacuum overnight). The use of unwashed copper(I) iodide  led to the 
formation of a significent amount of the 1,2-addition by-product 321’ (Table 2, 
Entry 1). The reaction temperature also had a dramatic influence on the 
outcome of this conjugate addition: when the reaction was performed at −78 °C, 
only a trace amount of the 1,4-adduct was formed (Table 2, Entry 2), but at 
−30°C, a moderate yield was observed (Table 2, Entry 3). The use of 3 
equivalents of the organocuprate at −10 °C was found to be optimal and this set 
of conditions delivered the desired 1,4-addition product 321 in 82% yield (Table 
2, Entry 5). 
Table 2 
 
Entry CuI, LiCl (equiv.) Grignard (equiv.) T (°C) 321 (%) 321’(%) 
1 2 2 −10 62 10a 
2 2 2 −78 trace − 
3 2 2 −30 39 − 
4 2 2 −10 73 − 
5 3 3 −10 82 − 
6 3 3 0 76 − 
a unwashed copper iodide used 
                                                                                                                         
111 Hansen, A. M. PhD Thesis, University of Glasgow, 2010 
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2.2.2.5 Cross-Metathesis and Overman Rearrangement on C2 Side Chain 
 
With alkene 321 in hand, attention was turned to the exploration of the 
sequence of cross-metathesis and Overman rearrangement for installation of the 
C10‒N chiral centre. 3-Buten-2-ol (370) was selected as the cross-metathesis 
partner, and initially the racemic allylic alcohol was used to investigate reaction 
conditions. After treating the alkene 321 with 3 equivalents of the allylic alcohol 
370 and 3 mol % of the Grubbs second-generation catalyst in DCM under reflux, 
the cross-metathesis product 371 was obtained in 50% yield, along with the 
homo-coupled by-product 372 (Table 3, Entry 1). Increasing the amount of the 
alcohol 370 to 10 equivalents marginally improved the yield (Table 3, Entry 2), 
although generation of a large amount of by-product 372 caused difficulties 
during purification. Higher catalyst loadings also proved to have a beneficial 
effect on the formation of the desired product (Table 3, Entry 3). Addition of 4 
equivalents of the alcohol 370 to a mixture of 321 and catalyst (6 mol %) was 
found to be optimal and the allylic alcohol 371 was obtained in 72% yield using 
these conditions (Table 3, Entry 4). 
 
Table 3 
 
 
Entry 
370 
(equiv.) Grubbs II (mol %) 371 (%)a 
1 3  3 50 
2 10  3  63 
3 5  6  70 
4 4  6  72 
 
a Isolated yield for the alcohol 371. 
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The successful preparation of alcohol 371 meant that the challenging imidate 
formation and Overman rearrangement sequence could be explored. In 1976, 
Overman and co-workers reported a general method for the synthesis of allylic 
amines by rearrangement of allylic trichloroacetimidates.123 In this procedure, 
allylic alcohols 373 are treated with a sub-stoichiometric amount of base and 
trichloroacetonitrile to afford trichloroacetimidates of type 374. These 
intermediates then undergo thermal or transition metal catalysed 
[3,3]-sigmatropic rearrangement to provide allylic amides 375 with transfer of 
stereochemical information (Scheme 90).  
 
Scheme 90 
 
Thermal [3,3]-sigmatropic rearrangement, which is driven by formation of an 
amide, proceeds through a 6-membered chair transition state 376, similar to 
that observed in the Claisen rearrangement reaction (Scheme 91). 
 
Scheme 91 
 
Alternatively, rearrangement could be induced by a transition metal catalyst, 
such as Pd(II) or Hg(II).124 This metal-catalysed reaction is a cyclisation-induced 
rearrangement process that proceeds through an iminometallation-
deoxymetallation sequence (Scheme 92). 
 
Scheme 92 
                                                                                                                         
123 Overman, L. E. J. Am. Chem. Soc. 1976, 98, 2901−2910 
124 Overman, L. E. Angew. Chem. Int. Ed. 1984, 23, 579–586 
Chapter 2: Results and Discussion  83 
 
The use of the thermal Overman rearrangement reaction in our synthetic route 
required formation of the trichloroacetatimidate 379 by reaction of the alcohol 
371 and trichloroacetonitrile. Initial screening of reaction conditions, which 
involved treating the alcohol 371 with 1.5 equivalents of trichloroacetonitrile 
and 0.5 equivalent of DBU, led to 50% conversion (Table 4, Entry 1). Only a trace 
amount of the desired product was formed when sodium hydride was employed 
as base (Table 4, Entry 2). The best result was obtained by increasing the 
amount of trichloroacetonitrile and DBU, giving the imidate 379 with a 
conversion level of 70% (Table 4, Entry 3). 
 
Table 4 
 
Entry Trichloroacetonitrile (eq.) DBU (eq.) NaH (eq.) Conversion (%) 
1 1.5  0.5  − 50 
2 1.5  − 0.3 trace 
3 3.0  1.0  − 70 
 
 
The imidate 379 was found to be unstable and was prone to decomposition back 
to the starting allylic alcohol 371 in the presence of water. Thus, the reaction 
mixture was passed through a short pad of silica, concentrated and used directly 
in the next step without further purification.  
 
 
Scheme 93 
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The thermal Overman rearrangement reaction was then investigated (Scheme 
93). Heating the imidate 379 in p-xylene at 160 °C under microwave irradiation 
gave the trichloroacetamide 380 in 18% yield over two steps. During the process, 
partial decomposition of the starting material was observed due to the high 
reaction temperature used. When the rearrangement was performed in a sealed 
tube at 140 °C, a slightly improved yield of 22% was obtained.   
 
Sequential cross-metathesis and Overman rearrangement with a different 
metathesis partner, benzyl alcohol 381, was also performed in parallel, leading 
to an improvement in the yields for both steps (Scheme 94). This result was 
believed to be a consequence of the increased stability of the imidate 383. 
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Scheme 94 
 
In summary, introduction of an allylic side chain to the AB ring core was 
achieved in high yield and with excellent regioselectivity. The following 
cross-metathesis and Overman rearrangement sequence was investigated on two 
substrates but with limited success.  
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2.2.2.5 Third-Generation Retrosynthetic Analysis 
 
As a consequence of the poor yields of the previous route, a modified 
retrosynthetic strategy was explored (Scheme 95). The revised ABCD core 385 
could be delivered by α-bromination and intramolecular nucleophilic cyclisation 
of the amine 386. The amide 387 could be converted into the tricyclic alkene 
386 by sequential cleavage of the trifluoroacetyl group and RCM. The diene 387 
would be derived from the allylic alcohol 371 through Overman rearrangement 
and the required starting material could be generated by stereoselective Corey-
Bakshi-Shibata reduction125 of the enone 388. Finally, a cross-metathesis 
reaction between the alkene 321 and methyl vinyl ketone would provide the 
enone intermediate 388. 
 
 
Scheme 95 
 
Previous studies concerning the cross-metathesis reaction between the alkene 
321 and racemic 3-buten-1-ol had been successful. However, enantiomerically 
pure 3-buten-1-ol is not commercially available and is difficult to prepare. 
Consequently, the plan was to circumvent this problem by employing methyl 
vinyl ketone as the cross-metathesis partner and introducing the required 
stereochemistry through CBS reduction. The synthesis commenced with 
protection of the ketone 321 as a ketal 389. Cross-metathesis of this ketal with 
methyl vinyl ketone was successful and afforded the enone 388 in high yield. 
                                                                                                                         
125 Corey, E. J.; Bakshi, R. K.; Shibata, S. J. Am. Chem. Soc. 1987, 109, 5551–5553 
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Subsequent asymmetric CBS reduction provided the allylic alcohol 390 in high 
yield and with an excellent diastereomeric ratio (Scheme 96). 
 
 
Scheme 96 
 
With the chiral allylic alcohol 390 in hand, the stage was set to investigate the 
key Overman rearrangement reaction. As described previously, rearrangement to 
form secondary allylic amides by Overman rearrangement is a well-developed 
reaction.126 However, only a few examples of the tertiary equivalents have been 
reported.127,128 In 2008, Peters and co-workers reported catalytic asymmetric 
formation of tertiary allylic amides by aza-Claisen rearrangement of 
trifluoroacetimidates (Scheme 97).129 Treatment of trifluoroimidates 391 with a 
catalytic amount of the palladium complex 394 under basic conditions led to the 
formation of amides 392 in moderate to high yields. These amides were further 
converted into the corresponding secondary amines 393 by reductive cleavage of 
the trifluoroacetyl group. The influence of the R3 substituent on the nitrogen 
was examined, and good yields were obtained for substrates bearing aryl or alkyl 
groups.  
 
                                                                                                                         
126 Overman, L. E. Angew. Chem. Int. Ed. 1984, 23, 579–586 
127 Calter, M.; Hollis, T. K.; Overman, L. E.; Ziller, J.; Zipp, G. G. J. Org. Chem. 1997, 62, 1449–
1456 
128 Moyano, A.; Rosol, M.; Moreno, R. M.; López, C.; Maestro, M. A. Angew. Chem. Int. Ed. 2005, 
44, 1865–1869 
129 Xin, Z.; Fischer, D. F.; Peters, R. Synlett. 2008, 1495–1499 
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Scheme 97 
 
Inspired by Peters’ work, the acetimidoyl bromide 395, which has the desired 
hexenyl side chain for the following RCM, was chosen as the O-alkylation partner 
(Scheme 98).  
 
 
Scheme 98 
 
The synthesis of bromide 395 started with reduction of the nitrile 398 to afford 
the primary amine 399 in good yield (Scheme 99). Unfortunately, attempted 
formation of the trifluoroacetimidoyl bromide 395 using Uneyama’s protocol130 
did not lead to the desired product. 
  
Scheme 99 
 
                                                                                                                         
130 Tamura, K.; Mizukami, H.; Maeda, K.; Watanabe, H.; Uneyama, K. J. Org. Chem. 1993, 58, 32–
35 
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As an alternate, nucleophilic attack of trifluoroacetamide onto 6-bromo-1-
hexene was investigated. This reaction delivered the amide 401 in quantitative 
yield and the compound was then converted into the target compound 395 by 
treatment with tetrabromomethane and triphenylphosphine (Scheme 100). Due 
to the instability of the bromide 395, this compound was employed directly in 
the next reaction after filteration of the reaction mixture through a short pad of 
silica.  
 
 
Scheme 100 
 
With the allylic alcohol 390 and the trifluoroacetimidoyl bromide 395 in hand, 
the coupling of these two fragments could be explored. Nucleophilic substitution 
of the bromide 395 with the alcohol 390 took place in the presence of NaHMDS. 
However, the trifluoroimidate 402 was found to be prone hydrolytic cleavage, 
regenerating the trifluoroacetamide 401 and the starting alcohol 390, and so a 
one-pot imidate formation and Overman rearrangement process was necessary 
(Scheme 101). On the formation of the intermediate 402, the reaction mixture 
was treated with K2CO3 in p-xylene and heated to 90 °C in a sealed tube for 2 
days. Thermal rearrangement led to the complete consumption of the starting 
material and delivered the trifluoroacetamide 396 in good yield over two steps. 
Treatment of the diene with 20 mol % of the Grubbs second-generation catalyst 
in DCM under reflux resulted in RCM, which delivered the azocine 397 in 82% 
yield. Subsequent acid-mediated hydrolysis of the ketal 363 provided the ketone 
403 in high yield. 
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Scheme 101 
 
Removal of the trifluoroacetamide group under standard conditions proved to be 
problematic (Scheme 102). The deprotection was first attempted on the amide 
epi-403 which was derived in three steps from (S)-CBS reduction of the enone 
388. When applying typical cleavage conditions (K2CO3 in MeOH at reflux)
131 to 
the amide epi-403, the expected product was not obtained and the unexpected 
spiroamide 404 was formed in quantitative yield instead. 
 
 
Scheme 102 
 
The proposed mechanism for this transformation commences with a 
trifluoroacetyl group transfer under basic conditions from the nitrogen to the C5 
position α to the carbonyl group to provide the diketone 406 (Scheme 103). The 
free secondary amine then participates in intramolecular nucleophilic attack of 
                                                                                                                         
131 Bergerson, R. B.; McManis, J. J. J. Org. Chem. 1988, 53, 3108–3111 
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the ketone to afford the hemiaminal 407, which undergoes a retro-aldol 
reaction to produce the δ-lactam 404.  
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Scheme 103 
 
The structure of the crystalline spiroamide 404 was elucidated by spectroscopic 
studies and stereochemical assignments were confirmed by single-crystal X-ray 
diffraction (Figure 4). 
 
Figure 4 
 
In order to avoid side-product formation, the deprotection sequence was 
reversed (Scheme 104). The trifluoroacetyl group was cleaved successfully under 
basic conditions in the presence of the ketal and the resulting intermediate 408 
was subjected to acid hydrolysis to reveal the ketone 386 in high yield over two 
steps. Subsequent cyclisation employing a procedure developed by Carreira for 
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cyclisation of an analogous substrate132 led to the formation of the tetracyclic 
ketone 385 in good yield.  
 
 
Scheme 104 
 
The structure of the tetracyclic core 385 was confirmed by spectroscopic studies 
and stereochemical assignments were confirmed by single-crystal X-ray 
diffraction (Figure 5). X-ray data showed that all four of the stereocentres 
required in (−)-nakadomarin A (1) had been installed correctly. Thus, the 
synthesis of the ABCD ring system had been performed in only 10 steps (longest 
linear sequence). 
 
Figure 5 
                                                                                                                         
132 Kreis, L. M.; Carreira, E. M. Angew. Chem. Int. Ed. 2012, 51, 3436–3439 
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Following completion of the ABCD ring system, optimisation studies were 
undertaken to forge a more efficient route. The initial efforts were focused on 
reducing the number of protecting group manipulations. The trifluoroacetyl 
cleavage step, which was previously proven to be problematic with free ketone, 
was re-evaluated first. Careful tuning of the reaction conditions by alteration of 
the temperature and the concentration of the K2CO3 solution allowed 
optimisation of the reaction. The amide 403 was converted into the amine 386 
in the presence of the ketone in good yield by treatment with 1 M aqueous K2CO3 
solution in MeOH at room temperature for 2 days (Scheme 105).   
 
 
Scheme 105 
 
After demonstrating that ketal protection during trifluoroacetyl group cleavage 
was not crucial, the next challenge was to prepare the cross-metathesis partner 
as a single enantiomer, thereby avoiding the need for the CBS reduction of the 
ketone after metathesis. The silyl ether 411 was prepared from (−)-ethyl 
L-lactate (409) in good yield and excellent ee133 by sequential TBS protection, 
partial ester reduction and Wittig olefination (Scheme 106).134 
 
 
Scheme 106 
 
Exploration of the cross-metathesis reaction was then undertaken. The initial 
experiment was performed using 3 equivalents of the allylic alcohol 411 and 3 
                                                                                                                         
133 Enantiomeric excess was determined by HPLC analysis of benzoyl allylic alcohol. Column 
Chiralpak AD-H, temperature 25 °C, hexane : (hexane: propan-2-ol [99.5: 0.5]) 90:10, flowrate 
0.5 mL.min-1, retention time 12.1 min. 
134 Uenishi, J.; Fujikura, Y.; Kawai, N. Org. Lett., 2011, 13, 2350–2353 
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mol % of the Grubbs second-generation catalyst in DCM under reflux, providing 
the product 371 in 61% yield after an acidic work-up to promote the cleavage of 
the TBS ether (Table 6, Entry 1). Replacing the Grubbs second-generation 
catalyst with the Hoveyda-Grubbs second-generation catalyst resulted in a 
higher yield (Table 6, Entry 2), thus further optimisation studies were explored 
with this catalyst. The best result was obtained when the alkene 321 was 
treated with 4 equivalents of the allylic alcohol 411 and 5 mol % of Hoveyda-
Grubbs second-generation catalyst to give the alcohol 371 in 88% yield (Table 6, 
Entry 4). It is also worth noting that the yield for the cross-metathesis reaction 
increased dramatically when the TBS ether 411 was employed as metathesis 
partner instead of 3-butene-2-ol. It is possible that the unprotected alcohol 
counterpart undergoes isomerisation in the presence of the ruthenium catalyst 
to generate butanone and deactivate the catalyst to the ruthenium hydride 
species.135 
 
Table 6 
 
Entry 411 (equiv.) Catalyst  Yield (%) 
1 3  G II (3 mol %) 61 
2 3  HG II (3 mol %) 67 
3 5  HG II (6 mol %) 86 
4 4  HG II (5 mol %) 88 
 
 
Careful consideration of the reaction sequence and optimisation of individual 
steps resulted in a shortened synthesis of the ABCD core of nakadomarin A 
(Scheme 107). The optimised strategy started with the Pauson-Khand reaction of 
alkyne 319 and then conjugate addition to deliver the ketone 321 in 57% yield 
over two steps. Subsequent cross-metathesis and Overman rearrangement 
                                                                                                                         
135 Finnegan, D.; Seigal, B. A.; Snapper, M. L. Org. Lett. 2006, 8, 2603–2606 
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afforded the trifluoroamide 387 in good yield. It is worth noting that better 
result was achieved when preformed Overman rearrangement in refluxing 
toluene. Treatment of the diene 387 with 20 mol % of the Grubbs second-
generation catalyst in DCM at reflux provided the azocine 386 in 82% yield, 
which underwent sequential trifluoroacetyl group removal and cyclisation to give 
the desired ABCD tetracyclic core 385 in only 7 steps (longest linear sequence) 
with good overall yield and stereoselectivity.  
 
 
Scheme 107 
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2.3 Introduction of Furan E Ring to ABCD Core 
 
Following the completion of the ABCD fragment using a concise 7-step strategy, 
attention was focused on installation of the furan E ring.  
 
2.3.1 Phosphine-Mediated Furan Formation 
 
The initial approach was inspired by the phosphine-initiated furan synthesis 
developed by Kuroda and co-workers as described in section 1.5.2.3 (Scheme 
108).79,80 It was reported that the ynenone 233 could be converted into the 
highly-substituted furan 234 by treatment with a stoichiometric amount of 
tributylphosphine and an aldehyde.  
 
 
Scheme 108 
 
The retrosynthetic analysis, incorporating Kuroda’s methodology, is shown in 
Scheme 109. The pentacyclic core 412 could be delivered by furan formation 
from the ynenone 413, which would be generated by aldol condensation 
between the tetracyclic ketone 385 and the propargylic aldehyde 349. 
 
 
Scheme 109 
 
 
                                                                                                                         
79 Kuroda, H.; Hanaki, E.; Kawakami, M. Tetrahedron Lett. 1999, 40, 3753–3756 
80 Kuroda, H.; Hanaki, E.; Izawa, H.; Kano, M.; Itahashi, H. Tetrahedron 2004, 60, 1913–1920 
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2.3.1.1 C17-C26 Side Chain Synthesis 
 
The propargylic aldehyde 349 could be prepared by nucleophilic substitution of 
the allylic bromide 415 with THP protected propargyl alcohol 414. The bromide 
415 would be prepared from the alkyne 416 by Lindlar reduction and an Appel 
reaction (Scheme 110). Finally, nucleophilic substitution of dibromide 417 with 
alkyne 414 and subsequent substitution with NaCN would provide the nitrile 416.   
 
 
Scheme 110 
 
The forward synthesis commenced with deprotonation of the alkyne 414 and 
subsequent alkylation of the anion with 1,3-dibromopropane to give the bromide 
418 (Scheme 111). Pleasingly, the bromide 418 was obtained in good yield by 
slow addition of a stoichiometric amount of the lithiated alkyne into the solution 
of the 1,3-dibromopropane  at −78 °C. This product was used in a second 
nucleophilic substitution reaction with NaCN to afford the nitrile 416. 
Subsequent nitrile hydrolysis under basic conditions followed by a tandem 
esterification and THP cleavage sequence provided the alcohol 420 in high yield. 
Partial hydrogenation of the alkyne 420 using Lindlar catalyst delivered the 
desired allylic alcohol 421. 
THPO THPO
Br
THPO
CN
THPO
CO2H
HO
CO2Me
CO2Me
nBuLi, THF, 78 C,
1,3-dibromopropane
NaCN, DMSO,
45 C
NaOH aq.
MeOH, 70 C
TsOH,
MeOH, 70 C
Lindlar cat.
H2, EtOAc, rt
414 418 416
419420421
81% 96%
95% 91%
(2 steps)OH
 
Scheme 111 
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The allylic alcohol 421 was converted into the bromide 415 by an Appel reaction 
(Scheme 112).136 The bromide was then displaced with a copper acetylide 
prepared from the alkyne 414 to give the skipped enyne 422 in good yield. 
Subsequent THP group removal followed by oxidation with Dess-Martin 
periodinane provided the propargylic aldehyde 349 in good yield. Overall, the 
C17 to C26 side chain 349 was formed in nine high-yielding steps from readily 
available starting materials. 
 
 
Scheme 112 
 
Successful synthesis of the aldehyde 349 meant that the stage was set to 
investigate aldol condensation and furan formation reactions. The ketone 424 
was synthesised for model studies by 1,4-addition of a methyl cuprate to the 
racemic enone 320 (Scheme 113). It was expected that the introduction of a 
methyl group at C2 position would allow the two α-carbonyl positions at C3 and 
C5 to be differentiated because of the increased steric hindrance at C3. 
Treatment of the ketone 424 with LDA provided an enolate, which then reacted 
with the aldehyde 349. The resulting β-hydroxyketone was subjected to an 
one-pot mesylation and elimination sequence, but the desired ynenone 425 was 
not obtained and a complex mixture was formed instead. 
 
 
Scheme 113 
                                                                                                                         
136 Appel, R. Angew. Chem. Int. Ed. 1975, 14, 801–811 
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2.3.1.2 Model Studies of Phosphine-Mediated Furan Formation 
 
Owing to the failed attempt to install the side chain and cyclise the product to 
give the required furan, attention was turned to the introduction of a simpler 
side chain. Treatment of the propargyl alcohol 426 with a Grignard reagent and 
copper iodide provided a reactive copper acetylide intermediate, which on 
nucleophilic attack of allyl bromide afforded the alkene 427 (Scheme 114). 
Subsequent oxidation of the propargylic alcohol with manganese dioxide resulted 
in full conversion of the alcohol 427 into the desired aldehyde 428. Due to the 
volatility and instability of the aldehyde 428, it was used immediately following 
filtration through a short pad of Celite.  
 
 
Scheme 114 
 
Coupling of the aldehyde 428 to the ketone 424 by aldol condensation was 
investigated next (Scheme 115). The enolate of ketone 424 was formed by 
deprotonation with LDA, and susbequent addition of the aldehyde 428 afforded 
a mixture of β-hydroxyketones that underwent dehydration to give the desired 
condensation product 429 in good yield, along with its C3 regioisomer 430. 
Pleasingly, the isomers were readily separable by column chromatography. The 
ynenone 429 was then subjected to phosphine-mediated furan formation in the 
presence of a stoichiometric amount of tributylphosphine and excess water 
under Kuroda’s conditions.80 However, the target furan 431 was not obtained; 
instead, decomposition of the starting ynenone 429 was observed.  
                                                                                                                         
80 Kuroda, H.; Hanaki, E.; Izawa, H.; Kano, M.; Itahashi, H. Tetrahedron 2004, 60, 1913−1920 
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Scheme 115 
 
As a consequence of the failure of the ynenone 429 to undergo cyclisation, a 
model side chain 433 bearing a methyl substituent on the alkyne was prepared 
for studies of cycloisomerisation step. The propargylic aldehyde 433 was 
synthesised by direct oxidation of commercially available 2-butyn-1-ol (Scheme 
116).137 Owing to the very low boiling point (48−50 °C) of the aldehyde 433, the 
isolated yield of this compound was modest. 
 
 
Scheme 116 
 
Aldol condensation between the ketone 424 and the aldehyde 433 gave a 
mixture of the desired C5 alkylation product 434 and bis-condensation product 
435 in low yield (Scheme 117). Following isolation of the ynenone 434, the 
phosphine-initiated cyclisation reaction was attempted employing Kuroda’s 
conditions, unfortunately the starting material decomposed into a complex 
mixture of inseparable products. 
  
                                                                                                                         
137 Tietze, L. F.; Gericke, K. M.; Singidi, R. R.; Schuberth, I. Org. Biomol. Chem. 2007, 5, 1191–
1200 
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Scheme 117 
 
The by-product 435 was also used to investigate furan formation, and an initial 
experiment was performed following Kuroda’s procedure but without success 
(Table 7, Entry 1). Lowering the reaction temperature to 0 °C led to the 
formation of furan products 437 and 438 as a separable mixture (5:3 ratio), 
albeit in poor yield and with formation of several by-products (Table 7, Entry 2). 
A slightly improved yield was obtained when the reaction was performed at a 
lower concentration (Table 7, Entry 3). It was proposed the low solubility of 
water in DCM was responsible for the formation of dimeric by-products. Hence, 
the ynenone 435 was converted into furans 437 and 438 in good yield when the 
reaction was peformed in THF (Table 7, entry 4). 
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Table 7 
 
Entry Solvent Concentration (mM) T (°C) Yield (437+438) 
1 DCM 25  rt 0% 
2 DCM 25  0  31% 
3 DCM 2.5  0  43% 
4 THF 2.5  0  80% 
 
After careful NMR studies, it was found that the by-products such as 439 and 
440 were generated from a Wittig reaction between the phosphonium ylide 
intermediate and the starting enone 435 (Scheme 118). This was further 
confirmed by mass spectrometry. 
 
Scheme 118 
 
Due to the promising results obtained during furan formation studies on the 
model system 435, the modified side chain 443 was chosen because it could be 
further converted into the alkene required for a subsequent RCM reaction. The 
aldehyde 443 was prepared from 3-butyn-1-ol using a similar 3-step sequence to 
that described previously (Scheme 119).  
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Scheme 119 
 
Aldol condensation between the ketone 424 and the aldehyde 443 delivered the 
ynenone 444 in moderate yield along with a trace amount of the C3 
regioisomeric compound 445 and bis-condensation product 446, which were 
readily separable by column chromatography (Scheme 120). 
 
 
Scheme 120 
 
With ynenone 444 in hand, furan formation was attempted under the optimised 
conditions described previously (Scheme 121), disappointingly, the furan product 
447 was not obtained. Instead, the highly conjugated enone 448, resulting from 
isomerisation of the starting material, was isolated in 37% yield along with 20% 
of the desilyated starting material 449.  
 
 
Scheme 121 
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The recovered alcohol 449 was reprotected as TIPS silyl ether 450 and this 
compound was subjected to furan-forming cyclisation reaction (Scheme 122). 
DMF was employed as a water miscible solvent to replace THF in this case. 
Pleasingly the desired furan 451 was obtained but in low yield (20%) along with a 
by-product. The two compounds could be separated and careful NMR analysis 
revealed that the by-product was in fact the 2-acyl furan 452, the structure of 
which was further confirmed by mass spectrometry. 
 
Scheme 122 
 
Based on Kuroda’s paper, the furan formation mechanism proceeds through a 
phosphine-initiated 1,6-addition to the ynenone 453 (Scheme 123), followed by 
the nucleophilic cyclisation of the allene intermediate 454 to afford the 
phosphonium ylide 455. Subsequent quenching of the reaction with water leads 
to the formation of the furan 456, and the by-product 2-acyl furan 457 is 
produced by reaction of the ylide 455 with oxygen present in the system. 
 
 
Scheme 123 
 
This proposed cause for the generation of 2-acyl furans was further confirmed by 
the outcome of a reaction performed under an oxygen atmosphere. Pleasingly, 
the desired product 452 was obtained in excellent yield (Table 8, Entry 1). 
Moreover, it was found that changing solvent from DMF to DCM didn’t affect the 
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outcome of the reaction (Table 8, Entry 2). Formation of the 2-carbonyl furan 
452 was not observed when tributylphosphine was replaced with either 
triphenylphosphine or tetrahydrothiophene (Table 8, Entry 3 and 4).  
 
Table 8 
 
Entry Solvent Initiator Yield (%) 
1 DMF n-Bu3P 93% 
2 DCM n-Bu3P 95% 
3 DCM Ph3P 0% 
4 DCM THT 0% 
 
The scope of the reaction was expanded by performing it on the 1,3-dicarbonyl 
compound 458, giving the diketone 459 in excellent yield (Scheme 124). It is 
worth noting that when this cyclisation reaction was performed on the terminal 
alkyne 460, the furfural 461 was also obtained in high yield.  
 
 
Scheme 124 
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2.3.2 Gold-Catalysed Furan Synthesis 
 
2.3.2.1 Furan Formation from Alk-4-yn-ones 
 
As a consequence of the failure to obtain the required furan, an alternative 
strategy was required. In 2009, Krause and co-workers reported a gold-catalysed 
cycloisomerisation reaction of alk-4-yn-ones (Scheme 125).138 Ketones of type 
462 were converted into furans 463 or 4-H-pyrans 464 in good yield by reactions 
with sub-stoichiometric quantities of chloro(triphenylphosphine)gold(I) and 
silver(I) triflate. 
 
 
Scheme 125 
 
Inspired by Krause’s work, it was proposed that this methodology could be used 
to install the furan E ring. The bromide 465 was synthesised by Appel reaction of 
the propargylic alcohol 423 in high yield (Scheme 126). The ketone 424 was 
deprotonated with LDA and the resulting enolate employed in a nucleophilic 
substitution reaction with bromide 465, delivering the alk-4-yn-one 466 in 
moderate yield and as an inseparable mixture of diastereoisomers. Subsequent 
furan formation using Krause’s protocol led only to decomposition of the starting 
material. 
 
Scheme 126 
                                                                                                                         
138 Belting, V.; Krause, N. Org. Biomol. Chem. 2009, 7, 1221–1225 
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2.3.2.2 Furan Formation from 2-En-4-yn-1-ols 
 
The failure of the gold-catalysed furan cyclisation reaction of alk-4-yn-ones led 
to the investigation of an alternative gold-catalysed reaction for furan formation. 
Liu and co-workers had reported new methodology for the synthesis of furans 
from 2-en-4-yn-1-ols in 2009.73 Alcohols of type 228 were reported to undergo 
cycloisomerisation in the presence of a gold catalyst to deliver 
highly-substituted furans 229 in variable yield (Scheme 127). 
 
R
HO H
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R
O
R
R
R
R
Ph3PAuCl (1 mol %),
AgOTf (1 mol %),
DCM, rt
11 99%
228 229  
Scheme 127 
 
Inspired by this work, the ynenone 444 was reduced under Luche conditions, 
giving the allylic alcohol 468 as a separable mixture of diastereoisomers in good 
yield (Scheme 128). Further treatment with a sub-stoichiometric amount of 
chloro(triphenylphosphine)gold(I) and silver(I) triflate resulted in a complex 
mixture of products, but the desired furan was not obtained.  
 
 
Scheme 128 
 
One explanation of the failure of the reaction comes by considering the 
proposed mechanism. The reaction commences with the coordination of gold(I) 
catalyst to both hydroxyl group and alkyne moiety (Scheme 129). Subsequent 
nucleophilic attack of oxygen long-pair onto the Lewis acid activated alkyne 
gives the oxonium ion 471, which further isomerises to afford the desired furan. 
It should be noted that the coordination of gold catalyst to substrate in order to 
                                                                                                                         
73 Du, X.; Song, F.; Lu, Y.; Chen, H.; Liu, Y. Tetrahedron 2009, 65, 1839−1845 
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facilitate cyclisation is not possible with the E-isomer, which is found in the 
alcohol 468. 
  
 
Scheme 129 
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2.3.3 Acid-Catalysed Furan Formation  
 
Undeterred by the disappointing failures of the phosphine and gold mediated 
cyclisation reactions, we decided to employ a dehydrative cyclisation strategy 
similar to that described in Mukai’s formal total synthesis of nakadomarin A 
(Section 1.3.5, Scheme 20).23 The revised strategy to install the furan E ring is 
illustrated in Scheme 130. It was anticipated that the furan 473 would be 
prepared from the hydroxyenone 474 through acid-catalysed dehydration. The 
intermediate 474 would, in turn, be obtained by using aldol condensation 
chemistry developed previously for the ketone 424.  
 
 
Scheme 130 
 
Investigation of the new approach started with the synthesis of a model system. 
Methyl glyoxylate (476) underwent Hosomi-Sakurai allylation139 to provide the 
alcohol 477 in quantitative yield (Scheme 131). Sequential TBS protection of the 
secondary alcohol and partial reduction of the methyl ester with DIBAL-H 
afforded the aldehyde 479.  
 
 
Scheme 131 
 
Due to the unsatisfactory regioselectivity of aldol reaction, as demonstrated 
previously (Section 2.3.1.2, Scheme 112), a Mukaiyama aldol reaction140 was 
employed to improve the regioselectivity. The ketone 424 was converted into 
                                                                                                                         
23 Inagaki, F.; Kinebuchi, M.; Miyakoshi, N.; Mukai, C. Org. Lett. 2010, 12, 1800−1803 
139 Hosomi, A.; Sakurai, H. Tetrahedron Lett. 1976, 17, 1295–1298 
140 Mukaiyama, T.; Narasaka, K.; Banno, K. Chem. Lett. 1973, 2, 1011–1014 
Chapter 2: Results and Discussion  109 
 
the TMS-enol ether 480 in moderate yield by treatment with LDA and TMSCl. 
The silyl enol ether was then subjected to Mukaiyama aldol condensation with 
the aldehyde 479, in the presence of TiCl4, to deliver the β-hydroxyketone 481 
in good yield (Scheme 132). Sequential mesylate formation and elimination 
furnished the enone 482, which was deprotected to give the secondary alcohol 
483 in 91% yield over 3 steps. Finally, the furan 484 was formed in high yield by 
treatment of α-hydroxyenone 483 with sub-stoichiometric amount of 
p-toluenesulfonic acid. 
 
Scheme 132 
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2.4 Fragment Coupling and 15-Membered Macrocycle 
Formation 
 
After successful installation of the furan E ring on the model substrate 484, the 
next challenge was to apply this protocol to the synthesis of the ABCD 
tetracyclic core 385. The initial strategy was based on coupling of the ABCD 
fragment 385 with C17-C26 side chain 487. The retrosynthetic analysis 
commenced with macrolactam formation from ester 485 and reduction of the 
resulting amide, which would deliver the final target (−)-nakadomarin A (Scheme 
133). The furan 485 could be generated by acid-catalysed cyclisation of the 
alcohol 486, while the enone of 486 would be derived from an aldol 
condensation reaction between the tetracyclic ketone 385 and the aldehyde 487.  
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2.4.1 Synthesis of C17-C26 Fragment 
 
2.4.1.1 First-Generation Synthesis: Ozonolysis and Wittig Olefination 
 
The initial sequence used to prepare the side chain 487 started with TBS 
protection of (S)-glycidol (488), followed by ring opening of the epoxide with an 
allyl Grignard reagent to provide the alcohol 490 in high yield over two steps 
(Scheme 134).141 Sequential TBS protection, ozonolysis and Wittig olefination 
afforded the alkene 492 as a mixture of inseparable alkene isomers (Z:E = 10:1). 
The acid 492 was then converted into its methyl ester and subjected to 
selective deprotection of the primary hydroxyl group by treatment with 
HF•pyridine complex, giving the alcohol 493 in excellent yield. Finally, 
Dess-Martin periodinane oxidation delivered the required side chain 487. 
Unfortunately, the desired Z-alkene isomer could not be separated from the 
unwanted E-isomer at any stage during this synthesis.  
 
 
Scheme 134 
  
                                                                                                                         
141 Florence, G. J.;  Morris, J. C.;  Murray, R. G.;  Osler, J. D.;  Reddy, V. R.;  Smith, T. K. Org. Lett. 
2011, 13, 514-517 
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2.4.1.2 Second-Generation Synthesis: Sonogashira Coupling 
 
As a result of the unsatisfactory stereoselectivity during Wittig olefination, a 
sequence involving Sonogashira coupling and Lindlar reduction was explored to 
circumvent the problem (Scheme 135). The alkyne 495 was accessed in 3 steps 
in good yield from (S)-glycidol 488 using a similar strategy to that employed 
previously; the remaining requisite functionality was to be installed by 
Pd-catalysed cross-coupling methodology.  
 
 
Scheme 135 
 
Despite numerous modifications to the reaction since its discovery by 
Sonogashira and co-workers in 1975,142 few examples have been published 
describing the coupling between terminal alkynes and alkyl halides.143,144,145,146 
Indeed, alkyl electrophiles are usually problematic substrates for the reaction 
because of their low reactivity as well as a tendency to undergo a β-hydride 
elimination side reaction. In 2003, Fu and co-workers published the first 
application of Sonogashira cross-coupling of terminal alkynes 497 with alkyl 
electrophiles 496 (Scheme 136). Moderate to good yields were obtained in most 
cases when the NHC precursor 499 was employed as a ligand. However, due to 
the instability of the reactive catalyst, it was necessary to perform the reaction 
in a glove box, thus severely limiting its application.    
 
                                                                                                                         
142 Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 16, 4467–4470 
143 Eckhardt, M.; Fu, G. C. J. Am. Chem. Soc. 2003, 125, 13642–13643 
144 Altenhoff, G.; Wurtz, S.; Glorius, F. Tetrahedron Lett. 2006, 47, 2925−2928 
145 Vechorkin, O.; Barmaz, D.; Proust, V.; Hu, X. L. J. Am. Chem.Soc. 2009, 131, 12078−12079 
146 Yi, J.; Lu, X.; Sun, Y. Y.; Xiao, B.; Liu, L. Angew. Chem. Int. Ed. 2013, 52, 12409−12413 
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Scheme 136 
 
In 2005, the Organ group developed a series of Pd-NHC complexes (PEPPSI, 
pyridine-enhanced precatalyst preparation, stabilisation and initiation), which 
can be used to accelerate various cross-coupling reactions.147 These catalysts 
feature increased stability towards air and moisture, as well as enhanced 
reactivity towards sp3 carbons. 
 
Inspired by the work of Fu and Organ, we explored the coupling of the alkyne 
495 and methyl 4-bromobutyronate (500) in the presence of a commercially 
available PEPPSI catalyst. The initial attempt was performed under Fu’s 
conditions (Table 9, Entry 1), but this reaction gave only trace amounts of the 
desired product 501. On increasing the catalytic loading to 5 mol %, the desired 
cross-coupled product was generated in poor yield (Table 9, Entry 2). Reducing 
the amount of bromide and elevating the temperature to 50 °C led to the 
highest conversion (Table 9, Entry 4). A higher loading of the PEPPSI catalyst (10 
mol %) resulted in a slight drop in the conversion (Table 9, Entry 5) and the 
cross-coupled product 501 was isolated as an inseparable mixture of the product 
and the alkyl bromide 500. The contaminant and the product could not be 
separated, so the mixture was taken on to Lindlar hydrogenation in the hope 
that the products could be separated at a later stage. 
 
 
 
 
                                                                                                                         
147 Hadei, N.; Kantchev, E. A. B.; O'Brie, C. J.; Organ, M. G. Org. Lett. 2005, 7, 3805–3807 
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Table 9 
 
Entry PEPPSI-IPr (mol %) 500 (equiv.) T (°C) Conversion (%)a 
1 2.5 1.2 rt trace 
2 5.0 1.2 rt 11 
3 5.0 0.9 rt 31 
4 5.0 0.9 50  66 
5 10.0 0.9 50 53 
 
a Conversion based on alkyne 430 
 
When the hydrogenation reaction was attempted in hexane, the starting alkyne 
was fully recovered (Table 10, Entry 1). Changing solvent from hexane to MeOH 
resulted in only trace amounts of the Z-alkene 502 being isolated (Table 10, 
Entry 2). The optimal result was obtained when ethyl acetate was used as the 
solvent and the concentration was 0.25 M (Table 10, Entry 3). It was also found 
that a high catalyst loading led to the over-reduction of the starting material to 
the fully saturated product (Table 10, Entry 4). It was assumed that the poor 
yield was a result of the presence of a bromide impurity that could react with 
the Lindlar catalyst.148 
 
 
 
 
                                                                                                                         
148 Coelho, A. V.; Souza, A. L. F.; Lima, P. G.; Wardell J. L.; Antunes, O. A. C. Appl. Organometal. 
Chem. 2008, 22, 39–42 
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Table 10 
 
Entry Solvent Concentration (M) Lindlar cat. (mol %) Conversion (%) 
1 hexane 0.05  5 0 
2 MeOH 0.05 5 < 5 
3 EtOAc 0.25 5 41 
4 EtOAc 0.25 10 0a 
 
a fully converted into saturated alkane by-product 
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2.4.1.3 Third-Generation Synthesis: Lithium Acetylide Substitution 
 
As a consequence of the problematic Sonogashira reaction, an alternative 
coupling strategy was sought. Using Taylor’s procedure,149 a new coupling 
partner 505 was synthesised from 4-bromobutyronitrile in high yield (Scheme 
137). The trimethyl orthoformate group represents a protected ester and is 
stable towards alkyl lithium species. 
 
 
Scheme 137 
 
Trimethyl ortho-4-bromobutanoate 505 was subjected to bromide substitution 
with the lithium acetylide of 495, providing the coupled product 501 in high 
yield (Scheme 112). Pleasingly, the alkyne 501 was readily separable from 
excess bromide 505 by silica gel chromatography, leading to an improved yield 
in the subsequent Lindlar reduction reaction. The Z-alkene 502 was then 
converted into the aldehyde 487 in two further steps using the sequence 
described previously (Scheme 138).  
 
 
Scheme 138 
 
  
                                                                                                                         
149 Casy, G.; Furber, M.; Richardson, K. A.; Stephenson, G. R.; Taylor, R. J. K. Tetrahedron 1986, 
42, 5849–5956 
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2.4.2 Fragment Coupling and Macrolactam Formation 
 
The successful synthesis of both the ABCD core 385 and the side chain 487 
meant that the stage was set for coupling of the two fragments (Scheme 139). 
Regioselective enolate formation, through treatment of the ketone 385 with LDA 
at −78 °C, followed by aldol condensation with the aldehyde 487 afforded the 
desired enone 506 in 77% yield. Cleavage of the TBS ether delivered the alcohol 
486, which underwent dehydrative cyclisation in the presence of TsOH to afford 
the furan 485 in good yield over two steps. It is noteworthy that 1.2 equivalents 
of acid were required to drive the reaction to completion due to protonation of 
the trialkylamine in the substrate. 
 
Scheme 139 
 
TBS protecting groups can be removed under acidic conditions,150 so direct 
transformation of the TBS-ether 506 to the furan 485 using excess tosic acid was 
investigated (Scheme 140). Pleasingly, the desired pentacyclic intermediate 485 
was obtained in excellent yield and this protocol shortened the route. With the 
furan in place, the next challenge was the cleavage of tosyl protecting group to 
                                                                                                                         
150 Thomas, E. J.; Williams, A. C. J. Chem. Soc. Chem. Commun. 1987, 992–994 
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afford the piperidine substrate 507. Treatment of the sulfonamide with a THF 
solution of sodium naphthalenide at −78 °C led to rapid consumption of the 
starting material. However, the desired free amine was contaminated with a 
large amount of 1,4-butanediol generated from ring opening of THF. 
 
 
Scheme 140 
 
Using DME as an alternative solvent successfully abolished the generation of the 
side-product (Scheme 141). However, subsequent purification of the product 
mixture was problematic as a consequence of the high polarity of the resulting 
amine along with its instability to light and open-atmosphere conditions. To 
address these problems, a one-pot sulfonamide deprotection and saponification 
sequence was examined. The tosyl-amine 485 was treated with sodium 
naphthalenide and then lithium hydroxide solution was added to cleave the ester. 
Unfortunately, the desired amino acid 508 was not isolated from this reaction 
sequence.  
 
 
Scheme 141 
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2.4.3 Fragment Coupling and Ring F Formation through Metathesis 
 
Direct installation of the complete side chain and closing the F ring through 
macrolactamisation was not successful and so a revised strategy was explored 
based on the introduction of a simple alkene chain which could be used to close 
the macrocycle by metathesis.  
 
The target compound (−)-nakadomarin A (1) could be formed by RCM of the 
diene 75 (Scheme 142).20 Acid-catalysed dehydrative furan formation, followed 
by sequential tosyl cleavage and reductive amination could afford the amine 75. 
The enone 509 could be derived from aldol condensation between the 
tetracyclic ketone 385 and the aldehyde 510.  
 
Scheme 142 
 
The aldehyde 510 was prepared from the protected diol 491 (synthesis 
described in Scheme 108) in two simple steps involving selective deprotection of 
the primary hydroxyl group followed by periodinane-mediated oxidation (Scheme 
143). 
 
Scheme 143 
                                                                                                                         
20 Jakubec, P.; Cockfield, D. M.; Dixon, D. J. J. Am. Chem. Soc. 2009, 131, 16632−16633 
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With the C17-C22 side chain 510 in hand, the familiar condensation reaction 
with enolate derived from the ketone 385 was undertaken to afford the enone 
508 in moderate yield. Only small quantities of the ketone 385 were available 
at this point in the project, which meant that only a single reaction was carried 
out at 0.19 mmol scale (Scheme 144). The enone 508 was subjected to furan 
cyclisation in the presence of tosic acid to provide the furan 512 in good yield. 
Subsequent sulfonamide cleavage delivered the piperidine 513, which was used 
directly without purification in the subsequent reductive amination reaction. 
The desired diene 75, which had been prepared by Dixon during his total 
synthesis of nakadomarin A, was obtained but only a small amount. 
Unfortunately, NMR analysis failed to provide high quality spectra due to small 
amount of material that had been prepared. However, the mass analysis result 
was consistent with the formation of Dixon’s intermediate 75. 
 
 
Scheme 144 
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2.5 Conclusions  
 
An efficient strategy for the total synthesis nakadomarin A and other manzamine 
alkaloids has been developed in which the tetracyclic ketone 385 serves as a 
common late-stage intermediate. The ABCD intermediate 385 was synthesised 
enantioselectively in 7 steps with high efficiency and overall yield (Scheme 145). 
The AB ring fragment was prepared stereoselectively employing an asymmetric 
Pauson-Khand reaction. Metathesis reactions (CM, RCM) and Overman 
rearrangement were employed to the construct the azocine C ring in good yield. 
The completion of the ABCD system was achieved by N-bromination and 
subsequent nucleophilic cyclisation. 
 
 
Scheme 145 
 
The C17-C26 side chains 349 and 465 were synthesised in 9 steps from the 
propargylic alcohol 414 (Scheme 146). Unfortunately, further fragment coupling 
with the ABCD core 385 failed to deliver the desired product. 
 
CO2Me
O
349 465
CO2Me
Br
OTHP
414
9 steps 9 steps
 
Scheme 146 
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The alternative side chains C17-C26 487 and C17-C22 510 were prepared from 
the epoxide 489 in 6 and 4 steps respectively (Scheme 147). Subsequent 
fragment coupling with the tetracyclic compound 385 through aldol 
condensation was successful, giving the condensation products 506 and 508. 
Further installation of the furan E ring using an acid-catalysed dehydrative 
cyclisation reaction provided pentacyclic intermediates 485 and 512, which 
could be manipulated to form the natural product in short order.  
 
 
Scheme 147 
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Efficient methodology for the synthesis of substituted 2-acyl furans 457 by 
phosphine-mediated cyclisation of ynenones 453 was also developed (Scheme 
148). Preliminary optimisation studies were performed using various solvents and 
initiators and these led to the formation of 2-acyl furans 452, 459 and 461 in 
high yield. 
 
 
Scheme 148 
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3 Experimental Section 
 
General Reaction Conditions 
 
Reactions involving air-sensitive reagents and dry solvents were performed in 
oven dried (125 °C) or flame dried glassware. These reactions were performed 
with the exclusion of air using an argon atmosphere. 
 
Solvents and Reagents  
 
Organic solvents were dried using a Pure Solv solvent purification system. Liquid 
reagents (DIPEA, Et3N, TiCl4, TMSCl) were distilled prior to use if needed. All 
reagents were purchased from commercial suppliers and used without further 
purification except where it is stated. 
 
Chromatography 
 
Column chromatography was performed under pressure using silica gel 
(Fluorochem LC60A, 35-70 micron or Merck Geduran Si60, 40-63 micron) as solid 
support and reagent-graded solvents as eluent. Petroleum ether used for column 
chromatography was the 40―60 °C fraction. The reactions were monitored by 
thin-layer chromatography (TLC) on Fisher and Merck silica gel 60 covered 
alumina plates. 
 
The TLC plates were developed under UV light and/or with a KMnO4 solution (3 g 
KMnO4, 20 g K2CO3, 5 mL 5% NaOH aq. and 300 mL H2O) or in an anisaldehyde 
solution (15 g anisaldehyde, 250 mL EtOH, 2.5 mL concentrated H2SO4). 
 
Apparatus 
 
Specific rotations of the chiral non-racemic compounds were recorded with an 
error ≤±0.1 using an automatic polarimeter Autopol V. The wavelength of the 
light was 589 nanometers. 
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IR spectra were recorded using a type IIa diamond single reflection element on a 
Shimadzu FTIR-8400S instrument. The IR spectrum of the compound was 
recorded directly on a thin film (liquid) or powder (solid) at ambient 
temperature. 
 
1H NMR spectra were recorded on a Bruker AvanceIII 400 MHz or Bruker AvanceIII 
UltraShield 500 MHz spectrometer at ambient temperature. Data are reported as 
follows: chemical shift in ppm relative to CDCl3 (7.26) on the δ scale, integration, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = 
broad, or a combination of these), coupling constant(s) J (Hz) and assignment. 
13C NMR spectra were recorded at 100 MHz or 126 MHz at ambient temperature. 
Data are reported as follows: chemical shift in ppm, relative to CHCl3 (77.16) on 
the δ scale, and assignment. 
 
High resolution mass spectra (HRMS) were obtained by the analytical services of 
the University of Glasgow on a Jeol MStation JMS-700 High Resolution Mass 
Spectrometer (EI, CI using isobutane) or a Bruker micro TOFq High Resolution 
Mass Spectrometer (ESI).  
 
Melting points were recorded with an Electrothermal IA 9100 apparatus. 
 
Nomenclature 
 
Compounds were named according to the IUPAC rules. Numbering of the carbon 
skeleton has been done independently according to the natural product 
numbering (Figure 9). 
 
 
Figure 9  
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4-Methyl-N-(prop-2-ynyl)benzenesulfonamide 319151  
                           
 C10H11NO2S 
 
Pyridine (2.3 mL, 29 mmol) was added to a solution of p-toluenesulfonyl chloride 
(5.6 g, 29 mmol) in THF (100 mL). The solution was cooled to 0 °C and 
propargylamine (2.0 mL, 29 mmol) was added dropwise. The mixture was stirred 
for 12 h, before a 2.0 M aqueous solution of NaOH (100 mL) was added. The 
resulting solution was stirred for 2 h at rt and the phases were separated. The 
aqueous phase was then extracted with EtOAc (3 × 100 mL), and the combined 
organic phases were washed with brine (200 mL), dried over magnesium sulfate, 
filtered and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 7:3) gave the title 
compound 319 (5.9 g, 94%) as a colourless solid.  
 
Rf = 0.48 (petroleum ether: EtOAc, 8:2); m.p. 74−76 °C; νmax (film) 3263, 3032, 
2862, 2121, 1597, 1435, 1319, 1149 cm―1; 1H NMR (400 MHz, CDCl3) δ 7.77 (2H, d, 
J = 8.2 Hz, CH-Ts), 7.31 (2H, d, J = 8.2 Hz, CH-Ts), 4.72 (1H, br s, NH), 3.84 (2H, 
dd, J = 6.0, 2.4 Hz, CH2-C1), 2.43 (3H, s, CH3-Ts), 2.10 (1H, t, J = 2.4 Hz, CH-C3); 
13C NMR (101 MHz, CDCl3) δ 143.9 (C-Ts), 136.5 (C-Ts), 129.8 (CH-Ts), 127.4 (CH-
Ts), 77.9 (C-C2), 73.0 (CH-C3), 32.9 (CH2-C1), 21.6 (CH3-Ts); HRMS (CI, isobutane) 
for C10H12NO2S [M+H]
+ calcd. 210.0589, found 210.0587.  
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
 
 
  
                                                                                                                         
151 Inamoto, K.; Yamamoto, A.; Ohsawa, K.; Hiroya, K.; Sakamoto, T. Chem. Pharm. Bull. 2005, 53, 
1502−1507 
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N-(But-3-enyl)-4-methyl-N-(prop-2-ynyl)benzenesulfonamide 321152 
 
 C14H17NO2S 
 
Potassium carbonate (4.4 g, 32 mmol) and 4-bromo-1-butene (3.6 mL, 32 mmol) 
were added to a solution of the alkyne 319 (5.5 g, 26 mmol) in acetone (150 ml) 
and the mixture was heated under reflux for 12 h. The reaction mixture was 
then cooled to rt and concentrated in vacuo. EtOAc (100 mL) and water (100 mL) 
were added and the phases were separated. The aqueous phase was extracted 
with EtOAc (2 × 100 mL). The combined organic phases were washed with brine 
(200 mL), dried over magnesium sulfate, filtered and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 8:1) provided the title compound 321 (6.3 g, 91%) as a 
colourless oil.  
 
Rf = 0.51 (petroleum ether: EtOAc, 6:1); νmax (film) 3279, 3070, 2924, 2121, 1597, 
1442, 1342, 1157 cm―1; 1H NMR (400 MHz, CDCl3) δ 7.72 (2H, d, J = 8.2 Hz, CH-
Ts), 7.28 (2H, d, J = 8.2 Hz, CH-Ts), 5.75 (1H, ddt, J = 17.3, 10.3, 7.0 Hz, CH-C6), 
5.08 (1H, dd, J = 17.3, 1.2 Hz, CH2-C5), 5.06 (1H, dd, J = 10.3, 1.2 Hz, CH2-C5), 
4.14 (2H, d, J = 2.2 Hz, CH2-C1), 3.26 (2H, t, J = 7.2 Hz, CH2-C8), 2.41 (3H, s, 
CH3-Ts), 2.33 (2H, td, J = 7.2, 7.0 Hz, CH2-C7), 2.02 (1H, t, J = 2.2 Hz, CH-C3); 
13C NMR (101 MHz, CDCl3) δ 143.5 (C-Ts), 135.9 (C-Ts), 134.5 (CH-C6), 129.5 (CH-
Ts), 127.7 (CH-Ts), 117.3 (CH2-C5), 76.5 (C-C2), 73.8 (CH-C3), 45.7 (CH2-C8), 
36.4 (CH2-C1), 32.2 (CH2-C7), 21.6 (CH3-Ts); HRMS (CI, isobutane) for C14H18NO2S 
[M+H]+ calcd. 264.1058, found 264.1054. 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
  
                                                                                                                         
152 Patel, M. C.; Livinghouse, T.; Pagenkopf, B. L. Org. Synth. 2003, 80, 93−103 
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(S)-2-Tosyl-3,4,4a,5-tetrahydro-cyclopenta[c]pyridin-6-one 320153 
                             
 C15H17NO3S 
 
To a stirred solution of dicobalt octacarbonyl (2.3 g, 6.9 mmol) in toluene (100 
mL) was added (R)-BINAP (4.3 g, 6.9 mmol) in one portion. The mixture was 
sparged with carbon monoxide for 15 min and stirred under a carbon monoxide 
atmosphere for 1 h at 65 °C. A solution of the alkene 321 (6.0 g, 23 mmol) in 
toluene (20 mL) was added dropwise to the reaction. The mixture was stirred at 
65 °C for 6 h and then concentrated in vacuo. Purification of the residue by flash 
column chromatography on silica gel (petroleum ether: EtOAc, 6:4) provided the 
title compound 320 (4.8 g, 72%, 97% ee) as a pale yellow solid. Enantiomeric 
excess was determined by HPLC analysis of intermediate 320. Column Chiralpak 
OD-H, temperature 25 °C, hexane: propan-2-ol 67:33, flowrate 0.5 mL.min-1, 
retention time 17.2 min.  
 
Rf = 0.18 (petroleum ether: EtOAc, 5:5); [α]D
28 −97.3 (c = 5.00, CHCl3); m.p. 
124−126 °C; νmax (film) 2980, 2870, 1708, 1342, 1155, 788 cm
―1; 1H NMR (400 
MHz, CDCl3) δ 7.65 (2H, d, J = 8.0 Hz, CH-Ts), 7.34 (2H, d, J = 8.0 Hz, CH-Ts), 
6.00 (1H, s, CH-C3), 4.72 (1H, d, J = 13.3 Hz, CH2-C1), 3.97−3.94 (1H, m, CH2-
C8), 3.20 (1H, d, J = 13.3 Hz, CH2-C1), 2.60−2.50 (3H, m, CH2-C8, CH2-C5, CH-
C6), 2.44 (3H, s, CH3-Ts), 2.13−2.10 (1H, m, CH2-C7), 2.01 (1H, dd, J = 16.2, 2.7 
Hz, CH2-C5), 1.46 (1H, ddt, J = 12.4, 11.7, 3.6 Hz, CH2-C7); 
13C NMR (101 MHz, 
CDCl3) δ 207.2 (C-C4), 172.2 (C-C2), 144.2 (C-Ts), 133.0 (C-Ts), 129.9 (CH-Ts), 
129.2 (CH-Ts), 127.8 (CH-C3), 47.5 (CH2-C1), 45.7 (CH2-C8), 41.4 (CH2-C5), 39.2 
(CH-C6), 32.1 (CH2-C7), 21.6 (CH3-Ts); HRMS (EI) for C15H17NO3S [M]
+ calcd. 
291.0929, found 291.0932.  
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
 
                                                                                                                         
153 Tang, Y. F.; Deng, L. J.; Zhang, Y. D.; Dong, G. B.; Chen, J. H.; Yang, Z. Org. Lett. 2005, 7, 
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(4aS*,6aR*,8aR*)-2-tosyl-1,2,3,4,4a,5-hexahydrocyclobuta[1,5]cyclopenta 
[1,2-c]pyridin-6-one 356 
 
 C17H19NO3S 
 
Trimethylsilyl acetylene (2.7 g, 25 mmol) was added to a solution of the enone 
320 (2.0 g, 6.9 mmol) in acetone (150 mL). The solution was stirred and 
subjected to UV (125 W Hanovia mercury lamp) irradiation for 18 h and then 
concentrated in vacuo. The resulting crude silane 358 was used directly in the 
next step without purification. 
 
TBAF (2.0 mL of a 1.0 M solution in THF, 2.0 mmol) was added to a solution of 
silane 358 (0.40 g, 1.0 mmol) in THF (50 mL). The mixture was stirred at rt for 3 
h then concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 6:1) gave the title 
compound 356 (251 mg, 18% over 2 steps) as a colourless foam.  
 
Rf = 0.48 (petroleum ether: EtOAc, 1:1); νmax (film) 3032, 2360, 1723, 1373, 1218 
cm―1; 1H NMR (400 MHz, CDCl3): δ 7.59 (2H, d, J = 8.0 Hz, CH-Ts), 7.29 (2H, d, J 
= 8.0 Hz, CH-Ts), 6.22 (1H, d, J = 2.7 Hz, CH-C9), 6.12 (1H, dd, J = 2.7, 1.3 Hz, 
CH-C10), 3.80−3.64 (2H, m, CH2-C1, CH2-C8), 3.16 (1H, dd, J = 16.9, 6.6 Hz, CH2-
C5), 3.03 (1H, d, J = 1.3 Hz, CH-C3), 2.48 (3H, s, CH3-Ts), 2.46−2.39 (1H, m, 
CH2-C1), 2.12 (1H, m, ddd, J = 12.6, 11.7, 2.2 Hz, CH2-C8), 1.92−1.70 (3H, m, 
CH2-C5, CH2-C7, CH-C6), 1.38−1.15 (1H, m, CH2-C7); 
13C NMR (101 MHz, CDCl3) δ 
214.0 (C-C4), 143.2 (C-Ts), 138.3 (CH-C10), 138.4 (CH-C9), 133.2 (C-Ts), 129.7 
(CH-Ts), 127.7 (CH-Ts), 56.7 (CH-C3), 54.4 (C-C2), 49.9 (CH2-C1), 45.5 (CH2-C8), 
41.9 (CH2-C5), 31.8 (CH-C6), 29.4 (CH2-C7), 21.6 (CH3-Ts); HRMS (ESI) for 
C17H19NNaO3S [M+Na]
+ calcd. 340.0978, found 340.0983.  
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(4aS*,6aR*,8aR*)-2-tosyl-1,2,3,4,4a,5-hexahydro-spiro[cyclobuta[1,5] 
cyclopenta[1,2-c]pyridine-6,2'-[1,3]dioxolane] 359 
 
 C19H23NO4S 
 
To a solution of the ketone 356 (0.20 g, 0.63 mmol) in dry toluene (30 mL) was 
added ethylene glycol (0.48 mL, 8.4 mmol), trimethyl orthoformate (0.62 mL, 
6.0 mmol) and p-toluenesulfonic acid monohydrate (34 mg, 0.18 mmol). The 
mixture was heated at 55 °C for 2 h with vigorous stirring. After cooling to rt, 
the mixture was neutralised by addition of saturated aqueous NaHCO3 solution. 
The phases were separated and the aqueous phase was extracted with Et2O (3 × 
30 mL). The combined organic phases were washed with brine (100 mL), dried 
over magnesium sulfate, filtered and concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (petroleum ether: EtOAc, 
4:1 to 2:1) afforded the title compound 359 (216 mg, 95%) as a colourless oil. 
  
Rf = 0.55 (petroleum ether: EtOAc, 1:1); νmax (film) 3030, 2358, 1354, 1211 cm
―1; 
1H NMR (400 MHz, CDCl3): δ 7.58 (2H, d, J = 8.0 Hz, CH-Ts), 7.25 (2H, d, J = 8.0 
Hz, CH-Ts), 6.12 (1H, d, J = 2.7 Hz, CH-C9), 5.98 (1H, dd, J = 2.7, 1.3 Hz, CH-
C10), 3.97−3.70 (5H, m, CH2-C8, OCH2CH2O), 3.66 (1H, d, J = 11.4 Hz, CH2-C1), 
2.78 (1H, d, J = 1.3 Hz, CH-C3), 2.52 (1H, dd, J = 13.9, 6.3 Hz, CH2-C5), 2.36 (3H, 
s, CH3-Ts), 2.32 (1H, d, J = 11.4 Hz, CH2-C1), 2.22−1.94 (2H, m, CH2-C7, CH2-C8), 
1.59−1.46 (3H, m, CH2-C5, CH2-C7, CH-C6); 
13C NMR (101 MHz, CDCl3) δ 143.3 (C-
Ts), 140.7 (CH-C10), 138.4 (CH-C9), 133.3 (C-Ts), 129.6 (CH-Ts), 127.8 (CH-Ts), 
114.9 (C-C4), 64.4 (OCH2), 64.0 (OCH2), 56.2 (CH-C3), 56.1 (C-C2), 50.4 (CH2-C1), 
46.0 (CH2-C8), 39.6 (CH2-C5), 32.7 (CH-C6), 27.2 (CH2-C7), 21.6 (CH3-Ts); HRMS 
(ESI) for C19H23NNaO4S [M+Na]
+ calcd. 384.1240, found 384.1251. 
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(4aS,7aR)-7a-Allyl-2-tosylhexahydro-cyclopenta[c]pyridin-6-one 322 
       
 C18H23NO3S 
 
Allylmagnesium chloride (1.7 mL of a 1.6 M solution in THF, 2.7 mmol) was added 
dropwise to a solution of copper(I) iodide (0.50 g, 2.7 mmol) and lithium 
chloride (0.11 g, 2.7 mmol) in THF (30 mL) at −10 °C. This was followed by the 
rapid addition of a solution of the ketone 320 (0.26 g, 0.91 mmol) and 
chlorotrimethylsilane (0.12 mL, 1.0 mmol) in THF (10 mL). The mixture was 
stirred at −10 °C for 1 h and then allowed to reach rt. The reaction was 
quenched by addition of saturated aqueous NH4Cl solution (30 mL), saturated 
aqueous Na2CO3 solution (30 mL) and EtOAc (50 mL). The phases were separated 
and the aqueous phase was extracted with EtOAc (3 × 50 mL). The combined 
organic phases were washed with water (150 mL) and brine (150 mL), dried over 
sodium sulfate, filtered and concentrated in vacuo. Purification by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 8:1 to 4:1) provided the 
title compound 322 (0.27 g, 93%) as a colourless solid. 
 
Rf = 0.29 (petroleum ether: EtOAc, 4:1); [α]D
22 +32.3 (c = 1.80, CHCl3); m.p. 
134−137 °C; νmax (film) 2901, 2856, 1728, 1597, 1334, 1157 cm
―1; 1H NMR (400 
MHz, CDCl3) δ 7.61 (2H, d, J = 7.8 Hz, CH-Ts), 7.32 (2H, d, J = 7.8 Hz, CH-Ts), 
5.72 (1H, ddt, J = 17.8, 10.3, 7.4 Hz, CH-C10), 5.17−5.11 (2H, m, CH2-C11), 
3.13−3.08 (1H, m, CH2-C8), 3.00 (1H, d, J = 12.1 Hz, CH2-C1), 2.89−2.83 (1H, m, 
CH2-C8), 2.58 (1H, d, J = 12.1 Hz, CH2-C1), 2.48−2.38 (1H, m, CH2-C9), 2.43 (3H, 
s, CH3-Ts), 2.31 (1H, dd, J = 18.5, 7.9 Hz, CH2-C5), 2.23 (1H, dd, J = 14.0, 7.4 Hz, 
CH2-C9), 2.22−2.18 (2H, m, CH2-C3), 2.12 (1H, ddd, J = 13.7, 7.9, 5.7 Hz, CH-C6), 
2.05−1.97 (2H, m, CH2-C5, CH2-C7), 1.55 (1H, ddt, J = 14.2, 5.7, 3.6 Hz, CH2-C7); 
13C NMR (101 MHz, CDCl3) δ 216.7 (C-C4), 143.9 (C-Ts), 133.0 (C-Ts), 132.6 (CH-
C10), 129.9 (CH-Ts), 127.7 (CH-Ts), 119.8 (CH2-C11), 49.6 (CH2-C1), 46.5 (CH2-C3), 
42.7 (CH2-C8), 41.6 (C-C2), 41.2 (CH2-C5), 40.5 (CH2-C9), 37.0 (CH-C6), 25.4 
(CH2-C7), 21.6 (CH3-Ts); HRMS (ESI) for C18H23NNaO3S [M+Na]
+ calcd. 356.1477, 
found 356.1479.  
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 (4aS,7aR)-7a-Allyl-2-tosyloctahydrospiro[cyclopenta[c]pyridine-6,2'-[1,3] 
dioxolane] 389 
 
 C20H27NO4S 
 
To a solution of the ketone 322 (0.20 g, 0.60 mmol) in dry toluene (20 mL) was 
added ethylene glycol (0.24 mL, 4.2 mmol), trimethyl orthoformate (0.31 mL, 
3.0 mmol) and p-toluenesulfonic acid monohydrate (17 mg, 90 µmol). The 
mixture was heated at 55 °C for 2 h with vigorous stirring. After cooling to rt, 
the mixture was neutralised by addition of saturated aqueous NaHCO3 solution. 
The phases were separated and the aqueous phase was extracted with Et2O (3 × 
30 mL). The combined organic phases were washed with brine (100 mL), dried 
over magnesium sulfate, filtered and concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (petroleum ether: EtOAc, 
4:1 to 2:1) afforded the title compound 389 (212 mg, 94%) as a pale yellow oil. 
 
Rf = 0.59 (petroleum ether: EtOAc, 1:1); νmax (film) 2925, 2853, 1471,1338, 1162 
cm―1; 1H NMR (400 MHz, CDCl3) δ 7.62 (2H, d, J = 8.2 Hz, CH-Ts), 7.31 (2H, d, J = 
8.2 Hz, CH-Ts), 5.76 (1H, ddt, J = 17.6, 10.2, 7.3 Hz, CH-C10), 5.16−5.06 (2H, m, 
CH2-C11), 3.99−3.76 (4H, m, OCH2CH2O), 3.22 (1H, dt, J = 9.6, 4.0 Hz, CH2-C8), 
3.07 (1H, d, J = 12.1 Hz, CH2-C1), 2.73−2.64 (1H, m, CH2-C8), 2.60 (1H, d, J = 
12.1 Hz, CH2-C1), 2.46−2.40 (1H, m, CH2-C9), 2.43 (3H, s, CH3-Ts), 2.15 (1H, dd, 
J = 14.0, 7.3 Hz, CH2-C9), 1.92−1.86 (3H, m, CH2-C5, CH-C6, CH2-C7), 1.87 (1H, d, 
J = 14.7 Hz, CH2-C3), 1.80−1.75 (1H, m, CH2-C5), 1.73 (1H, d, J = 14.7 Hz, CH2-
C3), 1.65−1.52 (1H, m, CH2-C7); 
13C NMR (101 MHz, CDCl3) δ 143.3 (C-Ts), 133.9 
(C-Ts), 133.7 (CH-C10), 129.6 (CH-Ts), 127.5 (CH-Ts), 118.6 (CH2-C11), 116.0 (C-
C4), 64.3 (OCH2), 63.8 (OCH2), 49.2 (CH2-C1), 45.2 (CH2-C3), 42.7 (C-C2), 42.3 
(CH2-C8), 40.4 (CH2-C9), 39.6 (CH2-C5), 38.9 (CH-C6), 24.2 (CH2-C7), 21.5 (CH3-
Ts); HRMS (EI) for C20H27NO4S [M]
+ calcd. 377.1661, found 377.1645. 
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(E)-5-((4aS,7aR)-2-Tosyloctahydrospiro[cyclopenta[c]pyridine-6,2'-[1,3] 
dioxolane]-7a-yl)pent-3-en-2-one 388 
 
 C22H29NO5S 
 
Methyl vinyl ketone (67 mg, 0.95 mmol) was added to a solution of the alkene 
389 (126 mg, 0.32 mmol) and the Grubbs second-generation catalyst (5.4 mg, 2 
mol %) in DCM (10 mL). The mixture was heated at 50 °C for 24 h and was 
concentrated in vacuo. Purification of the residue by column chromatography on 
silica gel (petroleum ether: EtOAc, 3:1 to 1:1) afforded the title compound 388 
(112 mg, 81%) as a colourless foam.  
 
Rf = 0.45 (petroleum ether: EtOAc, 1:2); [α]D
24 +30 (c = 0.53, CHCl3); νmax (film) 
2928, 2885, 1672, 1339, 1161 cm―1; 1H NMR (400 MHz, CDCl3) δ 7.60 (2H, d, J = 
8.2 Hz, CH-Ts), 7.30 (2H, d, J = 8.2 Hz, CH-Ts), 6.76 (1H, dt, J = 15.7, 7.8 Hz, 
CH-C10), 6.16 (1H, d, J = 15.7 Hz, CH-C11), 3.87−3.76 (4H, m, OCH2CH2O), 3.34 
(1H, dt, J = 9.6, 4.0 Hz, CH2-C8), 3.10 (1H, d, J = 12.3 Hz, CH2-C1), 2.66 (1H, dd, 
J = 13.9, 7.8 Hz, CH2-C9), 2.63−2.56 (1H, m, CH2-C8), 2.55 (1H, d, J = 12.3 Hz, 
CH2-C1), 2.37 (3H, s, CH3-Ts), 2.26−2.17 (1H, m, CH2-C9), 2.20 (3H, s, CH3-C27), 
1.96−1.85 (3H, m, CH2-C7, CH2-C5, CH-C6), 1.84 (1H, d, J = 14.3 Hz, CH2-C3), 
1.82−1.76 (1H, m, CH2-C5), 1.73 (1H, d, J = 14.3 Hz, CH2-C3), 1.65−1.55 (1H, m, 
CH2-C7); 
13C NMR (101 MHz, CDCl3) δ 198.3 (C-C12), 143.5 (C-Ts), 142.9 (CH-C10), 
134.2 (CH-C11), 133.5 (C-Ts), 129.7 (CH-Ts), 127.5 (CH-Ts), 115.5 (C-C4), 64.5 
(OCH2), 64.0 (OCH2), 49.1 (CH2-C1), 45.8 (CH2-C3), 43.1 (C-C2), 42.0 (CH2-C8), 
39.4 (CH2-C5), 39.3 (CH-C6), 39.1 (CH2-C9), 27.4 (CH3-C27), 24.0 (CH2-C7), 21.5 
(CH3-Ts); HRMS (ESI) for C22H29NNaO5S [M+Na]
+ calcd. 442.1659, found 442.1666. 
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(R,E)-5-((4aS,7aR)-2-Tosyloctahydrospiro[cyclopenta[c]pyridine-6,2'-[1,3] 
dioxolane]-7a-yl)pent-3-en-2-ol 390 
 
 C22H31NO5S 
 
To a solution of the enone 388 (200 mg, 0.475 mmol) in dry THF (20 mL) was 
added (S)-CBS catalyst (0.07 mL of a 1 M solution in THF, 0.07 mmol). The 
mixture was cooled to −30 °C and borane-THF complex (0.58 mL of a 1 M solution 
in THF, 0.58 mmol) was added. After the mixture had been strirred at −30 °C for 
2 h, the reaction was quenched by addition of saturated aqueous ammonium 
chloride solution (10 mL). The phases were separated and the aqueous phase 
was extracted with Et2O (3 × 20 mL). The combined organic phases were washed 
with brine (50 mL), dried over magnesium sulfate, filtered and concentrated in 
vacuo. Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 2:1 to 1:1) afforded the title compound 390 (199 mg, 
99%) as a colourless foam. 
 
Rf = 0.40 (petroleum ether: EtOAc, 1:2); νmax (film) 3502 (br), 2957, 2924, 2856, 
1468, 1337, 1161, 1092 cm―1; 1H NMR (400 MHz, CDCl3) δ 7.60 (2H, d, J = 8.2 Hz, 
CH-Ts), 7.32 (2H, d, J = 8.2 Hz, CH-Ts), 5.66 (1H, dd, J = 14.6, 6.4 Hz, CH-C11), 
5.55 (1H, ddd, J = 14.6, 8.1, 6.8 Hz, CH-C10), 4.28 (1H, qd, J = 6.6, 6.4 Hz, CH-
C12), 3.88−3.75 (4H, m, CH2-ketal), 3.34−3.25 (1H, m, CH2-C8), 3.16 (1H, d, J = 
12.8 Hz, CH2-C1), 2.66−2.43 (3H, m, CH2-C8, CH2-C1, CH2-C9), 2.43 (3H, s, CH3-
Ts), 2.09−2.02 (1H, m, CH2-C9), 1.96−1.85 (4H, m, CH2-C3, CH2-C5, CH-C6, CH2-
C7), 1.79−1.72 (2H, m, CH2-C3, CH2-C5), 1.59−1.51 (1H, m, CH2-C7), 1.25 (3H, d, 
J = 6.6 Hz, CH3-C27); 
13C NMR (101 MHz, CDCl3): δ 143.5 (C-Ts), 143.9 (CH-C11), 
133.5 (C-Ts), 129.8 (CH-Ts), 127.6 (CH-Ts), 125.5 (CH-C10), 115.9 (C-C4), 69.0 
(CH-C12), 64.4 (OCH2), 64.0 (OCH2), 49.0 (CH2-C1), 45.9 (CH2-C3), 42.8 (C-C2), 
42.2 (CH2-C8), 39.5 (CH2-C5), 39.2 (CH-C6), 39.1 (CH2-C9), 24.1 (CH2-C7), 23.5 
(CH3-C27), 21.6 (CH3-Ts); HRMS (ESI) for C22H31NNaO5S [M+Na]
+ calcd. 444.1815, 
found 444.1819. 
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(4aS,7aR)-7a-((S,E)-4-Hydroxypent-2-enyl)-2-tosylhexahydro-cyclopenta[c] 
pyridin-6-one 371 
 C20H27NO4S 
The TBS ether 411154 (1.4 g, 7.5 mmol) was added to a solution of the alkene 
322 (0.50 g, 1.5 mmol) and the Hoveyda-Grubbs second-generation catalyst (47 
mg, 5 mol %) in DCM (50 mL). The mixture was then heated at 50 °C for 12 h and 
then a 1 M aqueous solution of HCl (20 mL) was added. The biphasic mixture was 
stirred for 2 h and then neutralised by addition of saturated aqueous NaHCO3 
solution (40 mL). The phases were separated and the aqueous phase was 
extracted with EtOAc (3 × 50 mL). The organic phases were combined and 
washed with brine (100 mL), dried over magnesium sulfate, filtered and 
concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 3:1 to 1:1) afforded the 
title compound 371 (481 mg, 85%) as a colourless foam. 
Rf = 0.26 (petroleum ether: EtOAc, 1:2); [α]D
22 +40 (c = 0.50, CHCl3); νmax (film) 
3492 (br), 2969, 2926, 2851, 1738, 1337, 1161, 1092 cm―1; 1H NMR (500 MHz, 
CDCl3) δ 7.60 (2H, d, J = 8.0 Hz, CH-Ts), 7.33 (2H, d, J = 8.0 Hz, CH-Ts), 
5.71−5.65 (1H, m, CH-C11), 5.59−5.50 (1H, m, CH-C10), 4.29 (1H, dq, J = 6.5, 
6.5 Hz, CH-C12), 3.25−3.18 (1H, m, CH2-C8), 3.09 (1H, d, J = 12.1 Hz, CH2-C1), 
2.73 (1H, dt, J = 10.3, 5.3 Hz, CH2-C8), 2.50 (1H, dd, J = 13.9, 8.2 Hz, CH2-C9), 
2.44 (3H, s, CH3-Ts), 2.39 (1H, d, J = 12.1 Hz, CH2-C1), 2.30 (1H, dd, J = 18.7, 
8.2 Hz, CH2-C5), 2.20−2.00 (3H, m, CH2-C9, CH-C6, CH2-C7), 2.16 (2H, s, CH2-C3), 
2.02 (1H, dd, J = 18.7, 8.2 Hz, CH2-C5), 1.58 (1H, dtd, J = 14.2, 5.3, 3.5 Hz, CH2-
C7), 1.27 (3H, d, J = 6.5 Hz, CH3-C27); 
13C NMR (126 MHz, CDCl3) δ 216.3 (C-C4), 
144.0 (C-Ts), 139.8 (CH-C11), 133.0 (C-Ts), 130.0 (CH-Ts), 127.7 (CH-Ts), 124.1 
(CH-C10), 68.7 (CH-C12), 49.5 (CH2-C1), 47.3 (CH2-C3), 42.5 (C-C2), 41.8 (CH2-
C8), 40.9 (CH2-C5), 39.1 (CH2-C9), 37.3 (CH-C6), 25.1 (CH2-C7), 23.7 (CH3-C27), 
21.7 (CH3-Ts); HRMS (ESI) for C20H27NNaO4S [M+Na]
+ calcd. 400.1535, found 
400.1553.  
                                                                                                                         
154 Uenishi, J.; Fujikura, Y.; Kawai, N. Org. Lett. 2011, 13, 2350-2353 
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2,2,2-Trifluoro-N-(hex-5-enyl)acetamide 401155 
 
 C8H12F3NO 
 
To a solution of trifluoroacetamide (1.13 g, 10.0 mmol) in DMF (50 mL) was 
added NaH (480 mg of a 60% dispersion in mineral oil, 12.0 mmol) and the 
mixture was stirred at rt for 15 min. 6-Bromo-1-hexene (1.70 g, 10.5 mmol) was 
added and the mixture was heated at 50 °C for 12 h. The mixture was then 
cooled to rt, diluted with EtOAc (100 mL) and the reaction was quenched by the 
addition of saturated aqueous NH4Cl solution (100 mL). The phases were 
separated and the aqueous phase was extracted with EtOAc (3 × 50 mL). The 
combined organic phases were washed with water (3 × 100 mL) and brine (100 
mL), dried over magnesium sulfate, filtered and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 10:1) afforded the title compound 401 (1.26 g, 93%) as 
a colourless oil.  
 
Rf = 0.38 (petroleum ether: EtOAc, 10:1); νmax (film) 3304, 2938, 2862, 1701, 
1560, 1157 cm―1; 1H NMR (400 MHz, CHCl3) δ 6.27 (1H, brs, NH), 5.78 (1H, ddt, J 
= 16.9, 10.2, 6.7 Hz, CH-C12), 5.03 (1H, ddt, J = 16.9, 2.0, 1.5 Hz, CH2-C11), 
4.98 (1H, ddt, J = 10.2, 2.0, 1.5 Hz, CH2-C11), 3.37 (2H, dt, J = 7.0, 6.6 Hz, CH2-
C16), 2.09 (2H, tdd, J = 7.0, 6.7, 1.5, CH2-C13), 1.63 (2H, tt, J = 8.4, 6.6 Hz, 
CH2-C15), 1.46 (2H, tt, J = 8.4, 7.0 Hz, CH2-C14); 
13C NMR (101 MHz, CDCl3) δ 
157.1 (q, J2C−F = 36.6 Hz, C-C27), 137.8 (CH-C12), 115.7 (q, J
1
C−F = 287.7 Hz, C-
C28), 114.6 (CH2-C11), 39.5 (CH2-C16), 33.0 (CH2-C13), 28.0 (CH2-C15), 25.6 
(CH2-C14).  
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
  
                                                                                                                         
155 Teichert, J. F.; Fananas-Mastral, M.; Feringa, B. L. Angew. Chem. Int. Ed. 2011, 50, 688−691   
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2,2,2-Trifluoro-N-(hex-5-enyl)acetimidoyl bromide 395 
 
 C8H11BrF3N 
 
To a stirred solution of CBr4 (13.2 g, 40.0 mmol) in DCM (50 mL) at 0 °C was 
added PPh3 (10.5 g, 40.0 mmol) in DCM (25 mL) in one portion. The resulting 
mixture was stirred at 0 °C for 5 min before the addition of a solution of the 
acetamide 401 (1.95 g, 10.0 mmol) in DCM (5 mL). The reaction mixture was 
stirred at 0 °C for 1 h and then allowed to reach rt. The mixture was 
concentrated; the residue was suspended in pentane, filtered through a short 
pad of Celite and the filter cake washed with pentane (50 mL). The filtrate was 
concentrated and the residue was purified by flash column chromatography on 
silica gel (pentane) to afford the title product 395 (47% w/w, 4.58 g, 84%) as a 
colourless solution in pentane.  
 
Rf = 0.43 (pentane); νmax (film) 2924, 2855, 1705, 1643, 1458, 1273, 1157 cm
―1; 
1H NMR (500 MHz, C6D6) δ 5.60 (1H, ddt, J = 17.2, 10.2, 6.9 Hz, CH-C12), 
4.96−4.93 (1H, m, CH2-C11), 4.92−4.91 (1H, m, CH2-C11), 3.06 (2H, ddd, J = 8.5, 
5.4, 1.6 Hz, CH2-C16), 2.08 (2H, dt, J = 6.9, 2.2 Hz, CH2-C13), 1.33−1.26 (2H, m, 
CH2-C15), 1.16−1.10 (2H, m, CH2-C14); 
13C NMR (126 MHz, C6D6) δ 138.3 (CH-C12), 
125.2 (q, J2C−F = 43.3 Hz, C-C27), 116.4 (q, J
1
C−F = 277.0 Hz, C-C28), 115.1 (CH2-
C11), 57.5 (CH2-C16), 33.6 (CH2-C13), 28.3 (CH2-C15), 26.7 (CH2-C14). 
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2,2,2-Trifluoro-N-(hex-5-enyl)-N-((R,E)-1-((4aS,7aR)-6-oxo-2-tosyloctahydro-
cyclopenta[c]pyridin-7a-yl)pent-3-en-2-yl)acetamide 387 
 
 C28H37F3N2O4S 
 
To a solution of the allylic alcohol 371 (4.0 g, 10.5 mmol) in THF (40 mL) at 
−30 °C was added NaHMDS (9.5 mL of 1 M solution in THF, 11.5 mmol). To the 
solution was added the bromide 395 (6.3 g of a 47% w/w solution in pentane, 
11.5 mmol) over 5 min. After stirring at −30 °C for 1 h, the reaction mixture was 
added anhydrous K2CO3 (1.6 g, 11.5 mmol) and toluene (80 mL). The resulting 
mixture was heated at 115 °C for 2 d with vigorous stirring. After cooling to rt, 
the mixture was filtered through a short pad of Celite and the filter cake was 
washed with EtOAc (100 mL). The combined filtrate was concentrated in vacuo 
and the residue was purified by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 4:1 to 2:1) to afford the title compound 387 (4.3 g, 74% 
yield over two steps) as a colourless gum. 
 
Rf = 0.66 (petroleum ether: EtOAc, 1:1); νmax (film) 2928, 2856, 1741, 1684, 1445, 
1337, 1184, 1161, 1092, 980 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.50 (2H, d, J = 
8.0 Hz, CH-Ts), 7.24 (2H, d, J = 8.0 Hz, CH-Ts), 5.91 (1H, ddq, J = 15.7, 8.7, 1.5 
Hz, CH-C11), 5.79−5.65 (2H, m, CH-C12, CH-C30), 4.93 (1H, ddt, J = 17.0, 2.4, 
1.5 Hz, CH-C31), 4.88−4.84 (1H, m, CH-C31), 3.98 (1H, dd, J = 8.7, 8.7 Hz, CH-
C10), 3.45 (1H, d, J = 11.2 Hz, CH2-C1), 3.34−3.24 (3H, m, CH2-C16, CH2-C8), 
2.36−2.30 (1H, m, CH2-C9), 2.34 (3H, s, CH3-Ts), 2.26 (1H, d, J = 11.2 Hz, CH2-
C1), 2.17−1.97 (8H, m, CH2-C3, CH2-C5, CH-C6, CH2-C7, CH2-C9, CH2-C13), 
1.90−1.82 (2H, m, CH2-C5, CH2-C8), 1.73−1.64 (2H, m, CH2-C15), 1.62 (3H, dd, J 
= 6.4, 1.5 Hz, CH3-C29), 1.56−1.49 (1H, m, CH2-C7), 1.34 (2H, tt, J = 7.9, 7.8 Hz, 
CH2-C14); 
13C NMR (101 MHz, CDCl3) δ 216.2 (C-C4), 156.2 (q, J
2
C−F = 35.0 Hz, C-
C27), 144.1 (C-Ts), 138.4 (CH-C30), 132.5 (C-Ts), 131.2 (CH-C12), 130.0 (CH-Ts), 
129.9 (CH-C11), 128.9 (CH-Ts), 116.5 (q, J1C−F = 270.1 Hz, C-C28), 114.8 (CH2-
C31), 61.4 (CH-C10), 50.1 (CH2-C3), 49.3 (CH2-C16), 47.7 (CH2-C8), 41.8 (CH2-C1), 
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40.5 (C-C2), 38.7 (CH2-C5), 38.2 (CH-C6), 36.9 (CH2-C9), 33.2 (CH2-C13), 28.7 
(CH2-C15), 26.0 (CH2-C14), 23.4 (CH2-C7), 21.6 (CH3-Ts), 17.9 (CH3-C29); HRMS 
(ESI) for C28H37F3N2NaO4S [M+Na]
+ calcd. 554.2426, found 554.2429.  
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(4aS,7aR)-7a-(((R,Z)-1,2,5,6,7,8-Hexahydroazocin-2-yl)methyl)-2-tosylocta 
hydrospiro[cyclopenta[c]pyridine-6,2'-[1,3]dioxolane] 408 
 
 C25H36N2O4S 
 
To a stirred solution of the trifluoroamide 397 (200 mg, 0.360 mmol) in MeOH 
(50 mL) was added saturated aqueous K2CO3 solution (10 mL). The mixture was 
heated at 70 °C for 3 h with vigorous stirring. After cooling to rt, the mixture 
was dried over anhydrous sodium sulfate, filtered through a short pad of Celite 
and the filter cake was washed with EtOAc (2 × 50 mL). The filtrate was 
concentrated in vacuo and the residue was purified by flash column 
chromatography on silica gel (EtOAc, to EtOAc: MeOH, 10:1) to give  the title 
compound 408 (204 mg, 81%) as a colourless gum.  
 
Rf = 0.30 (EtOAc: MeOH: Et3N, 87:10:3); νmax (film) 3464 (br), 2924, 2853, 1740, 
1468, 1447, 1335, 1161, 754 cm―1; 1H NMR (500 MHz, C6D6) δ 7.72 (2H, d, J = 8.0 
Hz, CH-Ts), 6.79 (2H, d, J = 8.0 Hz, CH-Ts), 5.72 (1H, dd, J = 9.4, 8.1 Hz, CH-
C12), 5.26 (1H, dd, J = 9.4, 9.4 Hz, CH-C11), 5.21 (1H, brs, NH), 4.11−4.00 (1H, 
m, CH-C10), 3.79 (1H, d, J = 12.1 Hz, CH2-C1), 3.45−3.24 (5H, m, CH2-C8, 
OCH2CH2O), 3.12−3.04 (1H, m, CH2-C8), 2.91−2.84 (1H, m, CH2-C16), 2.88−2.80 
(1H, m, CH2-C16), 2.69 (1H, d, J = 12.1 Hz, CH2-C1), 2.53−2.40 (2H, m, CH2-C8, 
CH2-C13), 2.34 (1H, d, J = 11.4 Hz, CH-C9), 2.12 (1H, d, J = 14.5 Hz, CH2-C3), 
2.03 (1H, d, J = 14.5 Hz, CH2-C3), 2.02−1.95 (1H, m, CH2-C13), 1.84 (3H, s, CH3-
Ts), 1.82−1.59 (6H, m, CH2-C9, CH2-C5, CH2-C7, CH2-C15, CH-C6), 1.37−1.26 (2H, 
m, CH2-C14), 1.14−1.08 (2H, m, CH2-C5, CH2-C7); 
13C NMR (126 MHz, C6D6) δ 
144.2 (C-Ts), 137.6 (C-Ts), 132.4 (CH-C11), 131.2 (CH-Ts), 129.5 (CH-C12), 128.0 
(CH-Ts), 116.1 (C-C4), 64.3 (OCH2), 63.6 (OCH2), 50.0 (CH-C10), 49.9 (CH2-C1), 
48.7 (CH2-C3), 45.1 (CH2-C16), 41.9 (CH2-C8), 41.5 (CH2-C9), 40.7 (C-C2), 39.9 
(CH-C6), 38.6 (CH2-C15), 30.0 (CH2-C14), 28.3 (CH2-C5), 26.4 (CH2-C13), 23.5 
(CH2-C7), 20.7 (CH3-Ts); HRMS (ESI) for C25H37N2O4S [M+H]
+ calcd. 461.2462, 
found 461.2469. 
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 (4aS,7aR)-2-Ts-7a-(((R,Z)-1-(2,2,2-trifluoroacetyl)-1,2,5,6,7,8-hexahydro 
azocin-2-yl)methyl)octahydro-cyclopenta[c]pyridin-6-one 397 
 
 C25H31F3N2O4S 
 
The diene 387 (1.3 g, 2.3 mmol) in DCM (20 mL) was added to a solution of the 
Grubbs second-generation catalyst (0.20 g, 0.23 mmol) in DCM (1 L). The 
resulting solution was heated at reflux for 4 h. The solution was cooled to rt, 
MeOH (10 mL) was added and the mixture was concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 2:1) afforded the title compound 397 (0.97 g, 81%) as 
a colourless foam.  
 
Rf = 0.52 (petroleum ether: EtOAc, 1:1); νmax (film) 2926, 2860, 2257, 1744, 1681, 
1450, 1337, 1196, 1160, 1092 cm―1; 1H NMR (400 MHz, CDCl3) δ 7.51 (2H, d, J = 
8.3 Hz, CH-Ts), 7.25 (2H, d, J = 8.3 Hz, CH-Ts), 5.76−5.53 (2H, m, CH-C11, CH-
C12), 4.54 (1H, dt, J =  5.3, 4.3 Hz, CH-C10), 3.76 (1H, dt, J = 14.5, 5.1 Hz, CH2-
C16), 3.52−3.35 (2H, m, CH2-C16, CH2-C8), 3.38 (1H, d, J = 12.1 Hz, CH2-C1), 
2.37−2.27 (2H, m, CH2-C8, CH2-C13), 2.35 (3H, s, CH3-Ts) 2.30 (1H, d, J = 8.1 Hz, 
CH2-C3), 2.23 (1H, d, J = 8.1 Hz, CH2-C3), 2.16−1.99 (7H, m, CH2-C1, CH2-C9, 
CH2-C5, CH-C6, CH2-C7, CH2-C13), 1.92−1.78 (3H, m, CH2-C5, CH2-C14, CH2-C15), 
1.71−1.59 (2H, m, CH2-C14, CH2-C15), 1.57−1.50 (1H, m, CH2-C7); 
13C NMR (101 
MHz, CDCl3) δ 215.5 (C-C4), 156.5 (q, J
2
C−F = 35.3 Hz, C-C27), 144.0 (C-Ts), 132.5 
(C-Ts), 131.0 (CH-C12), 130.2 (CH-C11), 129.9 (CH-Ts), 127.4 (CH-Ts), 116.5 (q, 
J1C−F = 288.5 Hz, C-C28), 54.7 (CH-C10), 48.7 (CH2-C3), 48.4 (CH2-C1), 47.9 (CH2-
C16), 41.8 (CH2-C8), 40.9 (C-C2), 39.1 (CH2-C5), 37.9 (CH-C6), 37.5 (CH2-C9), 
28.1 (CH2-C15), 26.4 (CH2-C13), 24.8 (CH2-C14), 23.7 (CH2-C7), 21.4 (CH3-Ts); 
HRMS (EI) for C25H31F3N2O4Si [M]
+ calcd 512.1957, found 512.1960. 
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(4aS,7aR)-7a-(((R,Z)-1,2,5,6,7,8-Hexahydroazocin-2-yl)methyl)-2-Tsocta 
hydro-cyclopenta[c]pyridin-6-one 386 
 
 C23H32N2O3S 
To a stirred solution of the amide 397 (475 mg, 1.14 mmol) in MeOH (40 mL) at 
rt was added 2 M aqueous K2CO3 solution (20 mL). The mixture was stirred at rt 
for 2 d. The reaction was diluted with EtOAc (80 mL) and then 1 M aqueous HCl 
solution (40 mL) was added. The phases were separated and the aqueous phase 
was extracted with EtOAc (3 × 60 mL). The combined organic extracts were 
washed with brine (200 mL), dried over anhydrous sodium sulfate, filtered and 
concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 2:1) gave the title 
compound 386 (341 mg, 92%) as a pale yellow oil.  
 
Rf = 0.28 (EtOAc: MeOH: Et3N, 87:10:3); [α]D
22 +83 (c = 0.47, CHCl3); νmax (film) 
3464 (br), 2924, 2853, 1740, 1468, 1447, 1335, 1161, 754 cm―1; 1H NMR (500 MHz, 
C6D6) δ 7.66 (2H, d, J = 8.3 Hz, CH-Ts), 6.85 (2H, d, J = 8.3 Hz, CH-Ts), 5.71 (1H, 
td, J = 12.2, 9.9 Hz, CH-C12), 5.27 (1H, dd, J = 9.9, 9.9 Hz, CH-C11), 4.51 (1H, 
brs, NH), 4.16−4.04 (1H, m, CH-C10), 3.34 (1H, d, J = 12.7 Hz, CH2-C1), 
3.32−3.23 (1H, m, CH2-C16), 3.12−3.04 (1H, m, CH2-C8), 2.91−2.84 (1H, m, CH2-
C16), 2.60 (1H, d, J = 12.0 Hz, CH2-C9), 2.36−2.34 (1H, m, CH2-C13), 2.28−2.18 
(2H, m, CH2-C1, CH2-C8), 2.15 (1H, d, J = 18.0 Hz, CH2-C3), 2.02 (1H, d, J = 18.0 
Hz, CH2-C3), 1.96−1.88 (1H, m, CH2-C5), 1.86 (3H, s, CH3-Ts), 1.85−1.69 (6H, m, 
CH2-C9, CH2-C13, CH2-C7, CH2-C15, CH-C6), 1.54−1.47 (1H, m, CH2-C14), 1.47 
(1H, dd, J = 18.6, 9.8 Hz, CH2-C5), 1.06−0.91 (2H, m, CH2-C14, CH2-C7); 
13C NMR 
(126 MHz, C6D6) δ 215.0 (C-C4), 143.1 (C-Ts), 135.6 (C-Ts), 133.9 (CH-C11), 129.6 
(CH-Ts), 128.2 (CH-C12), 127.6 (CH-Ts), 49.1 (CH2-C3), 48.8 (CH-C10), 48.7 (CH2-
C1), 44.2 (CH2-C16), 42.0 (CH2-C8), 40.6 (C-C2), 39.3 (CH2-C9), 39.0 (CH2-C5), 
37.3 (CH-C6), 28.1 (CH2-C14), 26.2 (CH2-C13), 25.6 (CH2-C15), 23.8 (CH2-C7), 
20.8 (CH3-Ts); HRMS (ESI) for C23H33N2O3S [M+H]
+ calcd. 417.2175, found 
417.2182.  
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(2'R,4S,11a'R,Z)-1-Tosyl-4-(3,3,3-trifluoro-2-oxopropyl)-1',6',7',8',9',11a'-
hexahydrospiro[piperidine-3,2'-pyrido[1,2-a]azocin]-4'-one 404 
 
8
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 C25H31F3N2O4S 
To a solution of the trifluoroamide epi-403 (78 mg, 0.15 mmol) in MeOH (20 mL) 
was added saturated aqueous K2CO3 (2 mL) and the mixture was heated at 70 °C 
for 3 h with vigorous stirring. After cooling to rt, the mixture was filtered 
through a short pad of Celite and washed with DCM (2 × 50 mL). The organic 
phases were concentrated in vacuo. Purification of the residue by column 
chromatography on silica gel (petroleum ether: EtOAc, 5:1 to 2:1) afforded the 
title compound 404 (72 mg, 92%) as a colourless solid. 
 
Rf = 0.55 (petroleum ether: EtOAc, 1:1); [α]D
26 +108 (c = 0.24, CHCl3);  m.p. 
170−175 °C; νmax (powder) 2926, 2854, 1763, 1631, 1454, 1338, 1207, 1149, 1091, 
979, 750 cm―1; 1H NMR (400 MHz, CDCl3) 7.55 (2H, d, J = 8.0 Hz, CH-Ts), 7.29 (2H, 
d, J = 8.0 Hz, CH-Ts), 5.89 (1H, dt, J = 10.7, 8.4 Hz, CH-C12), 5.22 (1H, dd, J = 
10.7, 7.7 Hz, CH-C11), 4.36−4.25 (1H, m, CH-C10), 4.07 (1H, dd, J = 13.7, 10.1 
Hz, CH2-C16), 3.17 (1H, dd, J = 13.7, 7.0 Hz, CH2-C16), 3.24−3.15 (1H, m, CH2-
C8), 3.01 (1H, d, J = 12.0 Hz, CH2-C1), 2.71−2.64 (1H, m, CH2-C8), 2.62 (1H, dd, 
J = 18.5, 2.8 Hz, CH2-C5), 2.49 (1H, d, J = 12.0 Hz, CH2-C1), 2.48−2.42 (1H, m, 
CH2-C5), 2.39 (3H, s, CH3-Ts), 2.36−2.17 (3H, m, CH2-C9, CH2-C13), 2.26 (1H, d, 
J = 16.9 Hz, CH2-C3), 2.14 (1H, d, J = 16.9 Hz, CH2-C3), 2.08−1.92 (4H, m, CH-C6, 
CH2-C7, CH2-C15), 1.68−1.59 (1H, m, CH2-C14), 1.46−1.33 (3H, m, CH2-C7, CH2-
C9, CH2-C14); 
13C NMR (101 MHz, CDCl3) δ 190.3 (q, J
2
C−F = 36.8 Hz, C-C17), 168.1 
(C-C4), 144.1 (C-Ts), 134.9 (CH-C12), 132.9 (C-Ts), 130.0 (CH-Ts), 128.6 (CH-
C11), 127.6 (CH-Ts), 116.8 (q, J1C−F = 287.9 Hz, C-C18), 49.9 (CH-C10), 49.8 (CH2-
C1), 43.0 (CH2-C8), 42.6 (CH2-C16), 38.9 (CH2-C3), 37.2 (CH2-C9), 36.2 (CH-C6), 
34.8 (C-C2), 34.6 (CH2-C5), 27.7 (CH2-C7), 26.5 (CH2-C13), 26.3 (CH2-C14), 25.7 
(CH2-C15), 21.2 (CH3-Ts); HRMS (ESI) C25H30F3N2O4S [M-H]
− calcd. for 511.1880, 
found 511.1884. 
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(4aR,7R,5S,11R,Z)-N-Tosyl-1,2,3,4,4a,5,8,9,10,11,13a,14-dodecahydro 
pyrido [3'',4'':1',5']cyclopenta[1',2':4,5]pyrrolo[1,2-a]azocin-6-one 385 
 C23H30N2O3S 
To a stirred solution of the amine 386 (437 mg, 1.05 mmol) in THF (40 mL) at 
0 °C was added pyrrolidone hydrotribromide (550 mg, 1.10 mmol) in one portion. 
The mixture was stirred overnight before addition of DMAP (250 mg, 2.02 mmol). 
The reaction mixture was stirred at rt for 12 h and then washed with saturated 
aqueous Na2S2O3 solution (30 mL), saturated aqueous Na2CO3 solution (30 mL) 
and brine (30 mL). The phases were separated and the organic phase was dried 
over anhydrous sodium sulfate, filtered and concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether: 
EtOAc, 2:1) afforded the title compound 385 (288 mg, 66%) as a pale yellow 
solid.  
 
Rf = 0.42 (petroleum ether: EtOAc, 1:1); [α]D
24 −47 (c = 0.48, CHCl3); m.p. 
128−132 °C; νmax (powder) 2953, 2925, 2857, 1739, 1467, 1160, 935 cm
―1; 1H 
NMR (500 MHz, C6D6) δ 7.63 (2H, d, J = 8.2 Hz, CH-Ts), 6.80 (2H, d, J = 8.2 Hz, 
CH-Ts), 5.55 (1H, ddd, J = 10.9, 7.9, 4.4 Hz, CH-C12), 5.27 (1H, dd, J = 10.9, 6.5 
Hz, CH-C11), 3.49 (1H, td, J = 6.5, 6.5 Hz, CH-C10), 3.41 (1H, d, J = 11.9 Hz, 
CH2-C1), 3.25 (1H, dt, J = 13.3, 4.7 Hz, CH2-C16), 3.20−3.06 (1H, m, CH2-C8), 
2.96 (1H, s, CH-C3), 2.95−2.87 (1H, m, CH2-C16), 2.49−2.35 (2H, m, CH2-C1, CH2-
C13), 2.30 (1H, dd, J = 10.6, 9.8 Hz, CH2-C8), 2.04 (1H, dtd, J = 13.1, 9.0, 4.4 Hz, 
CH2-C13), 1.90 (3H, s, CH3-Ts), 1.89−1.83 (1H, m, CH2-C5), 1.72−1.62 (1H, m, 
CH2-C9), 1.62−1.53 (3H, m, CH2-C15, CH2-C5), 1.45−1.24 (4H, m, CH-C6, CH2-C14, 
CH2-C9), 1.18 (1H, ddt, J = 14.6, 4.3, 2.5 Hz, CH2-C7), 0.80 (1H, ddt, J = 14.6, 
9.8, 4.7 Hz, CH2-C7); 
13C NMR (126 MHz, C6D6) δ 215.0 (C-C4), 143.1 (C-Ts), 134.9 
(C-Ts), 132.5 (CH-C11), 130.5 (CH-Ts), 129.7 (CH-C12), 128.6 (CH-Ts), 72.3 (CH-
C3), 59.7 (CH-C10), 52.3 (CH2-C1), 49.3 (CH2-C16), 48.8 (C-C2), 44.8 (CH2-C5), 
44.7 (CH2-C9), 44.2 (CH2-C8), 36.9 (CH-C6), 28.3 (CH2-C7), 27.4 (CH2-C14), 26.5 
(CH2-C15), 26.0 (CH2-C13), 21.2 (CH3-Ts); HRMS (ESI) for C23H31N2O3S [M+H]
+ 
calcd. 415.2037, found 415.2050. 
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2-(6-Bromohex-2-ynyloxy)tetrahydro-pyran 418156 
 
 C11H17BrO2 
 
To a stirred solution of 2-(2-propynyloxy)-tetrahydro-2H-pyran 414 (100 mg, 
0.713 mmol) in THF (20 mL) at −30 °C was added n-BuLi (0.33 mL of a 2.38 M 
solution in THF, 0.79 mmol). The mixture was stirred at −30 °C for 10 min and a 
solution of 1,3-dibromo-propane 417 (174 mg, 0.862 mmol) in THF (20 mL) was 
added. The mixture was stirred at −30 °C for 1 h and allowed to reach rt over 1 
h. The reaction was quenched by the addition of saturated aqueous NH4Cl 
solution (50 mL). The phases were separated and the aqueous phase was 
extracted with EtOAc (2 × 50 mL). The combined organic extracts were washed 
with brine (100 mL), dried over anhydrous magnesium sulfate, filtered and 
concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 5:1) gave the title 
compound 418 (150 mg, 81%) as a pale yellow oil.  
 
Rf = 0.56 (petroleum ether: EtOAc, 4:1); νmax (film) 2955, 2911, 2876, 2211, 1694, 
1607, 1354, 1250, 1165, 1094, 907, 743 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.81 (1H, 
t, J = 3.4 Hz, CH-THP), 4.35−4.18 (2H, m, CH2-C20), 3.89−3.82 (1H, m, CH2-THP), 
3.60−3.56 (1H, m, CH2-THP), 3.53 (2H, t, J = 6.3 Hz, CH2-C25), 2.44 (2H, tt, J = 
6.7, 2.1 Hz, CH2-C23), 2.06 (2H, tt, J = 6.7, 6.3 Hz, CH2-C24), 1.90−1.51 (6H, m, 
CH2-THP); 
13C NMR (101 MHz, CDCl3) δ 96.7 (CH-THP), 84.1 (C-C21), 77.2 (C-C22), 
62.0 (CH2-THP), 54.4 (CH2-C20), 32.1 (CH2-C25), 31.1 (CH2-C24), 30.4 (CH2-THP),  
25.1 (CH2-THP), 19.1 (CH2-THP), 17.5 (CH2-C23). 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
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7-(Tetrahydro-2H-pyran-2-yloxy)hept-5-ynenitrile 416157 
 
 C12H17NO2 
 
To a stirred solution of the bromide 418 (3.70 g, 15.0 mmol) in DMSO (30 mL) at 
rt was added NaCN (810 mg, 16.5 mmol). This mixture was stirred at 50 °C for 12 
h and then poured into water (100 mL). The mixture was extracted with Et2O (4 
× 100 mL) and the combined organic phases were washed with brine (200 mL), 
dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 6:1) gave the title compound 416 (2.83 g, 96%) as a 
colourless oil.   
 
Rf = 0.32 (4:1 petroleum ether: EtOAc); νmax (film) 2948, 2242, 2215, 1446, 1345, 
1118, 1023 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.76 (1H, t, J = 3.4 Hz, CH-THP), 
4.32−4.13 (2H, m, CH2-C20), 3.86−3.77 (1H, m, CH2-THP), 3.55−3.45 (1H, m, 
CH2-THP), 2.48 (2H, t, J = 7.2 Hz, CH2-C25), 2.40 (2H, tt, J = 6.8, 2.1 Hz, CH2-
C23), 1.96 (2H, tt, J = 7.2, 6.8 Hz, CH2-C24), 1.91−1.48 (6H, m, CH2-THP); 
13C 
NMR (101 MHz, CDCl3) δ 118.5 (C-C26), 96.0 (CH-THP), 82.9 (C-C21), 77.2 (C-
C22), 61.2 (CH2-THP), 53.4 (CH2-C20), 29.7 (CH2-C25), 24.8 (CH2-C24), 23.8 (CH2-
THP),  18.3 (CH2-THP), 17.1 (CH2-THP), 15.5 (CH2-C23). 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
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Methyl 7-hydroxyhept-5-ynoate 420157 
 
 C8H12O3 
 
To a stirred solution of the nitrile 418 (3.00 g, 14.5 mmol) in MeOH (80 mL) at rt 
was added 10% aqueous NaOH solution (20 mL). The resulting mixture was 
heated at reflux for 12 h. The mixture was then cooled to rt and poured into ice-
water (100 mL), acidified with aqueous concentrated HCl solution and extracted 
with Et2O (4 × 100 mL). The combined organic extracts were washed with brine 
(300 mL), dried over anhydrous magnesium sulfate, filtered and concentrated in 
vacuo. The acid 419 (3.18 g, 97%) was sufficient pure to be used directly into 
the next step without further purification. 
 
To a stirred solution of the carboxylic acid 419 (3.00 g, 13.3 mmol) in MeOH (60 
mL) at rt was added p-toluenesulfonic acid monohydrate (250 mg, 1.33 mmol). 
The resulting mixture was heated at reflux for 12 h. The mixture was cooled to 
rt, neutralised by the addition of saturated aqueous NaHCO3 solution (30 mL) 
and the aqueous phase was extracted with EtOAc (3 × 100 mL). The combined 
organic extracts were washed with brine (200 mL), dried over anhydrous 
magnesium sulfate, filtered and concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (petroleum ether: EtOAc, 
4:1) gave the title compound 420 (1.95 g, 94%) as a colourless oil. 
 
Rf = 0.31 (petroleum ether: EtOAc, 1:1); νmax (film) 3442 (br), 2948, 2911, 2872, 
2221, 1740, 1444, 1163, 1094 cm-1; 1H NMR (400 MHz, CDCl3) δ 4.24−4.22 (2H, m, 
CH2-C20), 3.67 (3H, s, CH3-C27), 2.42 (2H, t, J = 7.3 Hz, CH2-C25), 2.28 (2H, tt, J 
= 6.8, 2.1 Hz, CH2-C23), 1.83 (2H, tt, J = 7.3, 6.8 Hz, CH2-C24); 
13C NMR (101 
MHz, CDCl3) δ 173.6 (C-C26), 84.9 (C-C21), 79.2 (C-C22), 51.5 (CH2-C20), 51.0 
(CH3-C27), 32.7 (CH2-C25), 23.8 (CH2-C24), 18.1 (CH2-C23). 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
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(Z)-Methyl 7-hydroxyhept-5-enoate 421157 
 
 C8H14O3 
 
To a solution of the alkyne 420 (200 mg, 1.28 mmol) in EtOAc (10 mL) at rt was 
added Lindlar catalyst (10 mg, 0.13 mmol). This mixture was sparged with 
hydrogen for 10 min then stirred under a static hydrogen atmosphere at rt for 2 
h. The reaction was filtered through a short pad of Celite and the filter cake 
waswashed with EtOAc (50 mL).The filtrate was concentrated in vacuo and the 
residue was purified by flash column chromatography on silica gel (petroleum 
ether: ether, 10:1) to afford the title compound 421 (192 mg, 95%) as a 
colourless oil. 
 
Rf = 0.31 (petroleum ether: EtOAc, 1:1); νmax (film) 3412 (br), 3015, 2952, 2860, 
2240, 1740, 1434, 1161, 1094 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.67 (1H, dtt, J = 
10.8, 6.8, 1.4,  Hz, CH2-C21), 5.50 (1H, dtt, J = 10.8, 7.4, 1.3 Hz, CH2-C22), 4.17  
(2H, dd, J = 6.8, 1.3 Hz, CH2-C20), 3.67 (3H, s, CH3-C27), 2.32 (2H, t, J = 7.3 Hz, 
CH2-C25), 2.14 (2H, dtd, J = 7.4, 7.2, 1.4 Hz, CH2-C23), 1.72 (2H, tt, J = 7.3, 7.2 
Hz, CH2-C24); 
13C NMR (101 MHz, CDCl3) δ 173.8 (C-C26), 130.3 (C-C21), 129.8 
(C-C22), 57.5 (CH2-C20), 51.0 (CH3-C27), 32.8 (CH2-C25), 26.4 (CH2-C24), 24.5 
(CH2-C23). 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
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(Z)-Methyl 7-bromohept-5-enoate 415158 
 
 C8H13BrO2 
 
To a stirred solution of the alcohol 421 (1.2 g, 7.6 mmol) in DCM (50 mL) at 0 °C 
was added a solution of CBr4 (2.8 g, 8.4 mmol) in DCM (15 mL) and a solution of 
PPh3 (2.3 g, 8.7 mmol) in DCM (20 mL). This mixture was stirred at 0 °C for 1 h, 
filtered through a short pad of silica and the filter cake was washed with DCM 
(50 mL). The filtrate was concentrated in vacuo and the residue was purified by 
flash column chromatography on silica gel (petroleum ether: EtOAc, 10:1) to give 
the title compound 415 (1.64 g, 98%) as a pale yellow oil.  
 
Rf = 0.71 (petroleum ether: EtOAc, 2:1); νmax (film) 3022, 2949, 2862, 2242, 1740, 
1434, 1370, 1201, 1165 cm-1; 1H NMR (400 MHz, CDCl3) δ 5.77 (1H, dtt, J = 10.5, 
6.8, 1.4 Hz, CH2-C21), 5.58 (1H, dtt, J = 10.5, 7.4, 1.3 Hz, CH2-C22), 3.99  (2H, 
dd, J = 6.8, 1.3 Hz, CH2-C20), 3.67 (3H, s, CH3-C27), 2.33 (2H, t, J = 7.3 Hz, CH2-
C25), 2.18 (2H, dtd, J = 7.4, 7.2, 1.4 Hz, CH2-C23), 1.74 (2H, tt, J = 7.3, 7.2 Hz, 
CH2-C24); 
13C NMR (101 MHz, CDCl3) δ 173.6 (C-C26), 134.4 (C-C21), 129.8 (C-
C22), 57.5 (CH2-C20), 51.0 (CH3-C27), 32.8 (CH2-C25), 26.4 (CH2-C24), 24.5 (CH2-
C23). 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
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(Z)-Methyl 10-(tetrahydro-2H-pyran-2-yloxy)dec-5-en-8-ynoate 422 
 
 C16H24O4 
 
To a stirred solution of the alkyne 414 (1.00 g, 7.13 mmol) in THF (50 mL) at 
−78 °C was added EtMgBr (10.0 mL of a 0.70 M solution in THF, 7.2 mmol) and 
CuI (450 mg, 2.37 mmol). The mixture was stirred at −78 °C for 10 min and a 
solution of the bromide 415 (1.05 g, 4.75 mmol) in THF (10 mL) was added. The 
mixture was stirred at −78 °C for 1 h and allowed to reach rt over 2 h. The 
reaction was quenched by addition of saturated aqueous NH4Cl solution (50 mL). 
The aqueous phase was extracted with EtOAc (2 × 50 mL). The combined organic 
phases were washed with brine (100 mL), dried over anhydrous magnesium 
sulfate, filtered and concentrated in vacuo. Purification of the residue by flash 
column chromatography on silica gel (petroleum ether: EtOAc, 10:1 to 4:1) gave 
the title compound 422 (1.16 g, 87%) as a colourless oil.   
 
Rf = 0.68 (petroleum ether: EtOAc, 2:1); νmax (film) 3020, 2950, 2861, 2241, 2212, 
1740, 1354, 1250, 1165, 1094 cm-1; 1H NMR (500 MHz, C6D6) δ 5.47−5.40 (1H, m, 
CH2-C21), 5.22−5.15 (1H, m, CH2-C22), 4.94 (1H, t, J = 3.3 Hz, CH-THP), 
4.36−4.23 (2H, m, CH2-THP), 3.71 (1H, td, J = 10.6, 3.0 Hz, CH2-C17), 3.35 (1H, 
td, J = 10.6, 1.4 Hz, CH2-C17), 3.33 (3H, s, CH3-C27), 2.81−2.74 (2H, m, CH2-20), 
2.00 (2H, t, J = 7.4 Hz, CH2-C25), 1.78 (2H, dtd, J = 8.2, 7.3, 1.4 Hz, CH2-C23), 
1.76−1.54 (3H, m, CH2-THP), 1.48 (2H, tt, J = 7.4, 7.3 Hz, CH2-C24), 1.38−1.13  
(3H, m, CH2-THP); 
13C NMR (126 MHz, C6D6) δ 173.0 (C-C26), 130.6 (C-C22), 125.5 
(C-C21), 96.5 (CH-THP), 84.5 (C-C18), 76.5 (C-19), 61.4 (CH2-C17), 54.6 (CH2-
THP), 51.0 (CH3-C27), 33.3 (CH2-C25), 30.7 (CH2-THP), 26.6 (CH2-C23), 25.8 (CH2-
THP), 24.7 (CH2-C24), 19.3 (CH2-THP), 17.5 (CH2-C20); HRMS (ESI) for C16H24NaO4 
[M+Na]+ calcd. 303.1553, found 303.1524. 
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(Z)-Methyl 10-hydroxydec-5-en-8-ynoate 423 
 
 C11H16O3 
 
To a stirred solution of the protected alcohol 422 (710 mg, 2.54 mmol) in MeOH 
(40 mL) at rt was added p-toluenesulfonic acid monohydrate (22 mg, 0.12 mmol) 
and the mixture was heated under reflux for 12 h. The mixture was cooled to rt, 
neutralised by addition of saturated aqueous NaHCO3 solution (30 mL) and 
extracted with EtOAc (3 × 50 mL). The combined organic extracts were washed 
with brine (100 mL), dried over anhydrous magnesium sulfate, filtered and 
concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 4:1) gave the title 
compound 423 (495 mg, 98%) as a colourless oil.  
 
Rf = 0.14 (petroleum ether: EtOAc, 2:1); νmax (film) 3450 (br), 3020, 2950, 2912, 
2861, 2241, 1740, 1354, 1250, 1165, 1094 cm-1; 1H NMR (400 MHz, CDCl3) δ 
5.52−5.39 (2H, m, CH2-C21, CH2-C22), 4.31−4.17 (2H, m, CH2-C17), 3.68 (3H, s, 
CH3-C27), 3.00−2.94 (2H, m, CH2-20), 2.33 (2H, t, J = 7.0 Hz, CH2-C25), 2.08 (2H, 
dtd, J = 7.9, 7.3, 1.4 Hz, CH2-C23), 1.74 (2H, tt, J = 7.3, 7.0 Hz, CH2-C24); 
13C 
NMR (101 MHz, CDCl3) δ 173.3 (C-C26), 130.9 (C-C22), 128.8 (C-C21), 85.9 (C-
C18), 77.5 (C-19), 54.5 (CH2-C17), 50.0 (CH3-C27), 33.9 (CH2-C25), 31.8 (CH2-
C23), 26.9 (CH2-C24), 17.8 (CH2-C20); HRMS (ESI) for C11H16NaO3 [M+Na]
+ calcd. 
219.0991, found 219.0992. 
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(Z)-Methyl 10-bromodec-5-en-8-ynoate 465 
 
 C11H15BrO2 
 
To a stirred solution of the alcohol 423 (300 mg, 1.53 mmol) in DCM (40 mL) at 
0 °C was added a solution of CBr4 (1.26 g, 3.83 mmol) in DCM (10 mL) and a 
solution of PPh3 (1.00 g, 3.83 mmol) in DCM (10 mL). The mixture was stirred at 
0 °C for 1 h, then filtered through a short pad of silica and the filter cake 
washed with DCM (50 mL). The filtrate was concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether: 
EtOAc, 10:1) gave the title compound 465 (367 mg, 93%) as a pale yellow oil.  
 
Rf = 0.41 (petroleum ether: EtOAc, 4:1); νmax (film) 3022, 2949, 2910, 2859, 2240, 
1742, 1436, 1354, 1211, 1163 cm-1; 1H NMR (500 MHz, C6D6) δ 5.08−4.82 (2H, m, 
CH2-C21, CH2-C22), 3.15 (2H, t, J = 2.4 Hz, CH2-C17), 3.12 (3H, s, CH3-C27), 
2.44−2.38 (2H, m, CH2-20), 1.76 (2H, t, J = 7.0 Hz, CH2-C25), 1.49 (2H, dtd, J = 
7.9, 7.3, 1.4 Hz, CH2-C23), 1.22 (2H, tt, J = 7.3, 7.0 Hz, CH2-C24); 
13C NMR (126 
MHz, C6D6) δ 173.6 (C-C26), 131.2 (C-C22), 124.0 (C-C21), 85.6 (C-C18), 77.3 (C-
19), 57.5 (CH2-C17), 49.9 (CH3-C27), 33.0 (CH2-C25), 28.3 (CH2-C23), 23.0 (CH2-
C24), 16.1 (CH2-C20); HRMS (ESI) for C11H15NaO2Br [M+Na]
+ calcd. 281.0135, 
found 281.0148. 
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(R)- 5,6-di(tert-butyldimethylsilyloxy)-1-hexyne 495159 
 
 C18H38O2Si2 
 
To a stirred solution of the alcohol 494 (3.42 g, 15.0 mmol) and imidazole (2.10 
g, 30.0 mmol) in DCM (40 mL) at 0 °C was added TBSCl (3.40 g, 22.5 mmol). The 
mixture was stirred at 0 °C for 1.5 h and then allowed to reach rt over 30 min. 
The reaction was quenched by addition of saturated aqueous NH4Cl solution (50 
mL) and extracted with Et2O (3 × 100 mL). The organic extracts were washed 
with brine (80 mL), dried over anhydrous magnesium sulfate, filtered and 
concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (100% petroleum ether to 50:1 petroleum ether: 
Et2O) afforded the title compound 495 (4.80 g, 94%) as a colourless oil.  
 
Rf = 0.91 (petroleum ether: Et2O, 10:1); [α]D
27 +21.2 (c = 1.44, CHCl3); νmax (film) 
3316, 2957, 2859, 1473, 1257, 1123, 836, 776 cm―1; 1H NMR (400 MHz, CDCl3) δ 
3.78−3.75 (1H, m, CH-C18), 3.55 (1H, dd, J = 10.0, 5.2 Hz, CH2-C17), 3.39 (1H, 
dd, J = 10.0, 6.8  Hz, CH2-C17), 2.27−2.26 (2H, m, CH2-C19), 1.93 (1H, t, J = 2.6 
Hz, CH-C22), 1.84−1.80 (1H, m, CH2-C20), 1.63−1.61 (1H, m, CH2-C20), 0.89 (9H, 
s, CH3-TBS), 0.88 (9H, s, CH3-TBS), 0.08 (3H, s, CH3-TBS), 0.07 (3H, s, CH3-TBS), 
0.05 (3H, s, CH3-TBS), 0.04 (3H, s, CH3-TBS); 
13C NMR (101 MHz, CDCl3) δ 84.6 (C-
C21), 71.6 (CH-C18), 68.2 (CH-C22), 67.1 (CH2-C17), 33.2 (CH2-C19), 25.9 (CH3-
TBS), 25.9 (CH3-TBS), 18.3 (C-TBS), 18.1 (C-TBS), 14.4 (CH2-C20), −4.3 (CH3-TBS), 
−4.8 (CH3-TBS), −5.3 (CH3-TBS), −5.4 (CH3-TBS). 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
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(R)-Methyl 9,10-bis(tert-butyldimethylsilyloxy)dec-5-ynoate 501 
 
       C23H46O4Si2 
 
To a stirred solution of the alkyne 495 (2.5 g, 7.3 mmol) in THF (60 mL) at 
−78 °C was added n-BuLi (3.8 mL of a 2.32 M solution in THF, 8.8 mmol). The 
mixture was stirred at −78 °C for 30 min before addition of HMPA (5.0 mL, 29 
mmol) and the bromide 505 (1.5 mL, 8.8 mmol). The reaction mixture was then 
stirred at −78 °C for 1 h and allowed to reach rt overnight. The reaction was 
quenched by addition of saturated aqueous NH4Cl solution (50 mL) and the 
mixture was extracted with Et2O (3 × 100 mL). The combined organic extracts 
were washed with brine (50 mL), dried over anhydrous magnesium sulfate, 
filtered and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: Et2O, 100:1 to 50:1) afforded the 
title compound 501 (2.6 g, 82%) as a colourless oil.  
 
Rf = 0.45 (petroleum ether: Et2O, 10:1); [α]D
27 +25.3 (c = 1.70, CHCl3); νmax (film) 
2955, 2928, 2856, 1738, 1472, 1252, 1121, 835, 775 cm―1; 1H NMR (500 MHz, 
CDCl3) δ 3.74 (1H, m, CH-C18), 3.64 (3H, s, CH3-C27), 3.52 (1H, dd, J = 10.0, 5.2 
Hz, CH2-C17), 3.39 (1H, dd, J = 10.0, 6.5  Hz, CH2-C17), 2.41 (2H, t, J = 7.5, CH2-
C25), 2.23−2.15 (4H, m, CH2-C20, CH2-C23), 1.81−1.70 (3H, m, CH2-C19, CH2-
C24), 1.50−1.49 (1H, m, CH2-C19), 0.87 (9H, s, CH3-TBS), 0.86 (9H, s, CH3-TBS), 
0.05 (3H, s, CH3-TBS), 0.04 (3H, s, CH3-TBS), 0.03 (3H, s, CH3-TBS), 0.02 (3H, s, 
CH3-TBS); 
13C NMR (126 MHz, CDCl3) δ 173.6 (C-C26), 81.0 (C-C22), 78.9 (C-C21), 
71.8 (CH-C18), 67.3 (CH2-C17), 51.4 (CH3-C27), 33.7 (CH2-C19), 32.8 (CH2-C25), 
25.9 (CH3-TBS), 25.9 (CH3-TBS), 24.2 (CH2-C24), 18.3 (C-TBS), 18.2 (C-TBS), 18.1 
(CH2-C20), 14.7 (CH2-C23), −4.3 (CH3-TBS), −4.8 (CH3-TBS), −5.3 (CH3-TBS), −5.4 
(CH3-TBS); HRMS (ESI) for C23H46NaO4Si2 [M+Na]
+ calcd. 465.2805, found 465.2827. 
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(R,Z)-Methyl 9,10-bis(tert-butyldimethylsilyloxy)dec-5-enoate 502 
 
 C23H48O4Si2 
 
To a stirred solution of the alkyne 501 (1.5 g, 3.4 mmol) in EtOAc (20 mL) at rt 
was added Lindlar catalyst (722 mg, 0.34 mmol) and quinoline (44 mg, 0.34 
mmol). The mixture was sparged with hydrogen for 10 min, and then stirred 
under a static hydrogen atmosphere at rt for 1h. The reaction was then filtered 
through a short pad of Celite and the filter cake was washed with EtOAc (100 
mL). The filtrate was concentrated in vacuo. Purification of the residue by flash 
column chromatography on silica gel (petroleum ether: Et2O, 50:1) afforded the 
title compound 502 (1.5 g, 98%) as a colourless oil.  
 
Rf = 0.51 (petroleum ether: Et2O, 10:1); [α]D
21 +14 (c = 0.63, CHCl3); νmax (film) 
2953, 2928, 2857, 1742, 1472, 1462, 1252, 1101, 831, 773 cm―1; 1H NMR (500 
MHz, CDCl3) δ 5.45−5.36 (1H, m, CH-C21), 5.36−5.27 (1H, m, CH-C22), 3.68−3.63 
(1H, m, CH-C18), 3.65 (3H, s, CH3-C27), 3.46 (1H, dd, J = 10.0, 5.5 Hz, CH2-C17), 
3.36 (1H, dd, J = 10.0, 6.2  Hz, CH2-C17), 2.22 (2H, t, J = 7.6, CH2-C25), 2.01 (2H, 
td, J = 7.5, 6.2  Hz, CH2-C23), 2.13−1.91 (2H, m, CH2-C20), 1.61 (2H, tt, J = 7.6, 
7.5 Hz, CH2-C24), 1.56−1.49 (1H, m, CH2-C19), 1.40−1.32 (1H, m, CH2-C19), 0.83 
(18H, s, CH3-TBS), 0.05 (6H, s, CH3-TBS), 0.04 (3H, s, CH3-TBS), 0.03 (3H, s, CH3-
TBS); 13C NMR (126 MHz, CDCl3) δ 174.0 (C-C26), 130.9 (C-C21), 128.5 (C-C22), 
72.8 (CH-C18), 67.2 (CH2-C17), 51.4 (CH3-C27), 34.4 (CH2-C19), 33.5 (CH2-C25), 
26.6 (CH2-C23), 25.9 (CH3-TBS), 25.9 (CH3-TBS), 24.9 (CH2-C24), 23.0 (CH2-C20), 
18.4 (C-TBS), 18.1 (C-TBS), −4.3 (CH3-TBS), −4.8 (CH3-TBS), −5.3 (CH3-TBS), −5.4 
(CH3-TBS); HRMS (ESI) for C23H48NaO4Si2 [M+Na]
+ calcd. 467.2967, found 467.2983. 
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(R,Z)-Methyl 9-(tert-butyldimethylsilyloxy)-10-hydroxydec-5-enoate 493 
 
 C17H34O4Si 
 
To a stirred solution of the bis-TBS ether 502 (2.5 g, 7.3 mmol) in THF (60 mL) 
at −10 °C was added HF•pyridine (23 mL of a 4.81 M solution in THF, 110 mmol). 
The mixture was stirred at −10 °C for 2 d. The reaction was quenched by 
addition of saturated aqueous NaHCO3 solution (100 mL) and the resulting 
mixture was extracted with Et2O (3 × 100 mL). The combined organic phases 
were washed with brine (100 mL), dried over anhydrous magnesium sulfate, 
filtered and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: Et2O, 10:1 to 5:1) afforded the 
title compound 493 (1.5 g, 90%) as a colourless oil. 
 
Rf = 0.31 (petroleum ether: Et2O, 4:1); [α]D
23= −1.8 (c = 0.73, CHCl3); νmax (film) 
3499 (br), 2951, 2930, 2857, 1740, 1472, 1252, 1107, 835, 775 cm―1; 1H NMR (500 
MHz, CDCl3) δ 5.36−5.18 (2H, m, CH-C21, CH-C22), 3.65 (1H, tt, J = 6.2, 3.2 Hz, 
CH-C18), 3.57 (3H, s, CH3-C27), 3.50−3.42 (1H, m, CH2-C17), 3.38 (1H, ddd, J = 
11.2, 6.2, 5.7  Hz, CH2-C17), 2.22 (2H, t, J = 7.6, CH2-C25), 2.08−1.86 (4H, m, 
CH2-C20, CH2-C23), 1.60 (2H, tt, J = 7.6, 7.5 Hz, CH2-C24), 1.53−1.37 (2H, m, 
CH2-C19), 0.82 (9H, s, CH3-TBS), 0.00 (6H, s, CH3-TBS); 
13C NMR (126 MHz, CDCl3) 
δ 174.0 (C-C26), 130.3 (CH-C21), 128.8 (CH-C22), 72.5 (CH-C18), 66.0 (CH2-C17), 
51.4 (CH3-C27), 33.9 (CH2-C19), 33.4 (CH2-C25), 26.5 (CH2-C23), 25.8 (CH3-TBS), 
24.8 (CH2-C24), 23.1 (CH2-C20), 18.0 (C-TBS), −4.5 (CH3-TBS), −4.6 (CH3-TBS); 
HRMS (ESI) for C17H34NaO4Si [M+Na]
+ calcd. 353.2108, found 353.2119. 
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Methyl (R,Z)-9-((tert-butyldimethylsilyl)oxy)-10-oxodec-5-enoate 487 
 
 C17H32O4Si 
 
To a stirred solution of the alcohol 493 (500 mg, 1.51 mmol) in DCM (30 mL) at 
0 °C was added NaHCO3 (378 mg, 4.52 mmol) and Dess-Martin periodinane (1.27 
g, 3.02 mmol) in one portion. The mixture was stirred overnight before addition 
of saturated aqueous Na2S2O3 solution (30 mL). The reaction was then stirred for 
10 min and the phases were separated. The organic phase was washed with 
saturated aqueous Na2CO3 solution (30 mL), brine (30 mL), dried over anhydrous 
magnesium sulfate, filtered and concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (petroleum ether: ether, 
4:1) afforded the title compound 487 (488 mg, 98%) as a colourless oil.  
 
Rf = 0.42 (petroleum ether: Et2O, 4:1); [α]D
23 +28 (c = 0.89, CHCl3); νmax (film) 
2953, 2930, 2857, 1736, 1437, 1252, 1155, 1117, 837, 777 cm―1; 1H NMR (500 
MHz, CDCl3) δ 9.60 (1H, d, J = 1.6 Hz, CH-C17), 5.40−5.35 (2H, m, CH-C21, CH-
C22), 3.99 (1H, ddd, J = 6.9, 5.4, 1.6 Hz, CH-C18), 3.67 (3H, s, CH3-C27), 2.53 
(2H, t, J = 7.5, CH2-C25), 2.23−2.15 (4H, m, CH2-C20, CH2-C23), 1.81−1.70 (3H, 
m, CH2-C19, CH2-C24), 1.51 (1H, m, CH2-C19), 0.87 (9H, s, CH3-TBS), 0.05 (3H, s, 
CH3-TBS), 0.04 (3H, s, CH3-TBS); 
13C NMR (126 MHz, CDCl3) δ 204.1 (CH-C17), 
173.6 (C-C26), 129.8 (CH-C22), 129.5 (CH-C21), 71.8 (CH-C18), 51.5 (CH3-C27), 
33.5 (CH2-C19), 32.8 (CH2-C25), 26.6 (CH3-TBS), 25.8 (CH2-C24), 24.8 (C-TBS), 
22.3 (CH2-C20), 18.7 (CH2-C23), −4.6 (CH3-TBS), −4.9 (CH3-TBS); HRMS (ESI) for 
C17H32NaO4Si [M+Na]
+ calcd. 351.1969, found 351.1962. 
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Methyl(R,5Z,10E)-9-((tert-butyldimethylsilyl)oxy)-10-((4aR,6aR,13aR,14aR,Z) 
-6-oxo-2-tosyl-2,3,4,4a,6,6a,8,9,10,11,13a,14-dodecahydropyrido[3'',4'':1', 
5']cyclopenta[1',2':4,5]pyrrolo[1,2-a]azocin-5-ylidene)dec-5-enoate 506 
 
 C40H60N2O6SSi 
 
To a stirred solution of diisopropylamine (26 µL, 0.19 mmol) in THF (2 mL) at 
−78 °C was added n-BuLi (88 µL of a 2.16 M solution in THF, 0.19 mmol). The 
mixture was stirred at −78 °C for 10 min and a solution of the ketone 385 (70 mg, 
0.17 mmol) in THF (1 mL) was added. The mixture was then stirred at −78 °C for 
30 min and then a solution of the aldehyde 487 (61 mg, 0.19 mmol) in THF (1 mL) 
was added. The mixture was stirred at −78 °C for 2 h and allowed to reach rt 
over 12 h. The reaction was quenched by addition of saturated aqueous NH4Cl 
solution (5 mL) and the resulting mixture was extracted with EtOAc (3 × 10 mL). 
The combined organic extracts were washed with brine (30 mL), dried over 
anhydrous sodium sulfate, filtered and concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (gradient, petroleum ether: 
EtOAc, 10:1 to 2:1) afforded the title compound 506 (56 mg, 77%) as a yellow 
gum.  
 
Rf = 0.78 (petroleum ether: EtOAc, 2:1); [α]D
21 −23.7 (c = 1.06, CHCl3); νmax (film) 
2951, 2928, 2855, 1738, 1462, 1358, 1252, 1165, 982, 835, 775 cm―1; 1H NMR 
(400 MHz, C6D6) δ 7.71 (2H, d, J = 8.2 Hz, CH-Ts), 6.83 (2H, d, J = 8.2 Hz, CH-Ts), 
6.67 (1H, dd, J = 8.9, 1.5 Hz, CH-C17), 5.53−5.29 (4H, m, CH-C12, CH-C21, CH-
C11, CH-C22), 4.27−4.12 (2H, m, CH-C18, CH2-C1), 3.80−3.66 (2H, m, CH2-C8, 
CH2-C16), 3.54 (1H, s, CH-C3), 3.49−3.42 (1H, m, CH-C10), 3.39 (3H, s, CH3–C27), 
3.26−3.16 (2H, m, CH2-C16, CH2-C13), 2.26−1.87 (11H, m, CH-C6, CH2-C20, CH2-
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C13, CH2-C25, CH2-C23, CH2-C8, CH2-C1, CH2-C9), 1.92 (3H, s, CH3-Ts), 1.66−1.20 
(10H, m, CH2-C19, CH2-C24, CH2-C7, CH2-C14, CH2-C9, CH2-C15), 1.09−1.03 (1H, 
m, CH2-C7), 0.93 (9H, s, CH3–TBS), 0.05 (3H, s, CH3–TBS), 0.00 (3H, s, CH3–TBS); 
13C NMR (101 MHz, C6D6) δ 206.8 (C-C4), 172.8 (C-C26), 142.7 (C-Ts), 139.8 (C-
C5), 137.3 (CH-C17), 134.7 (CH-C11), 134.6 (C-Ts), 129.7 (CH-C21), 129.6 (CH-
C22), 129.3 (CH-Ts), 127.8 (CH-Ts), 127.6 (CH-C12), 71.4 (CH-C3), 69.5 (CH-C10), 
59.4 (CH-C18), 51.5 (CH2-C1), 50.7 (CH3-C27), 50.6 (CH2-C16), 49.9 (C-C2), 46.0 
(CH2-C8), 44.1 (CH2-C9), 39.5 (CH-C6), 37.0 (CH2-C20), 32.9 (CH2-C7), 30.1 (CH2-
C14), 26.8 (CH2-C23), 25.8 (CH3-TBS), 25.6 (CH2-C15), 25.1 (CH2-C13), 24.8 (CH2-
C25), 24.7 (CH2-C19), 23.0 (CH2-C24), 20.8 (CH3-C27), 17.9 (C-TBS), −4.1 (CH3-
TBS), −4.9 (CH3-TBS); HRMS (ESI) for C40H61N2O6SSi [M+H]
+ calcd. 725.3961, found 
725.4014. 
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Methyl(R,5Z,10E)-9-hydroxy-10-((4aR,6aR,13aR,14aR,Z)-6-oxo-2-tosyl-
2,3,4,4a,6,6a,8,9,10,11,13a,14-dodecahydropyrido[3'',4'':1',5'] 
cyclopenta[1',2':4,5]pyrrolo[1,2-a]azocin-5-ylidene)dec-5-enoate 486 
 
C34H46N2O6S 
 
To a stirred solution of the TBS ether 506 (10 mg, 14 µmol) in THF (5 mL) at 0 °C 
was added TBAF (21 µL of a 1 M solution in THF, 21 µmol). The mixture was 
stirred at 0 °C for 1 h and allowed to reach rt over 2 h. The reaction was 
quenched by addition of saturated aqueous NH4Cl solution (20 mL) and the 
resulting mixture was extracted with EtOAc (3 × 20 mL). The combined organic 
phases were washed with brine (50 mL), dried over anhydrous sodium sulfate, 
filtered and concentrated in vacuo. Purification of the residue by flash column 
chromatograph on silica gel (petroleum ether: EtOAc, 3:1) afforded the title 
compound 486 (7 mg, 82%) as a pale yellow oil.  
 
Rf = 0.41 (petroleum ether: EtOAc, 1:1); [α]D
22 −58 (c = 0.81, CHCl3); νmax (film) 
3507 (br), 2924, 2853, 1734, 1719, 1651, 1458, 1354, 1163, 1096, 980, 816 cm―1; 
1H NMR (500 MHz, C6D6) δ 7.69 (2H, d, J = 8.3 Hz, CH-Ts), 6.81 (2H, d, J = 8.3 Hz, 
CH-Ts), 6.53 (1H, dd, J = 7.8, 1.5 Hz, CH-C17), 5.49 (1H, dddd, J = 10.7, 9.0, 7.5, 
1.5 Hz, CH-C12), 5.42−5.28 (3H, m, CH-C21, CH-C11, CH-C22), 4.12 (1H, dd, J = 
11.9, 1.9 Hz, CH2-C1), 4.02 (1H, dt, J = 7.8, 4.2 Hz, CH-C18), 3.75−3.68 (2H, m, 
CH-C16, CH2-C8), 3.52 (1H, s, CH-C3), 3.42 (1H, dt, J = 9.8, 4.7 Hz, CH-C10), 
3.33 (3H, s, CH3-C27), 3.22 (1H, dt, J = 12.4, 2.4 Hz, CH2-C16), 3.08 (1H, ddt, J = 
12.9, 9.0, 4.9 Hz, CH2-C13), 2.31 (1H, ddd, J = 12.0, 6.3, 1.5 Hz, CH2-C6), 
2.17−1.92 (7H, m, CH2-C13, CH2-C20, CH2-C8, CH2-C1, CH2-C23), 1.91 (3H, s, 
CH3-Ts), 1.83−1.76 (2H, m, CH2-C15, CH2-C9), 1.64−1.42 (7H, m, CH2-C25, CH2-
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C14, CH2-C15, CH2-C7, CH2-C19), 1.36−1.24 (3H, m, CH2-C19, CH2-C24), 
1.18−1.06 (2H, m, CH2-C9, CH2-C7); 
13C NMR (126 MHz, C6D6) δ 207.4 (C-C4), 
173.3 (C-C26), 142.7 (C-Ts), 141.2 (C-C5), 136.3 (CH-C17), 134.8 (CH-C11), 134.6 
(C-Ts), 129.7 (CH-C21), 129.6 (CH-C22), 129.3 (CH-Ts), 128.2 (CH-Ts), 127.1 (CH-
C12), 71.2 (CH-C3), 68.3 (CH-C10), 59.7 (CH-C18), 51.5 (CH2-C1), 50.8 (CH3-C27), 
50.0 (CH2-C16), 45.9 (C-C2), 44.8 (CH2-C8), 44.1 (CH2-C9), 39.5 (CH-C6), 37.0 
(CH2-C20), 32.9 (CH-C7), 30.1 (CH2-C14), 26.8 (CH2-C23), 26.4 (CH2-C15), 25.1 
(CH2-C13), 24.8 (CH2-C25), 24.7 (CH2-C19), 23.0 (CH2-C24), 20.8 (CH3-Ts); HRMS 
(ESI) for C34H47N2O6S [M+H]
+ calcd. 611.3120, found 611.3149. 
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Methyl (Z)-8-((4aR,7bR,14aR,15aR,Z)-2-tosyl-1,2,3,4,4a,7b,9,10,11,12,14a, 
15-dodecahydrofuro[2'',3'':3',4']pyrido[3'',4'':1',5']cyclopenta[1',2':4,5] 
pyrrolo[1,2-a]azocin-6-yl)oct-5-enoate 485 
 
C34H44N2O5S 
 
To a stirred solution of the alcohol 486 (10 mg, 16 µmol) in toluene (3 mL) at rt 
was added p-toluenesulfonic acid monohydrate (3.8 mg, 20 µmol). The mixture 
was stirred vigorously at rt for 12 h. The reaction was quenched by addition of 
saturated aqueous Na2CO3 solution (10 mL) and the resulting mixture was 
extracted with EtOAc (3 × 10 mL). The combined organic extracts were washed 
with brine (20 mL), dried over anhydrous sodium sulfate, filtered and 
concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 4:1 to 2:1) afforded the 
title 485 compound (7.8 mg, 82%) as a pale yellow oil.  
 
Rf = 0.21 (petroleum ether: EtOAc, 3:2); [α]D
27 −7.3 (c = 0.70, CHCl3); νmax (film) 
2924, 2855, 1736, 1445, 1346, 1260, 1163, 1092, 812 cm―1; 1H NMR (400 MHz, 
MeOD) δ 7.66 (2H, d, J = 8.3 Hz, CH-Ts), 7.40 (2H, d, J = 8.3 Hz, CH-Ts), 5.93 
(1H, s, CH-C17), 5.79 (1H, ddd, J = 10.7, 9.0, 7.5 Hz, CH-C12), 5.48−5.31 (3H, m, 
CH-C21, CH-C11, CH-C22), 4.11 (1H, s, CH-C3), 3.65 (3H, s, CH3-C27), 3.55 (1H, 
ddd, J = 10.7, 9.3, 4.5 Hz, CH-C10), 3.51 (1H, d, J = 12.1 Hz, CH2-C1), 3.13−3.02 
(4H, m, CH2-C16, CH2-C8, CH2-C1), 2.95 (1H, dt, J = 13.9, 6.9 Hz, CH2-C16), 2.84 
(1H, dd, J = 5.5, 1.7 Hz, CH-C6), 2.66 (2H, t, J = 7.3 Hz, CH2-C19), 2.44 (3H, s, 
CH3-Ts), 2.41−2.28 (4H, m, CH2-C20, CH2-C25), 2.22−2.18 (2H, m, CH2-C13), 
2.10−1.94 (3H, m, CH2-C9, CH2-C23), 1.71−1.54 (9H, m, CH2-C9, CH2-C24, CH2-C7, 
CH2-C14, CH2-C15); 
13C NMR (101 MHz, MeOD) δ 174.3 (C-C26), 163.4 (C-C4), 
152.9 (C-C18), 143.6 (C-Ts), 134.8 (C-Ts), 133.0 (CH-C12), 131.8 (C-C5), 130.0 
(CH-C11), 129.5 (CH-Ts), 129.3 (CH-C21), 129.0 (CH-C22), 126.9 (CH-Ts), 102.4 
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(CH-C17), 70.2 (CH-C3), 58.0 (C-C2), 56.6 (CH-C10), 50.6 (CH3-C27), 49.5 (CH2-
C1), 49.3 (CH2-C16), 45.6 (CH2-C9), 41.5 (CH-C6), 40.8 (CH2-C8), 32.7 (CH2-C25), 
28.4 (CH2-C19), 27.8 (CH2-C14), 27.6 (CH2-C7), 26.1 (CH2-C23), 25.7 (CH2-C20), 
24.8 (CH2-C13), 24.5 (CH2-C24), 24.4 (CH2-C15), 20.1 (CH3-Ts); HRMS (ESI) for 
C34H45N2O5S [M+H]
+ calcd. 593.3033, found 593.3044. 
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(R)-1-(tert-Butyldimethylsilyloxy)hex-5-en-2-ol 490160 
 
 C12H26O2Si 
 
To a stirred solution of the epoxide 489 (2.5 g, 7.3 mmol) in Et2O (60 mL) at 
−30 °C was added allyl magnesium chloride (3.8 mL of a 2.32 M solution in THF, 
8.8 mmol). The mixture was stirred at −30 °C for 1 h and allowed to reach rt 
over 2 h. The reaction was quenched by addition of saturated aqueous NH4Cl 
solution (50 mL) and the resulting mixture was extracted with Et2O (3 × 100 mL). 
The combined organic phases were washed with brine (50 mL), dried over 
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether: 
Et2O, 100:1 to 50:1) gave the title compound 490 (2.60 g, 82%) as a colourless oil.  
 
Rf = 0.52 (petroleum ether: EtOAc, 10:1); νmax (film) 3520 (br), 3314, 2956, 2928, 
2852, 1473, 1257, 1123, 1087, 836, 776 cm―1; 1H NMR (500 MHz, CDCl3) δ 5.76 
(1H, ddt, J = 16.9, 10.2, 6.6 Hz, CH-C21), 5.03−4.85 (2H, m, CH2-C22), 3.64−3.51 
(2H, m, CH2-C17, CH-C18), 3.34 (1H, dd, J = 9.7, 7.2 Hz, CH2-C17), 2.37 (1H, d, J 
= 3.5 Hz, OH), 2.21−1.97 (2H, m, CH2-C20), 1.51−1.37 (2H, m, CH2-C19), 0.83 
(9H, s, CH3-TBS), 0.00 (6H, s, CH3-TBS);
 13C NMR (126 MHz, CDCl3) δ 138.5 (CH2-
C22), 114.7 (CH-C21), 71.4 (CH-C18), 67.3 (CH2-C17), 32.1 (CH2-C20), 30.0 (CH2-
C19), 26.0 (CH3-TBS), 18.4 (C-TBS), −5.2(CH3-TBS), −5.3(CH3-TBS). 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
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(R)-5,6-Di(tert-butyldimethylsilyloxy)hex-1-ene 491161 
 
 C18H40O2Si2 
 
To a stirred solution of the alcohol 490 (7.20 g, 31.3 mmol) in DCM (300 mL) was 
added imidazole (3.13 g, 46.0 mmol), DMAP (719 mg, 5.89 mmol) and TBSCl 
(5.70 g, 37.8 mmol). The mixture was stirred at rt for 16 h. The reaction was 
quenched with saturated aqueous NH4Cl solution (100 mL) and phases were 
separated. The aqueous phase was extracted with DCM (3 × 100 mL) and the 
combined organic extracts were washed with brine (100 mL), dried over 
anhydrous sodium sulfate and concentrated in vacuo. Purification of the residue 
by flash column chromatography on silica gel (petroleum ether: EtOAc, 97.5:2.5) 
provided bis-TBS ether 491 (10.6 g, 98%) as a colourless oil. 
 
Rf = 0.91 (petroleum ether: Et2O, 10:1); [α]D
27 +21 (c = 1.44, CHCl3) {Lit.
11 [α]D
20 
+9.2 (c = 2.1, CHCl3)}; νmax (film) 3316, 2957, 2930, 2859, 1473, 1257, 1123, 1087, 
835, 776 cm―1; 1H NMR (500 MHz, CDCl3) δ 5.77 (1H, ddt, J = 16.9, 10.2, 6.5 Hz, 
CH-C21), 5.01−4.84 (2H, m, CH2-C22), 3.62 (1H, dtd, J = 6.5, 5.4, 4.3 Hz, CH-
C18), 3.47 (1H, dd, J = 9.9, 5.4 Hz, CH2-C17), 3.35 (1H, dd, J = 9.9, 6.5 Hz, CH2-
C17),  2.16−1.94 (2H, m, CH2-C20), 1.70−1.62 (1H, m, CH2-C19), 1.46−1.39 (1H, 
m, CH2-C19), 0.90 (9H, s, CH3-TBS), 0.89 (9H, s, CH3-TBS), 0.07−0.04 (12H, m, 
CH3-TBS); 
13C NMR (126 MHz, CDCl3) δ 139.0 (CH2-C21), 114.2 (CH-C22), 72.6 
(CH-C18), 67.3 (CH2-C17), 33.6 (CH2-C20), 29.4 (CH2-C19), 26.0 (CH3-TBS), 25.9 
(CH3-TBS), 18.4 (C-TBS), 18.2 (C-TBS), −4.2 (CH3-TBS), −4.7 (CH3-TBS), −5.3 (CH3-
TBS), −5.4 (CH3-TBS). 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
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(R)-2-(tert-Butyldimethylsilyloxy)hex-5-en-1-ol 511 
 
 C12H26O2Si 
 
To a stirred solution of the bis-TBS ether 491 (2.5 g, 7.3 mmol) in THF (60 mL) 
at −10 °C was added HF•pyridine (23 mL of a 4.81 M solution in THF, 110 mmol). 
The mixture was stirred at −10 °C for 2 d. The reaction was quenched by 
addition of saturated aqueous NaHCO3 solution (100 mL) and the resulting 
mixture was extracted with Et2O (3 × 100 mL). The combined organic phases 
were washed with brine (100 mL), dried over anhydrous magnesium sulfate, 
filtered and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: Et2O, 100:1 to 50:1) gave the 
title compound 511 (1.5 g, 90%) as a colourless oil.  
 
Rf = 0.48 (petroleum ether: EtOAc, 10:1); [α]D
21 −8.2 (c = 0.85, CHCl3); νmax (film) 
3395 (br), 2953, 2930, 2857, 1472, 1254, 1105, 1045, 910, 833, 773 cm―1; 1H NMR 
(500 MHz, CDCl3) δ 5.81 (1H, ddt, J = 16.9, 10.2, 6.5 Hz, CH-C21), 5.10−4.89 (2H, 
m, CH2-C22), 3.76 (1H, dtd, J = 6.5, 5.1, 3.7 Hz, CH-C18), 3.58 (1H, ddd, J = 
11.1, 5.8, 3.7 Hz, CH2-C17), 3.47 (1H, ddd, J = 11.1, 6.5, 5.1 Hz, CH2-C17),  
2.11−2.05 (2H, m, CH2-C20), 1.86 (1H, dd, J = 5.8, 5.1 Hz, OH), 1.65−1.56 (2H, 
m, CH2-C19), 0.91 (9H, s, CH3-TBS), 0.09 (3H, s, CH3-TBS), 0.08 (3H, s, CH3-TBS); 
13C NMR (126 MHz, CDCl3) δ 138.3 (CH2-C21), 114.7 (CH-C22), 72.3 (CH-C18), 
66.1 (CH2-C17), 33.1 (CH2-C20), 29.5 (CH2-C19), 25.9 (CH3-TBS), 18.1 (C-TBS), 
−4.4 (CH3-TBS), −4.5 (CH3-TBS); HRMS (ESI) for C12H26NaO2Si [M+Na]
+ calcd. 
253.1587, found 253.1594. 
 
 
  
Chapter 3: Experimental  167 
 
(R)-2-(tert-Butyldimethylsilyloxy)hex-5-enal 510 
 
 C12H24O2Si 
 
To a stirred solution of the alcohol 511 (1.4 g, 6.1 mmol) in DCM (50 mL) at 0 °C 
was added NaHCO3 (1.5 g, 18 mmol) and Dess-Martin periodinane (6.1 g, 12 mmol) 
in one portion. The mixture was stirred at 0 °C for 2 h, then allowed to reach rt 
over 1 h and saturated aqueous Na2S2O3 solution (60 mL) was added. The 
reaction was then stirred for 30 min and the phases were separated. The organic 
phase was washed with saturated aqueous Na2CO3 (60 mL), brine (60 mL), dried 
over anhydrous magnesium sulfate, filtered and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: Et2O, 4:1) gave the title compound 510 (1.3 g, 95%) as a 
colourless oil. 
 
Rf = 0.88 (petroleum ether: EtOAc, 4:1); [α]D
21 +34 (c = 0.99, CHCl3); νmax (film) 
2955, 2930, 2857, 1736, 1472, 1254, 1107, 837, 777 cm―1; 1H NMR (500 MHz, 
CDCl3) δ 9.57 (1H, d, J = 1.6 Hz, CH-C17), 5.75 (1H, ddt, J = 16.9, 10.2, 6.5 Hz, 
CH-C21), 5.06−4.82 (2H, m, CH2-C22), 3.97 (1H, ddd, J = 7.0, 5.2, 1.6  Hz, CH-
C18), 2.24−2.05 (2H, m, CH2-C20), 1.79−1.62 (2H, m, CH2-C19), 0.90 (9H, s, CH3-
TBS), 0.06 (3H, s, CH3-TBS), 0.05 (3H, s, CH3-TBS); 
13C NMR (126 MHz, CDCl3) δ 
204.0 (CH-C17), 137.5 (CH2-C21), 115.4 (CH-C22), 77.0 (CH-C18), 32.0 (CH2-C20), 
28.7 (CH2-C19), 25.7 (CH3-TBS), 18.1 (C-TBS), −4.6 (CH3-TBS), −5.0 (CH3-TBS); 
HRMS (ESI) for C12H24NaO2Si [M+Na]
+ calcd. 251.1426, found 251.1438. 
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(4aR,5E,6aR,12Z,13aR,14aR)-5-((R)-2-(tert-Butyldimethylsilyloxy)hex-5-en-1-
ylidene)-2-tosyl-1,2,3,4,4a,5,8,9,10,11,13a,14-dodecahydropyrido[3'',4'': 
1',5'] cyclopenta [1',2':4,5]pyrrolo[1,2-a]azocin-6-one 508 
 
11
12
13
14
15
16
N
10
321
456
H
78
N
9
Ts
H
H 17
O
18TBSO
19
20
21
22
 C35H52N2O4SSi 
 
To a stirred solution of diisopropylamine (32 µL, 0.21 mmol) in THF (2 mL) at 
−78 °C was added n-BuLi (96 µL of a 2.16 M solution in THF, 0.21 mmol). The 
mixture was stirred at −78 °C for 10 min before addition of the ketone 385 (78 
mg, 0.19 mmol) in THF (1 mL). The mixture was then stirred at −78 °C for 30 
min before addition of the aldehyde 510 (51 mg, 0.19 mmol) in THF (1 mL). The 
mixture was stirred at −78 °C for 2 h and allowed to reach rt overnight. The 
reaction was quenched by addition of saturated aqueous NH4Cl (5 mL) and the 
resulting mixture extracted with EtOAc (3 × 10 mL). The combined organic 
extracts were washed with brine (30 mL), dried over anhydrous sodium sulfate, 
filtered and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 10:1 to 2:1) gave the title 
compound 508 (33 mg, 32%) as a yellow gum.  
 
Rf = 0.31 (petroleum ether: EtOAc, 2:1); [α]D
27 −40 (c = 1.78, CHCl3); νmax (film) 
2953, 2926, 2855, 1721, 1449, 1256, 1163, 1086, 835, 775 cm―1; 1H NMR (500 
MHz, CD2Cl2) δ 7.65 (2H, d, J = 8.2 Hz, CH-Ts), 7.37 (2H, d, J = 8.2 Hz, CH-Ts), 
6.37 (1H, dd, J = 8.9, 1.5 Hz, CH-C17), 5.79 (1H, ddt, J = 17.0, 10.2, 6.5 Hz, CH-
C21), 5.56−5.46 (1H, m, CH-C12), 5.41 (1H, dd, J = 11.2, 4.7 Hz, CH-C11), 
5.04−4.94 (2H, m, CH2-C22), 4.23 (1H, td, J = 8.9, 4.0 Hz, CH-C18), 3.85 (1H, dd, 
J = 12.1, 1.9 Hz, CH2-C1), 3.73 (1H, d, J = 12.2 Hz, CH2-C8), 3.47−3.33 (2H, m, 
CH2-C16, CH-C10), 3.41 (1H, s, CH-C3), 3.10 (1H, dt, J = 12.2, 2.4 Hz, CH2-C16), 
2.78 (1H, ddt, J = 13.2, 6.8, 4.2 Hz, CH2-C13), 2.53 (1H, ddd, J = 11.9, 6.0, 1.5 
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Hz, CH-C6), 2.44 (3H, s, CH3-Ts), 2.33 (1H, dt, J = 12.2, 2.5 Hz, CH2-C8), 2.21 
(1H, d, J = 12.1 Hz, CH2-C1), 2.19−2.04 (3H, m, CH2-C13, CH2-C20), 1.94 (1H, dd, 
J = 13.8, 9.8 Hz, CH2-C9), 1.84−1.47 (6H, m, CH2-C7, CH2-C14, CH2-C15, CH2-C19), 
1.45−1.33 (3H, m, CH2-C7, CH2-C9, CH2-C19), 0.85 (9H, s, CH3–TBS), 0.01 (3H, s, 
CH3–TBS), −0.05 (3H, s, CH3–TBS); 
13C NMR (126 MHz, CD2Cl2) δ 208.1 (C-C4), 
143.8 (C-Ts), 139.4 (C-C5), 138.1 (CH-C17), 138.0 (CH-C21), 134.4 (CH-C11), 
133.5 (C-Ts), 129.7 (CH-Ts), 127.9 (CH-C12), 127.6 (CH-Ts), 114.7 (CH2-C22), 
71.5 (CH-C3), 69.1 (CH-C18), 59.0 (CH-C10), 51.6 (CH2-C1), 49.8 (CH2-C16), 46.1 
(C-C2), 45.0 (CH2-C8), 44.2 (CH2-C9), 39.9 (CH-C6), 37.4 (CH2-C19), 30.7 (CH2-
C7), 29.3 (CH2-C20), 27.0 (CH2-C14), 25.5 (CH3-TBS), 25.2 (CH2-C15), 24.6 (CH2-
C13), 21.3 (CH3-Ts), 17.9 (C-TBS), −4.4 (CH3-TBS), −5.0 (CH3-TBS); HRMS (ESI) for 
C35H53N2O4SSi [M+H]
+ calcd. 625.3460, found 625.3490. 
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(4aR,7bR,14aR,15aR,Z)-6-(But-3-en-1-yl)-2-tosyl-1,2,3,4,4a,7b,9,10,11,12, 
14a,15-dodecahydrofuro[2'',3'':3',4']pyrido[3'',4'':1',5']cyclopenta[1',2':4,5] 
pyrrolo[1,2-a]azocine 512 
 C29H36N2O3S 
To a stirred solution of TBS ether 508 (10 mg, 16 µmol) in toluene (3 mL) at rt 
was added p-toluenesulfonic acid monohydrate (3.8 mg, 20 µmol). The mixture 
was stirred vigorously overnight at rt. The reaction was quenched by addition of 
saturated aqueous Na2CO3 (10 mL) and the resulting mixture was extracted with 
EtOAc (3 × 10 mL). The combined organic extracts were washed with brine (20 
mL), dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 4:1 to 2:1) gave the title compound 512 (7.8 mg, 82%) 
as a pale yellow oil.  
Rf = 0.45 (petroleum ether: Et2O, 10:1); [α]D
26 + 36 (c = 0.23, CHCl3); νmax (film) 
2924, 2855, 1447, 1348, 1163, 1094, 912, 731 cm―1; 1H NMR (500 MHz, MeOD) δ 
7.55 (2H, d, J = 8.1 Hz, CH-Ts), 7.30 (2H, d, J = 8.1 Hz, CH-Ts), 5.83 (1H, s, CH-
C17), 5.79−5.66 (2H, m, CH-C12, CH-C21), 5.38−5.32 (1H, m, CH-C11), 4.97−4.85 
(2H, m, CH2-C22),  4.01 (1H, s, CH-C3), 3.49−3.43 (1H, m, CH-C10), 3.42 (1H, d, 
J = 12.6 Hz, CH2-C1), 3.00−2.93 (4H, m, CH2-C1, CH2-C8, CH2-C16), 2.85 (1H, dt, 
J = 13.8, 7.2 Hz, CH2-C16), 2.75 (1H, dd, J = 5.4, 1.7 Hz, CH-C6), 2.61 (2H, t, J = 
7.4 Hz, CH2-C19), 2.33 (3H, s, CH3-Ts), 2.31−2.25 (2H, m, CH2-C20), 2.14−2.04 
(2H, m, CH2-C13), 1.91−1.89 (2H, m, CH2-C9, CH2-C7), 1.67−1.25 (6H, m, CH2-C7, 
CH2-C9, CH2-C14, CH2-C15); 
13C NMR (126 MHz, MeOD) δ 161.9 (C-C17), 143.6 (C-
Ts), 137.2 (CH-C21), 134.8 (C-Ts), 133.2 (CH-C12), 129.8 (CH-C11), 129.5 (CH-Ts), 
127.8 (C-C4), 126.9 (CH-Ts), 121.0 (C-C18), 114.4 (CH2-C22), 102.3 (CH-C17), 
70.3 (CH-C3), 58.0 (C-C2), 56.5 (CH-C10), 49.4 (CH3-C1), 49.2 (CH2-C16), 45.5 
(CH2-C7), 41.5 (CH-C6), 40.7 (CH2-C8), 32.1 (CH2-C20), 29.4 (CH2-C14), 28.0 
(CH2-C19), 25.1 (CH2-C15), 24.7 (CH2-C13), 24.3 (CH2-C9), 20.1 (CH3-Ts); HRMS 
(ESI) for C29H37N2NaO3S [M+Na]
+ calcd. 493.2507, found 493.2495. 
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 (4aS*,7aR*)-7a-Methyl-2-tosylhexahydro-1H-cyclopenta[c]pyridin-6-one 424 
 
 C16H21NO3S 
 
To a stirred solution of CuI (1.4 g, 7.5 mmol) and LiCl (0.35 g, 8.2 mmol) in THF 
(40 mL) at 0 °C was added methyl magnesium bromide (6 mL of a 2.85 M solution 
in THF, 17.1 mmol). The mixture was stirred at 0 °C for 10 min and a solution of 
the enone 320 (2.00 g, 6.8 mmol) in THF (10 mL) was added. The mixture was 
then stirred at 0 °C for 2 h and the reaction was quenched with saturated 
aqueous NH4Cl solution (30 mL). The aqueous phase was extracted with EtOAc (2 
× 30 mL). The combined organic extracts were washed with brine (30 mL), dried 
over anhydrous magnesium sulfate, filtered and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 6:1 to 3:1) gave the title compound 424 (1.95 g, 93%) 
as a colourless foam.  
 
Rf = 0.21 (petroleum ether: EtOAc, 4:1); νmax (film) 2924, 1735, 1458, 1334, 1157 
cm―1; 1H NMR (400 MHz, CDCl3) δ 7.63 (2H, d, J = 8.0 Hz, CH-Ts), 7.33 (2H, d, J = 
8.0 Hz, CH-Ts), 3.24−3.19 (1H, m, CH2-C8), 3.30 (1H, d, J = 12.0, CH2-C1), 2.77 
(1H, dd, J = 12.0, 0.6, CH2-C1), 2.59 (1H, d, J = 12.0, CH2-C8), 2.46 (1H, d, J = 
18.7 Hz, CH2-C3), 2.44 (3H, s, CH3-Ts), 2.39−2.44 (1H, m, CH2-C5), 2.01−1.94 (2H, 
m, CH-C6, CH2-C5), 1.97 (1H, d, J = 18.7 Hz, CH2-C3), 1.94−1.91 (1H, m, CH2-C7), 
1.52−1.48 (1H, m, CH2-C7), 1.14 (3H, s, CH3-C9); 
13C NMR (101 MHz, CDCl3) δ 
217.1 (C-C4), 143.7 (C-Ts), 133.0 (C-Ts), 129.8 (CH-Ts), 127.6 (CH-Ts), 52.3 
(CH2-C1), 47.6 (CH2-C3), 43.9 (CH2-C8), 42.4 (CH2-C5), 38.9 (C-2), 38.4 (CH-C6), 
26.8 (CH2-C7), 24.8 (CH3-Ts), 21.5 (CH3-C9); HRMS (EI) for C16H21NO3S ([M]
+) 
calcd.307.1242, found 307.1244. 
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Hex-5-en-2-yn-1-ol 427 
 
  C6H8O 
 
To a solution of propargyl alcohol (3.0 mL, 54 mmol) in THF (60 mL) at 0 °C was 
added ethylmagnesium bromide (38.0 mL of a 3.0 M solution in Et2O, 112 mmol). 
The mixture was heated under reflux for 1 h. The mixture was then cooled to 
0 °C and CuI (1.0 g, 5.3 mmol) was added in one portion. The mixture was 
stirred at 0 °C for 30 min before addition of allyl bromide (7.1 g, 59 mmol), and 
the resulting mixture was stirred at 0 °C for 5 h. The reaction was quenched by 
addition of saturated aqueous NH4Cl solution (100 mL). The phases were 
separated and the aqueous phase was extracted with Et2O (2 × 100 mL). The 
combined organic extracts were washed with brine (200 mL), dried over 
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether: 
EtOAc, 5:1 to 3:1) gave the title compound 427 (4.5 g, 87%) as a colourless oil.  
 
Rf = 0.32 (petroleum ether: EtOAc, 3:1); νmax (film) 3440 (br), 3055, 3005, 2994, 
2923, 2223, 1642, 1579, 1560, 1465, 1260, 1180, 922, 840 cm―1; 1H NMR (400 
MHz, CDCl3) δ 5.81 (1H, ddt, J = 17.1, 8.8, 7.6 Hz, CH-C14), 5.31(1H, ddt, J = 
17.1, 1.7, 1.7 Hz, CH2-C15), 5.11 (1H, ddt, J = 8.8, 1.7, 1.5 Hz, CH2-C15), 4.28 
(2H, t, J = 2.4 Hz, CH2-C10), 3.00 (2H, dtdd, J = 7.6, 2.4, 1.7, 1.5 Hz, CH2-C13), 
2.74 (1H, s, OH); 13C NMR (100 MHz, CDCl3) δ 132.2 (CH-C14), 116.9 (CH2-C15), 
82.6 (C-C11), 80.6 (C-C12), 50.9 (CH2-C10), 22.9 (CH2-C13); HRMS (ESI) for 
C6H8NaO ([M+Na]
+) calcd.119.0743, found 119.0737. 
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Hex-5-en-2-ynal 428 
 
    C6H6O 
 
To a stirred solution of the alcohol 427 (500 mg, 5.21 mmol) in DCM (50 mL) at 
0 °C was added manganese dioxide (4.5 g, 52 mmol) in one portion. The mixture 
was stirred at rt for 12 h. The mixture was then filtered through a short pad of 
Celite, washed with DCM (50 mL) and the filterate was concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel (DCM: 
Et2O, 30:1) gave the title compound 428 (432 mg, 86%) as a pale yellow oil.  
 
Rf = 0.62 (petroleum ether: EtOAc, 9:1); νmax (film) 2953, 2930, 2857, 1736, 1437, 
1252, 1155, 1117, 837, 777 cm―1; 1H NMR (500 MHz, CDCl3) δ 9.22 (1H, s, CH-
C10), 5.80 (1H, ddt, J = 17.0, 10.0, 5.4 Hz, CH-C14), 5.36 (1H, dtd, J = 17.0, 1.8, 
1.1 Hz, CH2-C15), 5.22 (1H, ddt, J = 10.0, 1.1, 1.0 Hz, CH2-C15), 3.20 (2H, ddd, J 
= 5.4, 1.8, 1.0 Hz, CH2-C13); 
13C NMR (126 MHz, CDCl3) δ 178.6 (C-C10), 130.6 
(CH-C14), 115.8 (CH2-C15), 87.7 (C-C12), 75.8 (C-C11), 26.6 (CH2-C13); HRMS 
(ESI) for C6H6NaO [M+Na]
+ calcd. 117.0311, found 117.0298. 
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(4aR*,7aR*,E)-5-(Hex-5-en-2-ynylidene)-7a-methyl-2-tosylhexahydro-cyclo 
penta[c]pyridin-6-one 429 and (4aS*,7aS*,E)-7-(Hex-5-en-2-ynylidene)-7a-
methyl-2-tosylhexahydro-cyclopenta[c]pyridin-6-one 430 
 
  C22H25NO3S    C22H25NO3S 
 
To a stirred solution of diisopropylamine (0.34 mL, 2.2 mmol) in THF (6 mL) at 
−78 °C was added n-BuLi (1.0 mL of a 2.2 M solution in THF, 2.2 mmol). The 
mixture was stirred at −78 °C for 10 min before addition of the ketone 320 (615 
mg, 2.02 mmol) in THF (4 mL). The resulting mixture was further stirred at 
−78 °C for 30 min and a solution of the aldehyde 428 (226 mg, 2.41 mmol) in 
THF (2 mL) was added. The mixture was stirred at −78 °C for 2 h, then allowed 
to reach rt over 1 h. The reaction was quenched by addition of saturated 
aqueous NH4Cl solution (10 mL) and the phases were separated. The aqueous 
phase was extracted with Et2O (2 × 20 mL). The combined organic extracts were 
washed with brine (20 mL), dried over anhydrous magnesium sulfate, filtered 
and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 9:1) gave the title 
compound 429 (368 mg, 48%) and its C3 alkylation isomer 430 (124 mg, 16%) as 
pale yellow gums.  
 
429: Rf = 0.91 (petroleum ether: EtOAc, 7:3); νmax (film) 2955, 2926, 2855, 1717, 
1618, 1339, 1163, 1034, 733 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.55 (2H, d, J = 
8.2 Hz, CH-Ts), 7.26 (2H, d, J = 8.2 Hz, CH-Ts), 6.38 (1H, dt, J = 2.3, 2.3 Hz, CH-
C10), 5.72 (1H, ddt, J = 17.0, 10.3, 3.8 Hz, CH-C14), 5.19 (1H, dtd, J = 17.0, 2.0, 
1.7 Hz, CH-C15), 5.07 (1H, dtd, J = 10.3, 1.7, 1.6 Hz, CH-C15), 3.35−3.28 (1H, m, 
CH2-C8), 3.13 (1H, d, J = 12.1 Hz, CH2-C1), 3.08 (2H, dddd, J = 3.8, 2.3, 2.0, 1.6 
Hz, CH2-C13), 2.61 (1H, d, J = 17.9 Hz, CH2-C3), 2.58−2.50 (2H, m, CH-C6, CH2-
C8), 2.40 (1H, d, J = 12.1 Hz, CH2-C1), 2.37 (3H, s, CH3-Ts), 2.06−1.98 (1H, m, 
CH2-C7), 2.02 (1H, d, J = 17.9 Hz, CH2-C3), 1.79 (1H, dtd, J = 13.9, 10.0, 4.2 Hz, 
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CH2-C7), 0.97 (3H, s, CH3-C9); 
13C NMR (126 MHz, CDCl3) δ 203.5 (C-C4), 149.0 
(C-Ts), 143.8 (C-Ts), 133.3 (C-C5), 131.5 (CH-C14), 130.0 (CH-Ts), 127.6 (CH-Ts), 
116.8 (CH2-C15), 114.3 (CH-C10), 100.1 (CH-C12), 79.6 (C-C11), 52.8 (CH2-C1), 
46.8 (CH2-C3), 45.3 (CH-C6), 44.8 (CH2-C8), 36.4 (C-C2), 25.9 (CH2-C7), 25.6 
(CH3-C9), 24.3 (CH2-C13), 21.6 (CH3-Ts); HRMS (ESI) for C22H25NNaO3S [M+Na]
+ 
calcd. 406.1415, found 406.1447 
 
430: Rf = 0.88 (petroleum ether: EtOAc, 7:3); νmax (film) 2948, 2927, 2850, 1717, 
1620, 1339, 1160, 1032, 733 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.61 (2H, d, J = 
8.2 Hz, CH-Ts), 7.31 (2H, d, J = 8.2 Hz, CH-Ts), 6.57 (1H, t, J = 2.5 Hz, CH-C10), 
5.88 (1H, ddt, J = 17.0, 10.3, 5.3 Hz, CH-C14), 5.35 (1H, dtd, J = 17.0, 1.7, 1.5 
Hz, CH-C15), 5.20 (1H, dtd, J = 10.3, 1.6, 1.5 Hz, CH-C15), 3.29−3.24 (2H, m, 
CH2-C13), 3.18 (1H, d, J = 12.3 Hz, CH2-C1), 3.16−3.13 (1H, m, CH2-C8), 3.11 (1H, 
d, J = 12.3 Hz, CH2-C1), 2.79−2.73 (1H, m, CH2-C8), 2.43 (3H, s, CH3-Ts), 
2.38−2.32 (1H, m, CH2-C5), 2.07 (1H, dd, J = 18.0, 8.3 Hz, CH2-C5), 2.04−1.91 
(2H, m, CH2-C7, CH-C6), 1.53−1.45 (1H, m, CH2-C7), 1.20 (3H, s, CH3-C9); 
13C 
NMR (126 MHz, CDCl3) δ 203.8 (C-C4), 149.3 (C-Ts), 143.3 (C-Ts), 133.3 (C-C3), 
131.5 (CH-C14), 129.7 (CH-Ts), 127.7 (CH-Ts), 117.0 (CH2-C15), 115.9 (CH-C10), 
104.0 (CH-C12), 78.7 (C-C11), 50.4 (CH2-C1), 43.6 (C-C2), 42.9 (CH2-C8), 40.7 
(CH2-C5), 39.7 (CH-C6), 37.3 (CH2-C7), 25.6 (CH2-C13), 24.5 (CH3-C9), 21.5 (CH3-
Ts); HRMS (ESI) for C22H25NNaO3S [M+Na]
+ calcd. 406.1415, found 406.1453. 
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But-2-ynal 433162 
 
 C4H4O 
 
To a stirred solution of 2-butyn-1-ol (350 mg, 5.01 mmol) in DCM (40 mL) at 0 °C 
was added manganese dioxide (4.30 g, 50.2 mmol) in one portion. The mixture 
was stirred at rt for 12 h. The reaction mixture was then filtered through a short 
pad of Celite and the filter cake was washed with DCM (100 mL). The filterate 
was concentrated in vacuo and the residue was purified by flash column 
chromatography on silica gel (DCM: Et2O, 30:1) to give the title compound 433 
(162 mg, 48%) as a volatile, pale yellow oil.  
 
Rf = 0.78 (petroleum ether: EtOAc, 9:1); 
1H NMR (500 MHz, CDCl3) δ 9.13 (1H, q, 
J = 1.1 Hz, CH-C10), 2.05 (1H, d, J = 1.1 Hz, CH3-C13); 
13C NMR (126 MHz, CDCl3) 
δ 177.1 (C-C10), 95.2 (C-C12), 80.9 (C-C11), 4.1 (CH3-C13). 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
 
 
  
                                                                                                                         
162 Persich, P.; Llaveria, J.; Lhermet, R.; Haro, T.; Stade, R.; Kondoh, A.; Fürstner, A. Chem. Eur. J. 
2013, 19, 13047−13058 
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(4aR*,5E,7E,7aS*)-5,7-Di(but-2-ynylidene)-7a-methyl-2-tosylhexahydro-1H-
cyclopenta[c]pyridin-6-one 435 
 
 C24H25NO3S 
 
To a stirred solution of diisopropylamine (0.17 mL, 1.1 mmol) in THF (2 mL) at 
−78 °C was added n-BuLi (0.45 mL of a 2.4 M solution in THF, 1.1 mmol). The 
mixture was stirred at −78 °C for 10 min and a solution of the ketone 320 (0.30 
g, 1.0 mmol) in THF (2 mL) was added. The mixture was stirred for 30 min at 
−78 °C and a solution of the aldehyde 433 (80 mg, 1.2 mmol) in THF (1 mL) was 
then added. The resulting mixture was stirred at −78 °C for 2 h, then allowed to 
reach rt over 1 h. The reaction was quenched by addition of saturated aqueous 
NH4Cl solution (10 mL). The aqueous phase was extracted with Et2O (2 × 20 mL). 
The combined organic extracts were washed with brine (20 mL), dried over 
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether: 
EtOAc, 9:1 to 3:1) gave the title compound 435 (200 mg, 45%) as a pale yellow 
gum. 
 
Rf = 0.40 (petroleum ether: EtOAc, 3:1); νmax (film) 2945, 2922, 2853, 2212, 1694, 
1607, 1462, 1350, 1256, 1163, 1094, 656 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.61 
(2H, d, J = 8.2 Hz, CH-Ts), 7.29 (2H, d, J = 8.2 Hz, CH-Ts), 6.59 (1H, q, J = 2.5 
Hz, CH-C14), 6.50 (1H, q, J = 2.7 Hz, CH-C10), 3.47 (1H, d, J = 12.3 Hz, CH2-C1), 
3.19 (1H, d, J = 12.3 Hz, CH2-C1), 3.09−3.02 (1H, m, CH2-C8), 2.98 (1H, dt, J = 
11.0, 5.3 Hz, CH2-C8), 2.66−2.59 (1H, m, CH-C6), 2.41 (3H, s, CH3-Ts), 2.14 (3H, 
d, J = 2.7 Hz, CH3-C13), 2.09−2.02 (1H, m, CH2-C7), 2.03 (3H, d, J = 2.5 Hz, CH3-
C17), 1.80 (1H, dddd, J = 18.2, 9.0, 5.3, 4.4 Hz, CH2-C7), 1.34 (3H, s, CH3-C9); 
13C NMR (126 MHz, CDCl3) δ 192.3 (C-C4), 150.5 (C-C3), 148.1 (C-C5), 143.6 (C-
Ts), 133.8 (C-Ts), 129.7 (CH-Ts), 127.7 (CH-Ts), 117.1 (CH-C10), 116.3 (CH-C14), 
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104.2 (C-C11), 101.3 (C-C15), 77.2 (C-C12), 76.8 (C-C16), 50.4 (CH2-C1), 44.2 
(CH-C6), 43.6 (CH2-C8), 42.7 (C-C2), 25.4 (CH2-C7), 24.5 (CH3-C9), 21.6 (CH3-Ts), 
5.4 (CH3-C13), 5.2 (CH3-C17); HRMS (ESI) for C24H25NNaO3S [M+Na]
+ calcd. 
430.1431, found 430.1447. 
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(4aS*,7aR*,E)-3-(But-2-yn-1-ylidene)-11-ethyl-7a-methyl-8-tosyl-3b,5,6, 
7,7a,8-hexahydro-furo[3',2':3,4]cyclopenta[1,2-c]pyridine 437 and 
(4aR*,7aS*,E)-5-(But-2-yn-1-ylidene)-15-ethyl-7a-methyl-8-tosyl-3b,5,6, 
7,7a,8-hexahydro-furo[2',3':4,5]cyclopenta[1,2-c]pyridine 438 
 
 C24H27NO3S    C24H27NO3S 
 
To a stirred solution of tributylphosphine (12 µL, 40 µmol) in DCM (10 mL) at 
0 °C was added water (5.0 µL, 0.28 mmol) and a solution of the enyne 435 (20 
mg, 40 µmol) in DCM (2 mL). The mixture was stirred at rt for 6 h. The solution 
was dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 6:1 to 3:1) gave the title compound 437 (9.9 mg, 49%) 
as a pale yellow oil and its C3 isomer 438 (5.9 mg, 29%) as a pale yellow oil.    
 
437: Rf = 0.65 (petroleum ether: EtOAc, 3:1); νmax (film) 2963, 2924, 2855, 2216, 
1618, 1456, 1335, 1261, 1161, 1090 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.61 (2H, d, 
J = 8.3 Hz, CH-Ts), 7.26 (2H, d, J = 8.3 Hz, CH-Ts), 5.95 (1H, s, CH-C10), 5.33 
(1H, q, J = 2.5 Hz, CH-C14), 3.86 (1H, d, J = 12.5 Hz, CH2-C1), 3.71 (1H, ddd, J = 
6.7, 6.1, 1.9 Hz, CH-C6), 3.24 (1H, d, J = 12.5 Hz, CH2-C1), 3.15−3.11 (1H, m, 
CH2-C8), 3.01−2.97 (1H, m, CH2-C8), 2.62 (2H, q, J = 7.6 Hz, CH2-C12), 2.42 (3H, 
s, CH3-Ts), 2.21−2.14 (1H, m, CH2-C7), 2.09 (3H, d, J = 2.5 Hz, CH3-C17), 
2.06−2.00 (1H, m, CH2-C7), 1.25 (3H, s, CH3-C9), 1.21 (3H, t, J = 7.6 Hz, CH3-
C13); 13C NMR (126 MHz, CDCl3) δ 163.0 (C-C11), 156.2 (C-C4), 144.7 (C-C5), 
143.6 (C-Ts), 139.4 (C-C3), 133.8 (C-Ts), 129.7 (CH-Ts), 127.6 (CH-Ts), 107.2 
(CH-C10), 107.1 (CH-C14), 98.8 (C-C16), 74.6 (C-C15), 58.5 (CH2-C1), 49.2 (CH-
C6), 43.6 (C-C2), 43.4 (CH2-C8), 25.0 (CH2-C7), 24.6 (CH3-C9), 22.4 (CH2-C12), 
21.6 (CH3-Ts), 9.6 (CH3-C17), 5.2 (CH3-C13); HRMS (ESI) for C24H27NNaO3S [M+Na]
+ 
calcd. 432.1583, found 432.1604. 
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438: Rf = 0.68 (petroleum ether: EtOAc, 3:1); νmax (film) 2953, 2920, 2853, 2214, 
1616, 1456, 1333, 1261, 1165, 1091 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.59 (2H, d, 
J = 8.2 Hz, CH-Ts), 7.26 (2H, d, J = 8.2 Hz, CH-Ts), 5.85 (1H, s, CH-C14), 5.39 
(1H, q, J = 2.5 Hz, CH-C10), 3.31−3.27 (1H, m, CH2-C8), 3.26 (1H, d, J = 12.2 Hz, 
CH2-C1), 3.17 (1H, d, J = 12.2 Hz, CH2-C1), 3.15−3.11 (1H, m, CH2-C8), 3.01 (1H, 
dd, J = 7.3, 5.5 Hz, CH-C6), 2.62  (2H, q, J = 7.6 Hz, CH2-C16), 2.41 (3H, s, CH3-
Ts), 2.21−2.14 (1H, m, CH2-C7), 2.06−2.00 (1H, m, CH2-C7), 1.99 (3H, d, J = 2.5 
Hz, CH3-C13), 1.25 (3H, s, CH3-C9), 1.22 (3H, t, J = 7.6 Hz, CH3-C17); 
13C NMR 
(126 MHz, CDCl3) δ 159.3 (C-C15), 158.0 (C-C4), 144.8 (C-C5), 143.6 (C-Ts), 136.8 
(C-C3), 133.8 (C-Ts), 129.7 (CH-Ts), 127.6 (CH-Ts), 109.1 (CH-C14), 108.3 (CH-
C10), 79.1 (C-C12), 74.4 (C-C11), 52.2 (CH2-C1), 45.8 (CH-C6), 45.5 (C-C2), 43.4 
(CH2-C8), 25.0 (CH2-C7), 24.6 (CH3-C9), 22.4 (CH2-C16), 21.6 (CH3-Ts), 9.6 (CH3-
C17), 5.4 (CH3-C13); HRMS (ESI) for C24H27NNaO3S [M+Na]
+ calcd. 432.1583, found 
432.1594. 
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(But-3-yn-1-yloxy)triethylsilane 441163 
 
  C10H20OSi 
 
To a stirred solution of 3-butyn-1-ol (2.00 g, 28.5 mmol) in DCM (100 mL) at 0 °C 
was added TESCl (5.30 g, 34.5 mmol) and pyridine (2.90 g, 37.0 mmol). The 
mixture was stirred for 4 h at 0 °C and saturated aqueous NH4Cl solution (60 mL) 
was added. The aqueous phase was extracted with DCM (2 × 60 mL) and the 
combined organic extracts were washed with brine (100 mL), dried over 
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether: 
DCM, 3:1) gave the title compound 441 (5.02 g, 96%) as a colourless oil.  
 
Rf = 0.80 (petroleum ether: DCM, 3:2); νmax (film) 3315, 2943, 2926, 2866, 1464, 
1111 cm―1; 1H NMR (500 MHz, CDCl3) δ 3.75 (2H, t, J = 7.3 Hz, CH2-C14), 2.37 (2H, 
td, J = 7.3, 2.7 Hz, CH2-C13), 1.89 (1H, t, J = 2.7 Hz, CH-C11), 0.88 (9H, t, J = 
8.1 Hz, CH3-TES), 0.53 (6H, q, J = 8.1 Hz, CH2-TES); 
13C NMR (126 MHz, CDCl3) δ 
81.5 (CH2-C14), 69.4 (C-C12), 61.6 (C-C11), 23.0 (CH-C13), 6.8 (CH2-TES), 4.5 
(CH3-TES). 
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5-(Triethylsilyloxy)pent-2-yn-1-ol 442 
 
  C11H22O2Si 
 
To a stirred solution of the alkyne 441 (4.60 g, 25.0 mmol) in THF (80 mL) at 
−78 °C was added n-BuLi (10 mL of a 2.75 M solution in THF, 27.5 mmol). The 
mixture was stirred at −78 °C for 30 min, then at 0 °C for 30 min and 
paraformaldehyde (2.25 g, 75.0 mmol) was added. The reaction mixture was 
stirred at 0 °C for 1 h, then allowed to reach rt over 2 h. The reaction was 
quenched by addition of saturated aqueous NH4Cl solution (100 mL) and the 
aqueous phase was extracted with EtOAc (2 × 80 mL). The combined organic 
extracts were washed with brine (100 mL), dried over anhydrous magnesium 
sulfate, filtered and concentrated in vacuo. Purification of the residue by flash 
column chromatography on silica gel (petroleum ether: EtOAc, 1:5) gave the 
title compound 442 (5.13 g, 96%) as a colourless oil.  
 
Rf = 0.44 (petroleum ether: EtOAc, 4:1); νmax (film) 3372 (br), 2955, 2913, 2876, 
1414, 1238, 1098, 829, 725 cm―1; 1H NMR (500 MHz, CDCl3) δ 4.14−4.11 (2H, m, 
CH2-C10), 3.64 (2H, t, J = 7.2 Hz, CH2-C14), 3.23 (1H, s, OH), 2.36 (2H, tt, J = 
7.2, 2.1 Hz, CH2-C13), 0.88 (9H, t, J = 8.1 Hz, CH3-TES), 0.53 (6H, q, J = 8.1 Hz, 
CH2-TES); 
13C NMR (126 MHz, CDCl3) δ 82.5 (C-C12), 80.0 (C-C11), 61.5 (CH2-C14), 
50.8 (CH2-C10), 23.0 (CH2-C13), 6.6 (CH3-TES), 4.3 (CH2-TES); HRMS (ESI) for 
C11H22NaO2Si [M+Na]
+ calcd. 237.1287, found 237.1281. 
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5-(Triethylsilyloxy)pent-2-ynal 443 
 
  C11H20O2Si 
 
To a stirred solution of the alcohol 442 (1.3 g, 6.0 mmol) in DCM (50 mL) at 0 °C 
was added manganese dioxide (5.2 g, 60 mmol) in one portion. The mixture was 
stirred for 12 h at rt. The reaction was then filtered through a short pad of 
Celite, washed with DCM (100 mL) and the filtrate was concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 10:1) gave the title compound 443 (980 mg, 76%) as a 
pale yellow oil.  
 
Rf = 0.91 (petroleum EtOAc, 4:1); νmax (film) 3372 (br), 2955, 2913, 2876, 2205, 
1668, 1238, 1136, 1101, 749 cm―1; 1H NMR (500 MHz, CDCl3) δ 9.10 (1H , t, J = 
0.8 Hz, CH-C10), 3.73 (2H, t, J = 6.8 Hz, CH2-C14), 2.57 (2H, td, J = 6.8, 0.8 Hz, 
CH2-C13), 0.88 (9H, t, J = 8.1 Hz, CH3-TES), 0.54 (6H, q, J = 8.1 Hz, CH2-TES); 
13C 
NMR (126 MHz, CDCl3) δ 176.8 (CH-C10), 95.9 (C-C12), 82.2 (C-C11), 60.3 (CH2-
C14), 23.5 (CH2-C13), 6.6 (CH3-TES), 4.3 (CH2-TES); HRMS (ESI) for C11H20NaO2Si 
[M+Na]+ calcd. 235.1134, found 235.1125. 
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(4aR*,7aR*,E)-7a-Methyl-2-tosyl-5-(5-triethylsilyloxypent-2-ynylidene) 
hexahydro-cyclopenta[c]pyridin-6-one 444 and (4aR*,7aR*,E)-7a-Methyl-2-
tosyl-5-7-bis(5-triethylsilyloxypent-2-ynylidene)hexahydro-cyclopenta 
[c]pyridin-6-one 446 
 
  C27H39NO4SSi       C38H57NO5SSi2 
 
To a stirred solution of diisopropylamine (0.42 mL, 2.9 mmol) in THF (6 mL) at 
−78 °C was added n-BuLi (1.2 mLof a 2.38 M solution in THF, 2.9 mmol). The 
mixture was stirred for 10 min at −78 °C and a solution of ketone 320 (0.80 g, 
2.6 mmol) in THF (2 mL) was added. The resulting mixture was stirred at −78 °C 
for 30 min and a solution of the aldehyde 443 (0.66 mg, 3.1 mmol) in THF (2 mL) 
was added. The mixture was stirred at −78 °C for 2 h and then allowed to reach 
rt over 1 h. The reaction was quenched by addition of saturated aqueous NH4Cl 
solution (10 mL). The aqueous phase was extracted with EtOAc (2 × 20 mL) and 
the combined organic extracts were washed with brine (20 mL), dried over 
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether: 
EtOAc, 5:1) gave the title compound 444 (538 mg, 45%) as a colourless oil and 
bis-alkylated compound 446 (102 mg, 6%) as a pale yellow oil.  
 
444: Rf = 0.41 (petroleum ether: EtOAc, 3:1); νmax (film) 2955, 2911, 2876, 2212, 
1719, 1616, 1354, 1341, 1161, 1096 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.61 (2H, d, 
J = 8.2 Hz, CH-Ts), 7.31 (2H, d, J = 8.2 Hz, CH-Ts), 6.39 (1H, dt, J = 4.4, 2.2 Hz, 
CH-C10), 3.71 (2H, t, J = 6.8 Hz, CH2-C14), 3.40−3.27 (1H, m, CH2-C8), 3.16 (1H, 
d, J = 12.0 Hz, CH2-C1), 2.65 (1H, d, J = 17.8 Hz, CH2-C3), 2.61−2.52 (4H, m, 
CH2-C8, CH2-C13, CH-C6), 2.45 (1H, d, J = 12.0 Hz, CH2-C1), 2.42 (3H, s, CH3-Ts), 
2.05 (1H, d, J = 17.8 Hz, CH2-C3), 2.09−2.04 (1H, m, CH2-C7), 1.90−1.78 (1H, m, 
CH2-C7), 1.02 (3H, s, CH3-C9), 0.92 (9H, t, J = 8.0 Hz, CH3-TES), 0.57 (6H, q, J = 
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8.0 Hz, CH2-TES); 
13C NMR (126 MHz, CDCl3) δ 203.5 (C-C4), 148.9 (C-C5), 143.8 
(C-Ts), 133.1 (C-Ts), 129.9 (CH-Ts), 127.7 (CH-Ts), 114.5 (CH-C10), 101.1 (C-C11), 
78.4 (C-C12), 61.2 (CH2-C14), 52.9 (CH2-C1), 46.8 (CH2-C3), 45.2 (CH-C6), 44.8 
(CH2-C8), 36.3 (C-C2), 25.7 (CH2-C7), 25.6 (CH3-C9), 24.5 (CH2-C13), 21.6 (CH3-
Ts), 6.8 (CH3-TES), 4.5 (CH2-TES); HRMS (ESI) for C27H39NNaO4SSi [M+Na]
+ calcd. 
524.2238, found 524.2261. 
 
446: Rf = 0.61 (petroleum ether: EtOAc, 3:1); νmax (film) 2955, 2911, 2876, 2211, 
1694, 1607, 1354, 1250, 1165, 1094 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.60 (2H, d, 
J = 8.2 Hz, CH-Ts), 7.28 (2H, d, J = 8.2 Hz, CH-Ts), 6.61 (1H, t, J = 2.5 Hz, CH-
C15), 6.52 (1H, dt, J = 2.3, 2.2 Hz, CH-C10), 3.84 (2H, t, J = 7.1 Hz, CH2-C19), 
3.72 (2H, t, J = 6.8 Hz, CH2-C14), 3.48 (1H, d, J = 12.3 Hz, CH2-C1), 3.17 (1H, d, 
J = 12.3 Hz, CH2-C1), 3.07−2.94 (2H, m, CH2-C8), 2.73 (2H, td, J = 7.1, 2.5 Hz, 
CH2-C18), 2.65−2.61 (1H, m, CH-C6), 2.60 (2H, td, J = 6.8, 2.3 Hz, CH2-C13), 
2.42 (3H, s, CH3-Ts), 2.09−2.02 (1H, m, CH2-C7), 1.87−1.77 (1H, m, CH2-C7), 1.35 
(3H, s, CH3-C9), 0.95 (9H, t, J = 8.0 Hz, CH3-TES), 0.93 (9H, t, J = 8.0 Hz, CH3-
TES), 0.61 (6H, q, J = 8.0 Hz, CH2-TES), 0.58 (6H, q, J = 8.0 Hz, CH2-TES); 
13C 
NMR (126 MHz, CDCl3) δ 192.2 (C-C4), 150.7 (C-C3), 148.4 (C-C5), 143.8 (C-Ts), 
133.9 (C-Ts), 129.7 (CH-Ts), 127.7 (CH-Ts), 117.0 (CH-C15), 116.2 (CH-C10), 
105.5 (C-C16), 102.8 (C-C11), 78.9 (C-C17), 78.5 (C-C12), 61.2 (CH2-C19), 61.1 
(CH2-C14), 50.3 (CH2-C1), 44.3 (CH-C6), 43.5 (CH2-C8), 42.9 (C-C2), 25.3 (CH2-
C7), 24.9 (CH3-C18), 24.6 (CH2-C13), 21.6 (CH3-Ts), 20.9 (CH3-C9), 6.8 (CH3-TES), 
6.7 (CH3-TES), 4.5 (CH2-TES), 4.5 (CH2-TES); HRMS (ESI) for C38H57NNaO5SSi2 
[M+Na]+ calcd. 718.3327, found 718.3388. 
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(R*)-7a-Methyl-2-tosyl-5-((1E,3Z)-5-(triethylsilyloxy)penta-1,3-dienyl)-
3,4,7,7a-tetrahydro-1H-cyclopenta[c]pyridin-6-one 448 
 
  C27H39NO4SSi 
 
To a stirred solution of tributylphosphine (11 µL, 40 µmol) in DCM (10 mL) at 
0 °C was added water (3.6 µL, 0.20 mmol) and the enyne 444 (20 mg, 40 µmol). 
The mixture was stirred at rt for 12 h. The solution was dried over anhydrous 
magnesium sulfate, filtered and concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (petroleum ether: EtOAc, 
4:1) gave the title compound 448 (13.0 mg, 66%) as a pale yellow oil.  
 
Rf = 0.32 (petroleum ether: EtOAc, 4:1); νmax (film) 2953, 2930, 2857, 1736, 1437, 
1252, 1155, 1117, 1005, 837, 777 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.62 (2H, d, J 
= 8.2 Hz, CH-Ts), 7.32 (2H, d, J = 8.2 Hz, CH-Ts), 6.29 (1H, dd, J = 11.3, 11.3 Hz, 
CH-C11), 6.07 (1H, dd, 15.1, 11.3 Hz, CH-12), 5.88 (1H, dt, J = 15.1, 4.5 Hz, CH-
C13), 5.75 (1H, d, J = 11.3 Hz, CH-C10), 4.21 (2H, d, J = 4.5 Hz, CH2-C14), 
4.07−3.98 (1H, m, CH2-C8), 3.90 (1H, dd, J = 11.1 Hz, CH2-C1), 2.75−2.64 (1H, m, 
CH2-C7), 2.59 (1H, dd, J = 13.1, 3.3 Hz, CH2-C7), 2.42 (3H, s, CH3-Ts), 2.36 (1H, 
d, J = 18.5 Hz, CH2-C3), 2.22 (1H, dd, J = 11.9, 3.3 Hz, CH2-C8), 2.16 (1H, d, J = 
18.5 Hz, CH2-C3), 2.14 (1H, d, J = 11.1 Hz, CH2-C1), 1.48 (3H, s, CH3-C9), 0.95 
(9H, t, J = 8.0 Hz, CH3-TES), 0.59 (6H, q, J = 8.0 Hz, CH2-TES); 
13C NMR (126 MHz, 
CDCl3) δ 192.1 (C-C4), 173.9 (C-C6), 143.8 (C-Ts), 141.8 (C-C5), 136.3 (CH-C13), 
135.3 (CH-C11), 133.5 (C-Ts), 129.8 (CH-Ts), 127.4 (CH-Ts), 125.5 (CH-C12), 
117.6 (CH-C10), 62.6 (CH2-C14), 57.6 (CH2-C1), 47.1 (CH2-C3), 46.5 (CH2-C8), 
41.8 (C-C2), 26.5 (CH2-C7), 25.6 (CH3-C9), 21.6 (CH3-Ts), 6.8 (CH3-TES), 4.5 (CH2-
TES);  HRMS (ESI) for C27H39NNaO4SSi [M+Na]
+ calcd. 524.7426, found 524.7432. 
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(4aR*,6S,7aR*,E)-7a-Methyl-2-tosyl-5-(5-(triethylsilyloxy)pent-2-ynylidene) 
octahydro-cyclopenta[c]pyridin-6-ol 468 and (4aR*,6R,7aR*,E)-7a-Methyl-2-
tosyl-5-(5-(triethylsilyloxy)pent-2-ynylidene)octahydro-cyclopenta[c] pyridin-
6-ol epi-468 
 
   C27H41NO4SSi     C27H41NO4SSi 
 
To a stirred solution of the enone 320 (138 mg, 0.248 mmol) in MeOH (20 mL) at 
0 °C was added cerium chloride heptahydrate (134 mg, 0.361 mmol) and sodium 
borohydride (23 mg, 0.60 mmol) in one portion. The mixture was stirred 
overnight at rt before the reaction was quenched with saturated aqueous NH4Cl 
solution (20 mL). The aqueous phase was extracted with Et2O (2 × 30 mL) and 
the combined organic extracts were washed with brine (50 mL), dried over 
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether: 
EtOAc, 4:1 to 2:1) gave the title compound 468 (64 mg, 46%) and epi-468 (67 
mg, 47%) as colourless oils.  
 
468: Rf = 0.38 (petroleum ether: EtOAc, 2:1); νmax (film) 3495 (br), 2953, 2933, 
2874, 1460, 1339, 1161, 1092 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.57 (2H, d, J = 
8.0 Hz, CH-Ts), 7.26 (2H, d, J = 8.0 Hz, CH-Ts), 5.60 (1H, td, J = 2.3, 2.0 Hz, CH-
C10), 4.57 (1H, t, J = 7.8 Hz, CH-C4), 3.62 (2H, t, J = 6.8 Hz, CH2-C14), 
3.58−3.48 (1H, m, CH2-C8), 3.39 (1H, d, J = 11.9 Hz, CH2-C1), 2.44 (2H, td, J = 
6.8, 2.3 Hz, CH2-C13), 2.37 (3H, s, CH3-Ts), 2.31−2.20 (2H, m, CH2-C8, CH-C6), 
2.13 (1H, d, J = 11.9 Hz, CH2-C1), 2.09−1.95 (2H, m, CH2-C3, CH2-C7), 1.83−1.64 
(2H, m, CH2-C3, CH2-C7), 1.54 (1H, s, OH), 0.87 (9H, t, J = 7.9 Hz, CH3-TES), 
0.79 (3H, s, CH3-C9), 0.52 (6H, q, J = 7.9 Hz, CH2-TES); 
13C NMR (126 MHz, CDCl3) 
δ 160.9 (C-C5), 143.6 (C-Ts), 133.5 (C-Ts), 129.8 (CH-Ts), 127.8 (CH-Ts), 107.0 
(CH-C10), 92.3 (C-C11), 78.5 (C-C12), 73.5 (CH-C4), 61.7 (CH2-C14), 53.1 (CH2-
C1), 47.0 (CH-C6), 45.7 (CH2-C8), 42.5 (CH2-C3), 39.3 (C-C2), 26.8 (CH2-C7), 26.3 
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(CH3-C9), 24.2 (CH2-C13), 21.7 (CH3-Ts), 6.9 (CH3-TES), 4.6 (CH3-TES); HRMS (ESI) 
for C27H41NNaO4SSi [M+Na]
+ calcd. 526.2400, found 526.2415. 
 
epi-468: Rf = 0.35 (petroleum ether: EtOAc, 2:1); νmax (film) 3490 (br), 2952, 
2924, 2861, 1455, 1335, 1162, 1092 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.62 (2H, d, 
J = 8.3 Hz, CH-Ts), 7.31 (2H, d, J = 8.3 Hz, CH-Ts), 5.66 (1H, dt, J = 2.2, 2.0 Hz, 
CH-C10), 4.60−4.58 (1H, m, CH-C4), 3.69 (2H, t, J = 7.1 Hz, CH2-C14), 3.17 (1H, 
dd, J = 11.0, 5.0 Hz, CH2-C8), 3.39 (1H, d, J = 11.9, CH2-C1), 2.63 (1H, ddd, J = 
11.0, 8.2, 4.2 Hz, CH2-C8), 2.55−2.45 (3H, m, CH2-C13, CH-C6), 2.43 (3H, s, CH3-
Ts), 2.38 (1H, dd, J = 14.0, 8.2 Hz, CH2-C3), 2.13 (1H, d, J = 11.9 Hz, CH2-C1), 
1.92−1.83 (2H, m, CH2-C7), 1.72−1.59 (1H, brs, OH), 1.46−1.39 (1H, m, CH2-C3), 
1.09 (3H, s, CH3-C9), 0.94 (9H, t, J = 7.9 Hz, CH3-TES), 0.59 (6H, q, J = 7.9 Hz, 
CH2-TES); 
13C NMR (126 MHz, CDCl3) δ 160.9 (C-C5), 143.6 (C-Ts), 133.5 (C-Ts), 
129.8 (CH-Ts), 127.8 (CH-Ts), 106.2 (CH-C10), 92.9 (C-C11), 78.3 (C-C12), 73.1 
(CH-C4), 61.7 (CH2-C14), 53.2 (CH2-C1), 47.5 (CH-C6), 44.7 (CH2-C8), 44.0 (CH2-
C3), 39.8 (C-C2), 26.3 (CH2-C7), 25.3 (CH3-C9), 24.2 (CH2-C13), 21.7 (CH3-Ts),  
6.9 (CH3-TES), 4.5 (CH2-TES); HRMS (ESI) for C27H41NNaO4SSi [M+Na]
+ calcd. 
526.2400, found 526.2418. 
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(4aR*,7aR*,E)-7a-Methyl-2-tosyl-5-(5-triisopropylsilyloxypent-2-ynylidene) 
hexahydro-cyclopenta[c]pyridin-6-one 450 
 
  C30H45NO4SSi 
To a stirred solution of diisopropylamine (0.43 mL, 3.1 mmol) in THF (6 mL) at 
−78 °C was added n-BuLi (1.4 mL of a 2.38 M solution in THF, 3.1 mmol). The 
mixture was stirred at −78 °C for 10 min and a solution of the ketone 320 (900 
mg, 2.93 mmol) in THF (2 mL) was added. The resulting mixture was stirred at 
−78 °C for 30 min and a solution of the aldehyde 445 (820 mg, 3.22 mmol) in 
THF (2 mL) was added. The mixture was stirred at −78 °C for 2 h, then allowed 
to reach rt over 1 h. The reaction was quenched by addition of saturated 
aqueous NH4Cl solution (10 mL). The aqueous phase was extracted with EtOAc (2 
× 20 mL) and the combined organic extracts were washed with brine (20 mL), 
dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 5:1) gave the title compound 450 (608 mg, 39%) as a 
colourless oil.  
Rf = 0.74 (petroleum ether: EtOAc, 4:1); νmax (film) 2943, 2928, 2866, 2214, 1719, 
1618, 1356, 1163, 1098 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.63 (2H, d, J = 8.2 Hz, 
CH-Ts), 7.33 (2H, d, J = 8.2 Hz, CH-Ts), 6.41 (1H, dt, J = 2.3, 2.1 Hz, CH-C10), 
3.80 (2H, t, J = 6.7 Hz, CH2-C14), 3.34 (1H, dt, J = 10.9, 4.6 Hz, CH2-C8), 3.17 
(1H, d, J = 12.1 Hz, CH2-C1), 2.66 (1H, d, J = 17.8 Hz, CH2-C3), 2.63−2.57 (4H, m, 
CH2-C8, CH2-C13, CH-C6), 2.46 (1H, d, J = 12.1 Hz, CH2-C1), 2.44 (3H, s, CH3-Ts), 
2.12−2.05 (1H, m, CH2-C7), 2.07 (1H, d, J = 17.8 Hz, CH2-C3), 1.86 (1H, dtd, J = 
14.0, 9.9, 4.6 Hz, CH2-C7), 1.04 (18H, d, J = 5.3 Hz, CH3-TIPS), 1.02 (3H, s, CH3-
C9), 1.03−1.01 (3H, m, CH-TIPS); 13C NMR (126 MHz, CDCl3) δ 203.6 (C-C4), 148.9 
(C-C5), 143.8 (C-Ts), 133.4 (C-Ts), 129.9 (CH-Ts), 127.8 (CH-Ts), 114.6 (CH-C10), 
101.4 (C-C11), 78.6 (C-C12), 61.9 (CH2-C14), 52.9 (CH2-C1), 46.9 (CH2-C3), 45.3 
(CH-C6), 44.8 (CH2-C8), 36.4 (C-C2), 25.8 (CH2-C7), 25.6 (CH3-C9), 24.7 (CH2-
C13), 21.7 (CH3-Ts), 16.9 (CH3-TIPS), 12.1 (CH-TIPS); HRMS (ESI) for 
C30H45NNaO4SSi [M+Na]
+ calcd. 566.2711, found 566.2731. 
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(4aR*,7aR*)-7a-Methyl-2-tosyl-5-(3-triisopropylsilyloxypropyl)-3b,5,6,7,7a, 8-
hexahydro-furo[3',2':3,4]cyclopenta[1,2-c]pyridine 451 
 
  C30H47NO4SSi 
 
To a stirred solution of tributylphosphine (11 µL, 40 µmol) in DMF (1.5 mL) at rt 
was added water (1 mL) and a solution of the enyne 450 (20 mg, 40 µmol) in 
DMF (1.5 mL). The mixture was stirred at rt for 6 h and the solution was then 
dried over anhydrous magnesium sulfate, filtered and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 20:1 to 10:1 to 4:1) gave the title compound 451 (4.2 
mg, 21%) as a pale yellow oil.   
  
Rf = 0.76 (petroleum ether: EtOAc, 3:1); νmax (film) 2943, 2928, 2866, 1356, 1163, 
1098 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.61 (2H, d, J = 8.2 Hz, CH-Ts), 7.29 (2H, 
d, J = 8.2 Hz, CH-Ts), 5.75 (1H, s, CH-C10), 3.69 (2H, t, J = 6.2 Hz, CH2-C14), 
3.33−3.27 (1H, m, CH2-C8), 3.12 (1H, d, J = 11.8 Hz, CH2-C1), 2.75 (1H, d, J = 
11.8 Hz, CH2-C1), 2.64 (2H, t, J = 7.7 Hz, CH2-C12), 2.52 (1H, d, J = 14.7 Hz, 
CH2-C3), 2.44 (3H, s, CH3-Ts), 2.43 (1H, d, J = 14.7 Hz, CH2-C3), 2.05−1.98 (2H, 
m, CH-C6, CH2-C8), 1.84−1.77 (2H, m, CH2-C13), 1.75−1.68 (1H, m, CH2-C7), 
1.45−1.38 (1H, m, CH2-C7), 1.25 (3H, s, CH3-C9), 1.03 (18H, d, J = 5.1 Hz, CH3-
TIPS), 1.03-1.01 (3H, m, CH-TIPS); 13C NMR (126 MHz, CDCl3) δ 156.9 (C-C11), 
151.0 (C-C4), 142.9 (C-C5), 142.7 (C-Ts), 133.4 (C-Ts), 129.8 (CH-Ts), 127.6 (CH-
Ts), 107.1 (CH-C10), 66.3 (CH2-C14), 58.6 (CH2-C1), 43.4 (CH2-C3), 43.2 (CH-C6), 
42.5 (CH2-C8), 40.0 (C-C2), 33.3 (CH2-C12), 26.4 (CH2-C7), 25.8 (CH3-C9), 23.3 
(CH2-C13), 21.2 (CH3-Ts), 17.6 (CH3-TIPS), 12.6 (CH-TIPS); HRMS (ESI) for 
C30H47NNaO4SSi [M+Na]
+ calcd. 568.2863, found 568.2887. 
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1-((4aR*,7aR*)-7a-Methyl-2-tosyl-3b,5,6,7,7a,8-hexahydro-4H-furo[3',2':3,4] 
cyclopenta[1,2-c]pyridin-2-yl)-3-(triisopropylsilyloxy)propan-12-one 452 
 
  C30H45NO5SSi 
 
To a stirred solution of tributylphosphine (0.18 mL, 0.74 mmol) in DMF (25 mL) 
at rt was added a solution of the enyne 450 (0.10 g, 0.18 mmol) in DMF (1.5 mL). 
The mixture was sparged with oxygen and stirred under a static oxygen 
atmosphere at rt for 6 h. The mixture was then diluted with EtOAc (100 mL) and 
washed with water (2 × 50 mL), brine (50 mL), dried over anhydrous magnesium 
sulfate, filtered and concentrated in vacuo. Purification of the residue by flash 
column chromatography on silica gel (petroleum ether: EtOAc, 10:1 to 4:1) gave 
the title compound 452 (95 mg, 95%) as a colourless oil.   
 
Rf = 0.41 (petroleum ether: EtOAc, 3:1); νmax (film) 2942, 2928, 2866, 1663, 1499, 
1344, 1163, 1094 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.58 (2H, d, J = 8.0 Hz, CH-
Ts), 7.27 (2H, d, J = 8.0 Hz, CH-Ts), 6.96 (1H, s, CH-C10), 4.04 (2H, t, J = 6.4 Hz, 
CH2-C14), 3.25 (1H, dd, J = 10.8, 4.9 Hz, CH2-C8), 3.03 (1H, d, J = 11.8 Hz, CH2-
C1), 2.90 (2H, t, J = 6.4 Hz, CH2-C13), 2.71 (1H, dd, J = 5.3, 5.1 Hz, CH-C6), 
2.59 (1H, d, J = 11.8 Hz, CH2-C1), 2.56 (1H, d, J = 14.7 Hz, CH2-C3), 2.55−2.52 
(1H, m, CH2-C8), 2.48 (1H, d, J = 14.7 Hz, CH2-C3), 2.38 (3H, s, CH3-Ts), 2.08 (1H, 
dddd, J = 14.6, 10.3, 5.3, 4.9 Hz, CH2-C7), 1.76 (1H, ddd, J = 14.6, 5.1, 3.5 Hz, 
CH2-C7), 1.34 (3H, s, CH3-C9), 0.95 (18H, d, J = 6.5 Hz, CH3-TIPS), 1.01−0.95 (3H, 
m, CH-TIPS); 13C NMR (126 MHz, CDCl3) δ 187.6 (C-C12), 163.8 (C-C4), 157.2 (C-
C11), 143.6 (C-Ts), 133.9 (C-Ts), 129.9 (CH-Ts), 129.7 (C-C5), 127.6 (CH-Ts), 
115.5 (CH-C10), 60.0 (CH2-C14), 53.4 (CH2-C1), 48.4 (CH2-C8), 43.2 (CH2-C13), 
41.7 (CH-C6), 41.3 (C-C2), 37.5 (CH2-C3), 26.4 (CH2-C7), 25.8 (CH3-C9), 21.7 
(CH3-Ts), 17.4 (CH3-TIPS), 12.0 (CH-TIPS); HRMS (ESI) for C30H45NNaO5SSi [M+Na]
+ 
calcd. 582.2656, found 582.2680. 
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1-(4-Acetyl-5-methylfuran-2-yl)pentan-1-one 459 
 
  C12H16O3 
 
To a stirred solution of tributylphosphine (0.51 mL, 2.1 mmol) in DMF (25 mL) at 
rt was added a solution of the enyne 458 (0.10 mg, 0.52 mmol) in DMF (1.5 mL). 
The mixture was sparged with oxygen and stirred under a static oxygen 
atmosphere at rt for 3 h. The mixture was then diluted with EtOAc (100 mL) and 
washed with water (2 × 50 mL), brine (50 mL), dried over anhydrous magnesium 
sulfate, filtered and concentrated in vacuo. Purification of the residue by flash 
column chromatography on silica gel (petroleum ether: EtOAc, 10:1 to 4:1) gave 
the title compound 459 (92 mg, 92%) as a pale yellow oil.   
 
Rf = 0.28 (petroleum ether: EtOAc, 4:1); νmax (film) 2959, 2932, 2874, 1672, 1576, 
1528, 1234, 1151, 950 cm―1; 1H NMR (400 MHz, CDCl3) δ 7.40 (1H, d, J = 0.6 Hz, 
CH-C6), 2.81 (2H, t, J = 7.5 Hz, CH2-C9), 2.69 (3H, s, CH3-C5), 2.47 (3H, s, CH3-
C1), 1.70 (2H, tt, J = 7.5, 7.3 Hz, CH2-C10), 1.40 (2H, qt, J = 7.4, 7.3 Hz, CH2-
C11), 0.95 (3H, t, J = 7.4 Hz, CH3-C12); 
13C NMR (101 MHz, CDCl3) δ 193.4 (C-C2), 
189.4 (C-C8), 162.2 (C-C4), 150.1 (C-C7), 123.1 (C-C3), 117.1 (CH-C6), 38.1 (CH2-
C9), 29.1 (CH3-C1), 26.4 (CH2-C10), 22.4 (CH2-C11), 14.9 (CH3-C5), 13.9 (CH3-
C12); HRMS (ESI) for C12H16NaO3 [M+Na]
+ calcd. 231.0984, found 231.0992. 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature.164 
 
  
                                                                                                                         
164 Wang, T.; Zhang, J. Dalton Trans. 2010, 39, 4270−4273 
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(4aR*,7aR*,E)-7a-Methyl-2-tosyl-5-(3-trimethylsilylprop-2-ynylidene)hexa 
hydro-cyclopenta[c]pyridin-6-one 462 
 
  C22H29NO3SSi 
 
To a stirred solution of diisopropylamine (0.10 mL, 0.72 mmol) in THF (6 mL) at 
−78 °C was added n-BuLi (0.30 mL of a 2.38 M solution in THF, 0.72 mmol). The 
mixture was stirred at −78 °C for 10 min and a solution of the ketone 320 (0.20 
g, 0.65 mmol) in THF (2 mL) was added. The resulting mixture was stirred at 
−78 °C for 30 min and a solution of 3-(trimethylsilyl)-2-propynal (98 mg, 0.78 
mmol) in THF (2 mL) was added. The mixture was stirred for 2 h at −78 °C, then 
allowed to reach rt over 1 h. The reaction was quenched by addition of 
saturated aqueous NH4Cl solution (10 mL). The aqueous phase was extracted 
with EtOAc (2 × 20 mL) and the combined organic extracts were washed with 
brine (20 mL), dried over anhydrous magnesium sulfate, filtered and 
concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 6:1 to 4:1) gave the title 
compound 462 (136 mg, 51%) as a colourless oil.  
 
Rf = 0.71 (petroleum ether: EtOAc, 2:1); νmax (film) 2957, 2926, 2853, 1721, 1614, 
1356, 1165, 1097, 904 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.62 (2H, d, J = 8.2 Hz, 
CH-Ts), 7.33 (2H, d, J = 8.2 Hz, CH-Ts), 6.39 (1H, d, J = 2.1 Hz, CH-C10), 3.41 
(1H, dt, J = 10.8, 4.7 Hz, CH2-C8), 3.12 (1H, d, J = 12.1 Hz, CH2-C1), 2.65 (1H, d, 
J = 17.9 Hz, CH2-C3), 2.69−2.59 (2H, m, CH2-C8, CH-C6), 2.52 (1H, d, J = 12.1 Hz, 
CH2-C1), 2.43 (3H, s, CH3-Ts), 2.09 (1H, d, J = 17.9 Hz, CH2-C3), 2.12−2.05 (1H, 
m, CH2-C7), 1.93 (1H, ddt, J = 14.6, 9.7, 4.7 Hz, CH2-C7), 1.06 (3H, s, CH3-C9), 
0.18 (9H, s, CH3-TMS); 
13C NMR (126 MHz, CDCl3) δ 203.6 (C-C4), 150.6 (C-C5), 
144.1 (C-Ts), 133.5 (C-Ts), 130.2 (CH-Ts), 127.9 (CH-Ts), 113.8 (CH-C10), 108.9 
(C-C11), 101.4 (C-C12), 53.1 (CH2-C1), 47.1 (CH2-C3), 45.7 (CH-C6), 44.9 (CH2-
C8), 36.7 (C-C2), 25.7 (CH2-C7), 25.6 (CH3-C9), 21.9 (CH3-Ts), −0.2 (CH3-TMS); 
HRMS (ESI) for C22H29NNaO3SSi [M+Na]
+ calcd. 438.1512, found 438.1530. 
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(4aR*,7aR*,E)-7a-Methyl-5-(prop-2-ynylidene)-2-tosylhexahydro-cyclopenta 
[c]pyridin-6-one 460 
 
  C19H21NO3S 
 
To a stirred solution of the enynone 462 (35 mg, 0.12 mmol) in THF (5 mL) at 
0 °C was added TBAF (0.18 mL of a 1.0 M solution in THF, 0.18 mmol). The 
mixture was stirred at 0 °C for 1 h and allowed to reach rt over 2 h. The 
reaction was quenched by addition of saturated aqueous NH4Cl solution (5 mL). 
The aqueous phase was extracted with EtOAc (2 × 20 mL) and the combined 
organic extracts were washed with brine (20 mL), dried over anhydrous 
magnesium sulfate, filtered and concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (petroleum ether: EtOAc, 
5:1) gave the title compound 460 (28 mg, 97%) as a pale yellow oil.  
 
Rf = 0.26 (petroleum ether: EtOAc, 4:1); νmax (film) 2957, 2926, 2853, 1721, 1614, 
1356, 1165, 1097, 904 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.62 (2H, d, J = 8.2 Hz, 
CH-Ts), 7.33 (2H, d, J = 8.2 Hz, CH-Ts), 6.37 (1H, dd, J = 2.4, 2.2 Hz, CH-C10), 
3.42 (1H, d, J = 2.4 Hz, CH-C12), 3.46−3.37 (1H, m, CH2-C8), 3.24 (1H, d, J = 
12.2 Hz, CH2-C1), 2.72 (1H, d, J = 18.1 Hz, CH2-C3), 2.67−2.61 (1H, m, CH-C6), 
2.57 (1H, dt, J = 10.9, 4.1 Hz, CH2-C8), 2.44 (1H, d, J = 12.2 Hz, CH2-C1), 2.43 
(3H, s, CH3-Ts), 2.08 (1H, d, J = 18.1 Hz, CH2-C3), 2.12−2.05 (1H, m, CH2-C7), 
1.93 (1H, ddt, J = 14.3, 10.2, 4.1 Hz, CH2-C7), 1.03 (3H, s, CH3-C9); 
13C NMR (126 
MHz, CDCl3) δ 203.1 (C-C4), 151.7 (C-C5), 143.8 (C-Ts), 133.1 (C-Ts), 129.8 (CH-
Ts), 127.6 (CH-Ts), 112.3 (CH-C10),  88.8 (C-C11), 79.9 (C-C12), 52.7 (CH2-C1), 
46.4 (CH2-C3), 45.3 (CH-C6), 44.7 (CH2-C8), 36.3 (C-C2), 25.7 (CH2-C7), 25.6 
(CH3-C9), 21.6 (CH3-Ts); HRMS (EI
+) for C19H21NO3S [M]
+ calcd. 343.1242, found 
343.1239. 
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(4aR*,7aR*)-7a-Methyl-2-tosyl-3b,5,6,7,7a,8-hexahydro-furo[3',2':3,4] 
cyclopenta[1,2-c]pyridine-11-carbaldehyde 461 
 
  C19H21NO4S 
 
To a stirred solution of tributylphosphine (6.0 µL, 0.24 mmol) in DMF (5 mL) at rt 
was added a solution of the enynone 460 (21 mg, 60 µmol) in DMF (1.5 mL). The 
mixture was sparged with oxygen and stirred under a static oxygen atmosphere 
at rt for 8 h. The mixture was then diluted with EtOAc (20 mL), washed with 
water (2 × 10 mL) and brine (10 mL), dried over anhydrous magnesium sulfate, 
filtered and concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 6:1 to 3:1) gave the title 
compound 461 (19 mg, 92%) as a pale yellow oil. 
 
Rf = 0.19 (petroleum ether: EtOAc, 3:1); νmax (film) 2959, 2924, 2853, 1672, 1503, 
1344, 1331, 1163, 1092 cm―1; 1H NMR (500 MHz, CDCl3) δ 9.43 (1H, s, CH-C12), 
7.60 (2H, d, J = 8.2 Hz, CH-Ts), 7.30 (2H, d, J = 8.2 Hz, CH-Ts), 6.99 (1H, s, CH-
C10), 3.26 (1H, dd, J = 10.4, 4.8 Hz, CH2-C8), 3.10 (1H, d, J = 12.0 Hz, CH2-C1), 
2.75 (1H, t, J = 5.4 Hz, CH-C6), 2.71 (1H, d, J = 12.0 Hz, CH2-C1), 2.68−2.64 (1H, 
m, CH2-C8), 2.67 (1H, d, J = 13.7 Hz, CH2-C3), 2.60 (1H, d, J = 13.7 Hz, CH2-C3), 
2.42 (3H, s, CH3-Ts), 2.15−2.08 (1H, m, CH2-C7), 1.79 (1H, ddd, J = 14.1, 4.8, 2.7 
Hz, CH2-C7), 1.36 (3H, s, CH3-C9); 
13C NMR (126 MHz, CDCl3) δ 193.6 (CH-C12), 
149.4 (C-C11), 146.9 (C-C4), 143.5 (C-Ts), 133.7 (C-C5), 133.5 (C-Ts), 130.0 (CH-
Ts), 127.6 (CH-Ts), 123.1 (CH-C10), 53.2 (CH2-C1), 48.5 (C-C2), 43.2 (CH2-C8), 
41.1 (CH-C6), 37.4 (CH2-C3), 25.9 (CH2-C7), 25.0 (CH3-C9), 21.7 (CH3-Ts); HRMS 
(ESI) for C19H21NNaO4S [M+Na]
+ calcd. 382.1067, found 382.1083. 
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Ethyl 2-hydroxypent-4-enoate 477165 
 
  C7H12O3 
 
To a stirred solution of ethyl glyoxylate (2.00 mL of a 50% solution in toluene, 
10.0 mmol) in DCM (40 mL) at rt was added freshly distilled TiCl4 (1.90 mL, 12.0 
mmol). The mixture was stirred at rt for 15 min and a solution of 
allyltrimethylsilane (2.10 g, 11.0 mmol) in DCM (10 mL) was added. The resulting 
mixture was stirred at rt for 1 h before addition of saturated aqueous NaHCO3 
solution (40 mL). The aqueous phase was extracted with DCM (3 × 50 mL) and 
the combined organic extracts were washed with brine (100 mL), dried over 
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether: 
EtOAc, 8:1 to 4:1) gave the title compound 477 (1.40 g, 96%) as a colourless oil.  
 
Rf = 0.30 (petroleum ether: EtOAc, 4:1); 
1H NMR (400 MHz, CDCl3) δ 5.80 (1H, 
ddt, J = 17.2, 10.1, 7.1 Hz, CH-C13), 5.18−5.11 (2H, m, CH2-C14), 4.30−4.18 (3H, 
m, CH-C11, CH2-C15), 2.85 (1H, brs, OH), 2.62−2.54 (1H, m, CH2-C12), 2.48−2.38 
(1H, m, CH2-C12), 1.29 (3H, t, J = 7.1 Hz, CH3-C16); 
13C NMR (101 MHz, CDCl3) δ 
174.6 (C-C10), 132.6 (CH-C13), 118.7 (CH2-C14), 70.0 (CH-C11), 61.8 (CH2-C15), 
38.6 (CH2-C12), 14.4 (CH3-C16). 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
 
 
  
                                                                                                                         
165 Boussonnière, A.; Bénéteau, R.; Zimmermann, N.; Lebreton, J.; Dénès, F. Chem. Eur. J. 2011, 
17, 5613−5627 
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Ethyl 2-(tert-butyldimethylsilyloxy)pent-4-enoate 478165 
 
  C13H26O3Si 
 
To a stirred solution of TBSCl (1.66 g, 11.0 mmol) and imidazole (1.02 g, 15.0 
mmol) in DCM (50 mL) at 0 °C was added the alcohol 477 (1.40 g, 9.71 mmol). 
The mixture was stirred at 0 °C for 1 h then allowed to reach rt over 5 h. The 
reaction was quenched by addition of saturated aqueous NH4Cl solution (40 mL). 
The aqueous phase was extracted with DCM (3 × 50 mL) and the combined 
organic extracts were washed with brine (100 mL), dried over anhydrous 
magnesium sulfate, filtered and concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (DCM: Et2O, 10:1) gave the 
title compound 478 (2.48 g, 99%) as a colourless oil.  
 
Rf = 0.92 (petroleum ether: EtOAc, 4:1); 
1H NMR (400 MHz, CDCl3) δ 5.82 (1H, 
ddt, J = 17.2, 10.1, 7.1 Hz, CH-C13), 5.16−5.04 (2H, m, CH2-C14), 4.28−4.10 (3H, 
m, CH-C11, CH2-C15), 2.54−2.39 (2H, m, CH2-C12), 1.27 (3H, t, J = 7.1 Hz, CH3-
C16), 0.90 (9H, s, CH3-TBS), 0.08 (3H, s, CH3-TBS), 0.05 (3H, s, CH3-TBS); 
13C 
NMR (101 MHz, CDCl3) δ 173.3 (C-C10), 133.8 (CH-C13), 118.1 (CH2-C14), 72.3 
(CH-C11), 60.9 (CH2-C15), 39.9 (CH2-C12), 25.9 (CH3-TBS), 18.5 (C-TBS), 14.4 
(CH3-C16), −4.8  (CH3-TBS), −5.1  (CH3-TBS). 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
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2-(tert-Butyldimethylsilyloxy)pent-4-enal 479165 
 
  C11H22O2Si 
 
To a stirred solution of the ester 478 (1.0 g, 4.0 mmol) in Et2O (40 mL) at −78 °C 
was added diisobutylaluminium hydride (4.0 mL of a 1.0 M solution in THF, 4.0 
mmol) dropwise. The mixture was stirred at −78 °C for 2 h and then the reaction 
was quenched by addition of MeOH (1 mL). The mixture was allowed to reach rt 
before addition of saturated aqueous potassium sodium tartrate solution (50 mL). 
The mixture was then stirred vigorously for 30 min and the two phases were 
separated. The aqueous phase was extracted with Et2O (3 × 50 mL) and the 
combined organic extracts were washed with brine (100 mL), dried over 
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether: 
Et2O, 98:2) gave the title compound 479 (751 mg, 88%) as a colourless oil.  
 
Rf = 0.52 (petroleum ether: Et2O, 50:1); 
1H NMR (400 MHz, CDCl3) δ 9.60 (1H, d, 
J = 1.6 Hz, CH-C10), 5.80 (1H, ddt, J = 17.3, 10.2, 7.1 Hz, CH-C13), 5.18−5.06 
(2H, m, CH2-C14), 4.31 (1H, ddd, J = 6.9, 5.1, 1.6 Hz, CH-C11), 2.51−2.31 (2H, m, 
CH2-C12), 0.93 (9H, s, CH3-TBS), 0.10 (3H, s, CH3-TBS), 0.09 (3H, s, CH3-TBS); 
13C 
NMR (101 MHz, CDCl3) δ 203.2 (CH-C10), 132.9 (CH-C13), 118.3 (CH2-C14), 77.3 
(CH-C11), 37.4 (CH2-C12), 25.7 (CH3-TBS), 18.2 (C-TBS), −4.7 (CH3-TBS), −4.9  
(CH3-TBS). 
 
The analytical and spectroscopic data are in agreement with those reported in 
the literature. 
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(4aS*,7aR*)-5-(2-(tert-Butyldimethylsilyloxy)-1-hydroxypent-4-enyl)-7a-
methyl-2-tosylhexahydro-1H-cyclopenta[c]pyridin-6-one 481  
8
N
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O
Ts
H
9
10
11
12
TBSO OH
13
14
  C27H43NO5SSi 
To a stirred solution of the aldehyde 479 (125 mg, 0.582 mmol) in DCM (20 mL) 
at −78 °C was added TiCl4 (64 µL, 0.58 mmol). The mixture was stirred at −78 °C 
for 10 min and a solution of the enol ether 480 (200 mg, 0.534 mmol) in DCM (3 
mL) was added. The mixture was stirred at −78 °C for 1 h and then allowed to 
reach rt over 1 h. The reaction was quenched by addition of saturated aqueous 
NaHCO3 solution (20 mL). The aqueous phase was extracted with EtOAc (2 × 30 
mL) and the combined organic extracts were washed with brine (50 mL), dried 
over anhydrous magnesium sulfate, filtered and concentrated in vacuo. 
Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc, 8:1 to 4:1) gave the title compound 481 (176 mg, 64%) 
as a colourless foam. 
Rf = 0.42 (petroleum ether: Et2O, 4:1); νmax (film) 3557(br), 2953, 2928, 2857, 
1740, 1337, 1252, 1163, 1090 cm―1; 1H NMR (400 MHz, CDCl3) δ 7.60 (2H, d, J = 
8.2 Hz, CH-Ts), 7.34 (2H, d, J = 8.2 Hz, CH-Ts), 5.79 (1H, dddd, J = 17.3, 10.2, 
8.3, 5.9  Hz, CH-C13), 4.88 (1H, ddt, J = 10.2, 2.2, 1.1 Hz, CH2-C14), 4.78 (1H, 
ddt, J = 17.3, 2.2, 1.6  Hz, CH2-C14), 4.25 (1H, ddd, J = 8.2, 5.4, 3.7 Hz, CH-
C11), 3.71−3.62 (1H, m, CH2-C8), 3.41 (1H, ddd, J = 8.2, 4.3, 2.1 Hz, CH-C10), 
3.31 (1H, d, J = 12.0 Hz, CH2-C1), 2.49 (1H, d, J = 4.3 Hz, OH), 2.45 (3H, s, CH3-
Ts), 2.37−2.26 (2H, m, CH2-C12, CH-C6), 2.23 (1H, d, J = 17.9 Hz, CH2-C3), 
2.19−2.04 (5H, m, CH2-C7, CH2-C8, CH2-C12, CH-C5, CH2-C3), 1.91 (1H, d, J = 
12.0 Hz, CH2-C1), 1.55−1.51 (1H, m, CH2-C7), 1.36 (3H, s, CH3-C9), 0.88 (9H, s, 
CH3-TBS), 0.09 (3H, s, CH3-TBS), 0.07 (3H, s, CH3-TBS); 
13C NMR (101 MHz, CDCl3) 
δ 216.6 (C-C4), 143.9 (C-Ts), 134.3 (CH-C13), 133.1 (C-Ts), 129.9 (CH-Ts), 127.7 
(CH-Ts), 117.1 (CH2-C14),  73.0 (CH-C10), 71.6 (CH-C11), 52.6 (CH2-C3), 51.8 
(CH2-C1), 48.7 (CH-C5), 41.5 (CH-C6), 41.3 (CH2-C8), 38.5 (CH2-C12), 36.7 (C-C2), 
25.9 (CH3-TBS), 23.5 (CH3-C9), 22.2 (CH2-C7), 21.7 (CH3-Ts), 18.2 (C-TBS), −4.0 
(CH3-TBS), −4.6 (CH3-TBS); HRMS (ESI) for C27H43NNaO5SSi [M+Na]
+ calcd. 
544.2511, found 544.2523. 
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(4aS*,7aS*)-5,7-Bis(2-(tert-butyldimethylsilyloxy)-1-hydroxypent-4-enyl)-7a-
methyl-2-tosylhexahydro-cyclopenta[c]pyridin-6-one 474 
 
  C38H65NO7SSi2 
 
To a stirred solution of diisopropylamine (0.24 mL, 1.7 mmol) in THF (15 mL) at 
−78 °C was added n-BuLi (0.72 mL of a 2.38 M solution in THF, 1.7 mmol). The 
mixture was stirred at −78 °C for 10 min and a solution of the ketone 320 (0.50 
g, 1.6 mmol) in THF (2 mL) was added. The reaction was stirred at −78 °C for 30 
min and a solution of the aldehyde 479 (0.38 g, 1.8 mmol) in THF (2 mL) was 
added. The mixture was stirred at −78 °C for 2 h and then allowed to reach rt 
over 1 h. The reaction was quenched by addition of saturated aqueous NH4Cl 
solution (20 mL). The aqueous phase was extracted with EtOAc (2 × 30 mL) and 
the combined organic extracts were washed with brine (50 mL), dried over 
anhydrous magnesium sulfate, filtered and concentrated in vacuo. Purification 
of the residue by flash column chromatography on silica gel (petroleum ether: 
EtOAc, 10:1 to 4:1) gave the title compound 474 (370 mg, 31%) as a colourless 
gum. 
 
Rf = 0.44 (petroleum ether: Et2O, 4:1); νmax (film) 3457 (br), 2953, 2928, 2857, 
1728, 1358, 1252, 1171, 1088 cm―1; 1H NMR (400 MHz, CDCl3) δ 7.60 (2H, d, J = 
8.0 Hz, CH-Ts), 7.34 (2H, d, J = 8.0 Hz, CH-Ts), 5.88−5.61 (2H, m, CH-C13, CH-
C13’), 5.05−4.85 (4H, m, CH2-C14, CH2-C14’), 4.16 (1H, dt, J = 8.8, 4.3 Hz, CH-
C11), 3.98 (1H, dt, J = 8.5, 4.4 Hz, CH-C11’), 3.69 (1H, d, J = 8.5 Hz, CH-C10’), 
3.54−3.41 (1H, m, CH2-C8), 3.22 (1H, d, J = 8.8 Hz, CH-C10), 3.10 (1H, d, J = 
11.5 Hz, CH2-C1), 2.71 (1H, s, OH), 2.51 (1H, s, OH), 2.40−2.37 (1H, m, CH-C5), 
2.29 (3H, s, CH3-Ts), 2.26−2.14 (5H, m, CH2-C12, CH2-C12’, CH-C6), 2.04−1.98 
(2H, m, CH2-C8, CH2-C7), 1.97−1.94 (1H, m, CH-C3), 1.59 (1H, d, J = 11.5 Hz, 
CH2-C1), 1.49−1.38 (1H, m, CH2-C7), 1.30 (3H, s, CH3-C9), 0.75 (9H, s, CH3-TBS), 
0.55 (9H, s, CH3-TBS), 0.00 (3H, s, CH3-TBS), −0.04 (3H, s, CH3-TBS), −0.09 (3H, s, 
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CH3-TBS), −0.51 (3H, s, CH3-TBS); 
13C NMR (101 MHz, CDCl3) δ 219.2 (C-C4), 143.6 
(C-Ts), 134.3 (CH-C13), 134.1 (CH-C13’), 132.2 (C-Ts), 129.8 (CH-Ts), 127.6 (CH-
Ts), 117.8 (CH2-C14), 117.7 (CH2-C14’), 75.4 (CH-C10), 73.6 (CH-C10’), 70.6 (CH-
C11), 70.5 (CH-C11’), 56.5 (CH2-C3), 52.8 (CH2-C1), 48.4 (CH-C6), 40.9 (CH2-C8), 
40.0 (CH-C5), 39.2 (C-C2), 38.4 (CH2-C12), 38.1 (CH2-C12’), 25.9 (CH3-TBS), 25.6 
(CH3-TBS), 21.9 (CH2-C7), 21.5 (CH3-Ts), 19.0 (CH3-C9), 18.1 (C-TBS), 17.8 (C-
TBS), −4.1 (CH3-TBS), −4.5 (CH3-TBS), −4.8 (CH3-TBS), −5.2 (CH3-TBS);  HRMS (ESI) 
for C38H65NNaO7SSi2 [M+Na]
+ calcd. 758.3885, found 758.3912. 
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2-(tert-Butyldimethylsilyloxy)-1-((4aS*,7aR*)-7a-methyl-6-oxo-2-tosylocta 
hydro-cyclopenta[c]pyridin-5-yl)pent-4-enyl methanesulfonate 475 
 
  C28H45NO7S2Si 
 
To a stirred solution of DMAP (74 mg, 0.60 mmol) and the alcohol 481 (80 mg, 
0.15 mmol) in DCM (20 mL) at 0 °C was added MsCl (22 µL, 0.30 mmol). The 
mixture was stirred at 0 °C for 2 h, then allowed to reach rt over 1 h. The 
reaction was quenched by addition of saturated aqueous NH4Cl solution (20 mL). 
The aqueous phase was extracted with DCM (2 × 20 mL) and the combined 
organic extracts were washed with brine (50 mL), dried over anhydrous 
magnesium sulfate, filtered and concentrated in vacuo. Purification of the 
residue by flash column chromatography on silica gel (DCM: Et2O, 50:1) gave the 
title compound 475 (82 mg, 91%) as a colourless gum. 
 
Rf = 0.27 (petroleum ether: Et2O, 4:1); νmax (film) 2955, 2930, 2857, 1744, 1344, 
1256, 1169, 1070 cm―1; 1H NMR (400 MHz, CDCl3) δ 7.59 (2H, d, J = 8.2 Hz, CH-
Ts), 7.35 (2H, d, J = 8.2 Hz, CH-Ts), 5.80−5.67 (1H, m, CH-C13), 5.07−4.96 (2H, 
m, CH2-C14), 4.75 (1H, dd, J = 6.1, 4.4 Hz, CH-C10), 4.07 (1H, td, J = 6.2, 4.4 Hz, 
CH-C11), 3.50 (1H, dd, J = 11.8, 4.8 Hz, CH2-C8), 3.19 (1H, d, J = 12.0 Hz, CH2-
C1), 2.99 (3H, s, CH3-Ms), 2.52 (1H, ddd, J = 10.8, 6.1, 1.1 Hz, CH-C5), 2.42 (3H, 
s, CH3-Ts), 2.37−2.05 (7H, m, CH2-C12, CH2-C3, CH2-C7, CH2-C8, CH-C6), 2.02 
(1H, d, J = 12.0 Hz, CH2-C1), 1.84−1.81 (1H, m, CH2-C7), 1.34 (3H, s, CH3-C9), 
0.77 (9H, s, CH3-TBS), 0.03 (3H, s, CH3-TBS), −0.16 (3H, s, CH3-TBS); 
13C NMR 
(101 MHz, CDCl3) δ 214.6 (C-C4), 143.8 (C-Ts), 133.3 (CH-C13), 132.5 (C-Ts), 
129.8 (CH-Ts), 127.6 (CH-Ts), 118.6 (CH2-C14), 81.5 (CH-C10), 71.7 (CH-C11), 
52.0 (CH2-C3), 50.8 (CH2-C1), 48.2 (CH-C5), 41.7 (CH-C6), 40.8 (CH2-C8), 38.1 
(CH3-Ms), 37.9 (CH2-C12), 36.6 (C-C2), 25.7 (CH3-TBS), 23.8 (CH3-C9), 23.7 (CH2-
C7), 21.5 (CH3-Ts), 17.9 (C-TBS), −4.4 (CH3-TBS), −4.6 (CH3-TBS); HRMS (ESI) for 
C28H45NNaO7S2Si [M+Na]
+ calcd. 622.2281, found 622.2299. 
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(4aR*,7aR*,E)-5-(2-tert-Butyldimethylsilyloxypent-4-enylidene)-7a-methyl-2-
tosylhexahydro-cyclopenta[c]pyridin-6-one 482 
 
  C27H41NO4SSi 
 
To a stirred solution of the mesylate 475 (67 mg, 0.11 mmol) in THF (20 mL) at 
0 °C was added DBU (33 µL, 0.22 mmol). The mixture was stirred at 0 °C for 2 h, 
then allowed to reach rt over 1 h. The reaction was quenched by addition of 
saturated aqueous NH4Cl solution (20 mL). The aqueous phase was extracted 
with EtOAc (2 × 20 mL) and the combined organic phases were washed with 
brine (50 mL), dried over anhydrous magnesium sulfate, filtered and 
concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 10:1 to 6:1) gave the title 
compound 482 (54 mg, 98%) as a colourless gum.  
 
Rf = 0.68 (petroleum ether: Et2O, 3:1); νmax (film) 2955, 2928, 2857, 1724, 1659, 
1356, 1343, 1252, 1163, 1097 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.64 (2H, d, J = 
8.2 Hz, CH-Ts), 7.35 (2H, d, J = 8.2 Hz, CH-Ts), 6.45 (1H, dd, J = 9.0, 1.4 Hz, 
CH-C10), 5.71 (1H, ddt, J = 18.7, 9.4, 7.2 Hz, CH-C13), 5.07−4.99 (2H, m, CH2-
C14), 4.14 (1H, ddd, J = 9.0, 7.1, 5.2 Hz, CH-C11), 3.77 (1H, dd, J = 9.2, 2.6 Hz, 
CH2-C8), 3.63 (1H, dd, J = 12.2, 1.6 Hz, CH2-C1), 2.83 (1H, d, J = 17.9 Hz, CH2-
C3), 2.51 (3H, s, CH3-Ts), 2.41−2.09 (5H, m, CH2-C12, CH2-C1, CH2-C8, CH-C6), 
1.98 (1H, dd, J = 17.9, 1.6 Hz, CH2-C3), 1.74 (1H, ddd, J = 14.3, 5.6, 2.6 Hz, 
CH2-C7), 1.55−1.47 (1H, m, CH2-C7), 0.97 (3H, s, CH3-C9), 0.82 (9H, s, CH3-TBS), 
−0.02 (3H, s, CH3-TBS), −0.07 (3H, s, CH3-TBS); 
13C NMR (126 MHz, CDCl3) δ 205.9 
(C-C4), 143.9 (C-Ts), 139.6 (C-C5), 137.9 (CH-C10), 133.9 (CH-C13), 133.1 (C-Ts), 
129.8 (CH-Ts), 127.6 (CH-Ts), 117.8 (CH2-C14), 70.3 (CH-C11), 52.8 (CH2-C1), 
45.4 (CH2-C8), 45.2 (CH2-C3), 43.7 (CH-C6), 42.9 (CH2-C12), 36.6 (C-C2), 29.1 
(CH2-C7), 26.6 (CH3-C9), 25.7 (CH3-TBS), 21.6 (CH3-Ts), 18.1 (C-TBS), −4.3 (CH3-
TBS), −4.7 (CH3-TBS); HRMS (ESI) for C27H41NNaO4SSi [M+Na]
+ calcd. 526.2402, 
found 526.2418. 
Chapter 3: Experimental  204 
 
(4aR*,7aR*,E)-5-(2-Hydroxypent-4-enylidene)-7a-methyl-2-tosylhexahydro-
cyclopenta[c]pyridin-6-one 483 
 
  C21H27NO4S 
 
To a solution of the TBS ether 482 (20 mg, 40 µmol) in THF (10 mL) at 0 °C was 
added TBAF (80 µL, 1 M solution in THF, 80 µmol). The mixture was stirred at 
0 °C for 1 h and allowed to reach rt over 2 h. The reaction was quenched by 
addition of saturated aqueous NH4Cl (10 mL) and the aqueous phase was 
extracted with EtOAc (3 × 20 mL). The combined organic extracts were washed 
with brine (50 mL), dried over anhydrous sodium sulfate, filtered and 
concentrated in vacuo. Purification of the residue by flash column 
chromatography on silica gel (petroleum ether: EtOAc, 3:1 to 1:1) gave the title 
compound 483 (13 mg, 81%) as a colourless oil.  
 
Rf = 0.33 (petroleum ether: Et2O, 1:1); νmax (film) 3476 (br), 2955, 2924, 2857, 
1724, 1655, 1341, 1163, 1097, 933, 732 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.65 
(2H, d, J = 8.2 Hz, CH-Ts), 7.37 (2H, d, J = 8.2 Hz, CH-Ts), 6.47 (1H, dd, J = 7.3, 
1.4 Hz, CH-C10), 5.71 (1H, ddt, J = 18.7, 9.4, 7.2 Hz, CH-C13), 5.22−5.12 (2H, m, 
CH2-C14), 4.32 (1H, dd, J = 7.3, 5.3 Hz, CH-C11), 3.77 (1H, ddd, J = 11.3, 4.3, 
2.3 Hz, CH2-C8), 3.63 (1H, dd, J = 12.1, 1.5 Hz, CH2-C1), 2.83 (1H, d, J = 18.0 Hz, 
CH2-C3), 2.58 (1H, ddd, J = 11.9, 6.4, 1.4 Hz, CH-C6), 2.45 (3H, s, CH3-Ts), 
2.35−2.21 (3H, m, CH2-C12, CH2-C8), 2.18 (1H, d, J = 12.1 Hz, CH2-C1), 2.00 (1H, 
dd, J = 18.0, 1.5 Hz, CH2-C3), 1.87 (1H, ddd, J = 11.8, 6.4, 2.3 Hz, CH2-C7), 
1.57−1.46 (1H, m, CH2-C7), 0.93 (3H, s, CH3-C9); 
13C NMR (126 MHz, CDCl3) δ 
205.1 (C-C4), 143.8 (C-Ts), 141.6(C-C5), 135.9 (CH-C10), 135.7 (CH-C13), 132.9 
(C-Ts), 129.8 (CH-Ts), 127.7 (CH-Ts), 117.0 (CH2-C14), 68.8 (CH-C11), 52.8 (CH2-
C1), 45.5 (CH2-C8), 45.3 (CH2-C3), 43.7 (CH-C6), 41.9 (CH2-C12), 36.4 (C-C2), 
28.8 (CH2-C7), 26.5 (CH3-C9), 21.6 (CH3-Ts); HRMS (ESI) for C21H27NNaO4S [M+Na]
+ 
calcd. 412.1536, found 412.1553. 
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(4aR*,7aR*)-11-Allyl-7a-methyl-2-tosyl-3b,5,6,7,7a,8-hexahydro-furo 
[3',2':3,4]cyclopenta [1,2-c]pyridine 484 
 
  C21H25NO3S 
 
To a solution of the alcohol 483 (10 mg, 26 µmol) in toluene (3 mL) at rt was 
added p-toluenesulfonic acid monohydrate (0.5 mg, 3 µmol). The mixture was 
stirred vigorously at rt for 12 h. The reaction was quenched by addition of 
saturated aqueous Na2CO3 solution (10 mL) and the aqueous phase was extracted 
with EtOAc (3 × 10 mL). The combined organic extracts were washed with brine 
(20 mL), dried over anhydrous sodium sulfate, filtered and concentrated in 
vacuo. Purification of the residue by flash column chromatography on silica gel 
(petroleum ether: EtOAc 4:1 to 2:1) gave the title compound 484 (9.0 mg, 90%) 
as a pale yellow oil.  
 
Rf = 0.63 (petroleum ether: Et2O, 3:1); νmax (film) 2954, 2924, 2856, 1614, 1341, 
1163, 1097 cm―1; 1H NMR (500 MHz, CDCl3) δ 7.62 (2H, d, J = 8.2 Hz, CH-Ts), 
7.32 (2H, d, J = 8.2 Hz, CH-Ts), 5.89 (1H, ddt, J = 18.7, 9.4, 7.2 Hz, CH-C13), 
5.72 (1H, s, CH-C10), 5.14−5.07 (2H, m, CH2-C14), 3.29−3.17 (3H, m, CH2-C12, 
CH2-C8), 3.05 (1H, dd, J = 11.8, 1.4 Hz, CH2-C1), 2.68 (1H, d, J = 11.8 Hz, CH2-
C1), 2.64−2.55 (2H, m, CH2-C8, CH-C6), 2.46 (1H, dd, J = 15.2, 1.4 Hz, CH2-C3), 
2.35 (1H, d, J = 15.2 Hz, CH2-C3), 2.34 (3H, s, CH3-Ts), 1.95 (1H, ddd, J = 10.3, 
5.8, 2.9 Hz, CH2-C7), 1.68−1.61 (1H, m, CH2-C7), 1.26 (3H, s, CH3-C9); 
13C NMR 
(126 MHz, CDCl3) δ 157.2 (C-C4), 155.5 (C-C11), 143.2 (C-Ts), 134.3 (C-Ts), 134.1 
(CH-C13), 129.7 (CH-Ts), 127.4 (CH-Ts), 126.9 (C-C5), 116.8 (CH2-C14), 103.2 
(CH-C10), 53.4 (CH2-C1), 47.7 (C-C2), 43.0 (CH2-C8), 41.6 (CH-C6), 37.6 (CH2-C3), 
33.5 (CH2-C12), 25.9 (CH2-C7), 25.3 (CH3-C9), 21.5 (CH3-Ts); HRMS (ESI) for 
C21H25NNaO3S [M+Na]
+ calcd. 394.1429, found 394.1447.
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Appendices  
1H and 13C NMR Spectra of Selected Compounds 
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Empirical formula C23H30N2O3S 
Formula weight 414.55 
Temperature 150(2) K 
Wavelength 0.71073 
Crystal system Orthorhombic 
Space group P 21 21 21 
Unit cell dimension a = 12.6438(12) Å   α = 90 ° 
 b = 17.2238(18) Å   β = 90 ° 
 c = 29.188(3) Å       γ = 90 ° 
Volume 6356.4(11) Å3 
Z 12 
Density (calculated) 1.300 mg/m3 
Radiation type MoK\a 
Absorption coefficient 0.180 µ/mm 
F(000) 2664 
Crystal size 0.512 × 0.120 × 0.048 
θ range for data collection 1.373 to 25.070 ° 
Index ranges −15 ≤ h ≤ +15, −20 ≤ k ≤ +20, −34 ≤ l ≤ +34 
Number of reflections measured 74994 
Number of independent reflections 11253 
Rint 0.093 
Completeness to θ = 25.242 0.981 
Absorption correction type Multi-scan 
Max. and min. transmission 0.862 and 0.698 
Refinement method Full-matrix least-squares on F2 
Data / restraints/ parameters 11253 / 0 / 788 
Goodness-of-fit on F2 1.018 
Final R indices [I>2σ(I)] R1 = 0.0608, wR2 = 0.1060 
R indices (all data)  R1 = 0.0399, wR2 = 0.0938 
Largest diff. peak and hole 0.219 and −0.253 e.Å−3 
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Empirical formula C25H31F3N2O4S 
Formula weight 512.58 
Temperature 100(2) K 
Wavelength 0.71073 
Crystal system Orthorhombic 
Space group P 21 21 21 
Unit cell dimension a = 5.6601(7) Å  α = 90 ° 
 b = 16.842(2) Å  β = 90 ° 
 c = 25.809(3) Å  γ = 90 ° 
Volume 2460.3(5) Å3 
Z 4 
Density (calculated) 1.384 mg/m3 
Radiation type MoK\a 
Absorption coefficient 0.085 µ/mm 
F(000) 1080 
Crystal size 0.6 × 0.2 × 0.02 
θ range for data collection 2.54 to 25.05 ° 
Index ranges −6 ≤ h ≤ +6, −20 ≤ k ≤ +20, −30 ≤ l ≤ +30 
Number of reflections measured 22857 
Number of independent reflections 4295 
Rint 0.039 
Completeness to θ = 25.242 0.973 
Absorption correction type Multi-scan 
Max. and min. transmission 0.843 and 0.732 
Refinement method Full-matrix least-squares on F2 
Data / restraints/ parameters 4295 / 0 / 317 
Goodness-of-fit on F2 1.04 
Final R indices [I>2σ(I)] R1 = 0.0849, wR2 = 0.1446 
R indices (all data) R1 = 0.0554, wR2 = 0.1347 
Largest diff. peak and hole 0.635 and −0.460 e.Å−3 
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